Last updated: April 14, 2020
Steffanie Ann Strathdee
Curriculum Vitae sstrathdee@ucsd.edu
Business Address
University of California, San Diego, School of
Medicine
9500 Gilman Drive, La Jolla, CA 92093-0507
Phone: (858) 822-1952 Fax: (858) 534-4642
E DUCATION
1990
–1994
1988
–1990
1984
–1988
University of Toronto, Department of Preventive Medicine & Biostatistics
Doctor of Philosophy in Epidemiology
University of Toronto, Department of Preventive Medicine & Biostatistics
Master of Science in Epidemiology
University of Toronto, Faculty of Arts & Science
Honors Bachelor of Science Degree
Microbiology Specialist, Minor: English
P ROFESSIONAL E XPERIENCE
2015-present Adjunct Professor, School of Social Work, College of Health and Human Services, San
Diego State University
2008 –present Associate Dean of Global Health Sciences, University of California, San Diego
2008 –present Professor and Harold Simon Chair; Chief, Division of Global Public Health, Department of
2004 –2008
Medicine, University of California, San Diego
Professor and Harold Simon Chair; Chief, Division of International Health and Cross-
Cultural Medicine, Department of Family and Preventive Medicine, University of
California, San Diego
2004 –present Adjunct Professor, Department of Epidemiology, Johns Hopkins University, Bloomberg
1998
2002
1996
1997
1996
–2004
–2004
–1998
–1998
–1998
School of Public Health
Associate Professor, Department of Epidemiology, Johns Hopkins University, Bloomberg
School of Public Health
Joint Appointment, Department of International Health, Johns Hopkins University,
Bloomberg School of Public Health
Assistant Professor, Department of Health Care and Epidemiology, University of British
Columbia
Program Director, Division of Epidemiology and Population Health, British Columbia
Center for Excellence in HIV/AIDS
Project Manager, Vancouver Injection Drug Use Study, British Columbia Center for
1995
1993
1993
1991
1990
1987
1986
–1998
–1998
–1996
–1993
–1991
–1988
Excellence in HIV/AIDS
Project Manager, Vanguard Project, Department of Health Care and Epidemiology,
University of British Columbia
Project Manager, Vancouver Lymphadenopathy AIDS Study, Department of Health Care and Epidemiology, University of British Columbia
Research Associate, Department of Health Care and Epidemiology, University of British
Columbia
Research Consultant, Casey House AIDS Hospice, Toronto.
Research Assistant, Department of Preventive Medicine and Biostatistics, University of
Toronto
Research Assistant, Department of Microbiology, University of Toronto
Research Assistant, Department of Zoology, University of Toronto

P ROFESSIONAL A CTIVITIES
Memberships in Professional Societies
2010 –present Consortium of Universities in Global Health (CUGH)
2009 –present National Hispanic Science Network on Substance Abuse, Steering Committee member
2006 –present National Hispanic Science Network on Substance Abuse, member
2003 –present International Society on Urban Health
1999 –present International Harm Reduction Association
1999 –present Delta Omega Alpha, Honorary Society of Public Health
1999 –present College on Problem Drug Dependence
1999 –present American Public Health Association
1999 –present International AIDS Society
1997 –2000 Monitoring the AIDS Pandemic Network, UNAIDS & Family Health International
1996 –present Canadian Consortium on Characterizing Injection Drug Users in Canada, Founding member
1995 –present Society for Epidemiologic Research
1994 –1995
1993 –2001
Asia-Pacific Alliance against AIDS
Canadian Association for HIV Research
Academic Committees/University Service
2015-present UC-Mexico Initiative Health Working Group
2012
–present Member, International Education Committee
2012-present National Advisory Board, HIV/AIDS Mentoring Program, Wayne State University
2010 –present Graduate Programs Educational Committee, UC San Diego
2010
–present
Advisory Committee, Center for Iberian and Latin American Studies, UC San Diego
2010 –2011 Member, UCSD Senate-Administration Task Force, UC San Diego’s Sustainability 2.0
Initiative
2009 –2012 Co-director, UC Center of Expertise on Migration and Health
2009 –present Leadership Committee, UC Global Health Institute
2009
2009
UC-wide ad hoc Task Force for Pandemic Preparedness
UC-wide ad hoc Task Force on Global Health
2008 Reviewer - Hartwell Foundation
2008 –present Co-Chair, Annual CFAR research day
2008 Co-Chair, UC-wide Workshop on Pandemic Infectious Diseases, Oct 8, 2008
2008 –present Member, UC San Diego School of Medicine, Executive Research Council
2007 –2009 All Campus Planning Committee for Development of University-wide School of Global
2007 – 2008
Health, (Academic Senate Representative, Co-Chair, Governance Sub-Committee
Joint Review Committee, Institute for International, Comparative and Area Studies, the
Center for Comparative Immigration Studies and the Center for Iberian and Latin
American Studies
2007 –present Director, NIDA Training Program in Substance Abuse, HIV and Related Infections
2007 –2008 Chair, Department of Family & Preventive Medicine, Sub-committee on Graduate
Student Funding
2006 –present Co-director and Steering Committee Member, UCSD/SDSU Joint Doctoral Program in
Global Health
2006 –present Co-director, International Program, UCSD Center for AIDS Research
2006 –present Faculty Affiliate, Center for Iberian and Latin American Studies
2005 –2009 Faculty Senate, Department of Family and Preventive Medicine, UCSD
2005 –2007 Institute for International, Comparative and Area Studies, Advisory group member
2005 –2006 Scripps/UCSD Environmental Sustainability Working Group, SOM representative
2004 Moderator, Visit of Dr. Gro Brundtland to UCSD, former Director General of WHO
2

2002
2002
2001
2001
–2003
–2003
–2003
Chair, Faculty Advisory Committee, Department of Epidemiology, Johns Hopkins
Bloomberg School of Public Health
DrPH Review Committee, Johns Hopkins Bloomberg School of Public Health
Appointment and Promotions Committee, Ad hoc Committee, Johns Hopkins Bloomberg
School of Public Health
Curriculum Committee, Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health
Academic Calendar Catalog Subcommittee, Johns Hopkins Bloomberg School of Public 2000 –2003
1999 –2003
1997 –1998
Health
Academic Standards Committee, Johns Hopkins Bloomberg School of Public Health
Thesis Screening Panel, University of British Columbia
Professional Service and Experience
2015-present Scientific Network Member, United Nations Office on Drugs and Crime
2015-present U.S.México Border Health Commission Border Health Research Committee
2015-present Member, National Institute on Drug Abuse Council
2014-present Member, Coordinating Group Implementing Programmes for HIV and STI Prevention for
People who Inject Drugs, UNAIDS and UNDP
2014 Member, Working Group on HIV/AIDS and Drug Use, United Nations Office on Drug
Control Policy
2013-present International AIDS Conference Coordinating Committee (IAS 2015)
2013-present Co-Chair, HIV Treatment as Prevention Workshop
2012 –2013 Program Advisory Committee, 4 th Annual Conference of the Consortium of Universities for Global Health (CUGH)
2012 –present Member, UNAIDS Advisory Group for the Strategic Support of HIV Treatment as
Prevention
2011 –present Co-chair, Substance Use Working Group, HIV Prevention Trials Network
2011 –2013 Member, Global HIV Prevention Working Group
2011
2010-2012
Co-Chair, US Centers for Disease Control and Prevention Conference
Reviewer, NIDA-International AIDS society fellowship program
2010
2008 –2009
Steering Committee Member, William and Flora Hewlett Foundation
Global Burden of Diseases, Injuries and Risk Factors Study, Expert Group
Corresponding Member, Hepatitis Expert Group, Communicable Diseases Cluster
2008
–2011
NIDA Networking Project, Member
2007 –2008 Program Committee (Epidemiology and Public Health), XVI International Conference on
2006
2005
–2010
2004 –2009
HIV/AIDS, Mexico City
Rapporteur, International Harm Reduction Association, Annual Conference
Member, Community Epidemiology Work Group, National Institute on Drug Abuse
Scientific Advisory Board Member, HIV Neurobehavioral Research Center, UCSD
2004 Oversight Committee Member, Pediatric Adolescent Clinical Trials Group
2003 –present Consultant, Office on AIDS Research, HIV Natural History Working Group, Advisory
Committee to The White House
2003 –present Substance Use Working Group, HIV Prevention Trials Network
2002 –2013 Member, United Nations Reference Group on HIV Prevention among Injection Drug
2001
Users
Consultant, Office on AIDS Research, HIV Natural History Working Group, Advisory
2001
2001
–2003
–2007
Committee to The White House, Chair, Substance Abuse and HIV/AIDS Sub-committee
Member, National Advisory Board, Institute of Infection and Immunity, Canadian Institute of Health Research
Member, National Advisory Board, Committee on Hepatitis C and HIV/AIDS, Canadian
2001 –2006
Institutes for Health Research
Consultant, Office on AIDS Research, HIV Prevention Science Working Group, Advisory
Committee to the White House
3

2001
2000
1999
1998
1998
1998
–2008
Rapporteur, Annual Meeting of the Canadian Association for HIV Research,
Epidemiology and Public Health, May 25-29
Program Committee Member, International Harm Reduction Association Annual Meeting
U.S. Senate Staff Briefing. Research Studies on Needle Exchange Program
Effectiveness. March 30
U.S. Senate Staff Briefing. Research on HIV Incidence among Needle Exchange
Program Attendees in Vancouver, Canada: Policy Implications for the United States. July
21, Washington DC
Rapporteur Assistant, 12th International Conference on AIDS, Geneva, July 1-6
Co-chair, Epidemiology and Public Health Track, Canadian Conference on AIDS/HIV
Research, 7 th Annual Conference.
1998
1997
1997
Steering Committee, 2nd Annual Conference, British Columbia First Nations AIDS
Society
Rapporteur, Northwest Regional Workshop on HIV Prevention for Alcohol and Drug Use among Men who have Sex with Men, Seattle, Washington, September 3-5
Co-chair, Epidemiology and Public Health Track, Canadian Association for HIV
Research 6 th Annual Conference, Ottawa, May 22-25
1996
1997
1995
1995
1994
Rapporteur Assistant, XI International Conference on AIDS, Vancouver, July 7-12
Moderator, XI International Conference on AIDS, Vancouver, July 7-12
Temporary Advisor, World Health Organization, May 11-15
Member, British Columbia Task Force into Illicit Narcotic Deaths
Member, AIDS Treatment Information System, Member, National Consultation
Committee, Canada
Grant Review Panels
2012
2008 –2010
Reviewer, World Health Organization – Guidelines for the Prevention of Hepatitis B and
C among Injection Drug Users
Chair, National Institute of Health Review Panel (Behavioral and Social Consequences of HIV/AIDS) (chartered)
2008
2006 –2007
Chair, National Institute of Health Review Panel, Ad hoc panel, ACE study section
Study Section Member, National Institute of Health Review Panel (Behavioral and Social
2004 –2009
2004
2002
2001
–2007
Consequences of HIV/AIDS) (chartered)
Chair, Scientific Review Committee, Ontario HIV Treatment Network, Canada
Review Committee Member, Tides Foundation, Fund for Drug Policy Reform
Chair, Special Emphasis Panel, National Institute of Health (ARR-6)
Chair, Special Emphasis Panel, International Studies of HIV among Injecting drug users, National Institute of Health
2000
–present
Ad hoc Study Section Member, National Institute on Drug Abuse, National Institute of
Health, ARR-7, ARR-8
2000 –2003
1999 –2003
Reviewer, Canadian Institutes for Health Research
Study Section Member (chartered), National Institute on Drug Abuse, National Institute of
1998 –2002
1996 –2001
Health, ARR-6
Scientific Review Committee, Ontario HIV Treatment Network, Toronto, Ontario, Canada
Reviewer, Canadian Foundation for AIDS Research
Reviewer/Editorial Board
2013-2014 Guest Editor, Lancet, Special issue on HIV among Sex Workers
2012 –present Academic Editor, PeerJ
2013-present Academic Editor, PLoS Medicine
2011 and 2014 Reviewer/Interviewer , NIH Director’s ‘Pathways to Independence’ Awards
2009-2010
2007
2007 –2008
Guest Editor, Lancet, Special issue on HIV among People who Inject Drugs
Reviewer, Institute of Medicine, Report on ‘Methodologic Challenges of Preventive HIV
Interventions’
Guest Editor, AIDS Journal (special issue, 08/08)
4

2007 –present Editorial Board, AIDS Care Journal
2005 –present Associate Editor, Drug and Alcohol Dependence
2005 –2010 Editorial Board, AIDS Journal
2004 –present Editorial Board, Drug and Alcohol Dependence
2004 –present Reviewer, Social Science and Medicine
2004 –present Reviewer, American Journal of Preventive Medicine
2003 Guest Editor, International Journal of Drug Policy, special issue on Needle Exchange
Programs
2003 –present Editorial Board, Harm Reduction Journal
2006-present Editorial Board, International Journal of Drug Policy
2001 –2006
2003
Assistant Editor (Americas), International Journal of Drug Policy
Guest Editor, International Journal of Drug Policy, special issue on International Studies on HIV and Drug Abuse
2002 –present Reviewer, Evaluation and Program Planning
2001 –present Reviewer, American Journal of Epidemiology
2000 –present Reviewer, International AIDS Society, Tracks C, D and E
2000 –present Reviewer, American Journal of Public Health
2000 –present Reviewer, Clinical Infectious Diseases
2000 –present Reviewer, Annals of Epidemiology
1999 –present International Harm Reduction Association, International Review Committee
1999 –present Reviewer, Drug and Alcohol Dependence
1999 –present Reviewer, Journal of American Medical Association
1999 –present Reviewer, AIDS and Behavior
1998 –present Reviewer, Epidemiology
1998 –present Reviewer, Journal of AIDS
1998 –present Reviewer, American Journal of Drug and Alcohol Dependence
1998 –present Reviewer, Culture, Health and Sexuality
1998 –2003 Reviewer, Journal of Parasitology
1998 –1999
1998 –2000
Reviewer, Medical Research Council, Health Canada
Reviewer, National Health Research Development Program, Health Canada
1996 –present Reviewer, Journal of Acquired Immune Deficiency Syndrome
1996 –present Reviewer, Journal of Infectious Diseases
1994 –present Reviewer, Canadian Medical Association Journal
Other Public and Professional Service
2007
–present
Scientific Advisor, Prevencasa, A.C., Tijuana, Mexico
2011 –present External Advisory Board, University of Washington Center for AIDS Research
2006
–2010
External Advisory Board, Emory University Center for AIDS Research
2003 –2007 Board of Directors, Hepatitis Foundation International
2002 –2005 External Advisory Committee, University of Miami Drug Abuse and AIDS Research
Center
Scientific Advisory Committee, Female Microbicide Project, Laval University, Quebec 2002
2002
2001 –2004
2001 –2003
1997 –1998
1995 –1998
1995 –1998
Spokesperson, United Way, Baltimore (Substance Use Awareness Campaign)
Advisory Board Member, Hepatitis Foundation International
Scientific Advisory Panel, Community AIDS Treatment Information Exchange
Provincial Advisory Committee on HIV/AIDS, British Columbia Ministry of Health
Research Consultant, Health Research Support Unit, St. Paul’s Hospital, Vancouver
Community Research Advisory Committee, British Columbia Center for Excellence in
HIV/AIDS
1995
1995
1994
1994
Member, British Columbia Needle Exchange Advisory Group
Member, St. Paul’s Hospital Harm Reduction Committee and Needle Exchange
Evaluation Group
Advisory Committee, Progressive AIDS Research and Information Society, Vancouver
Working Group, Positive Women’s Network, Vancouver
5

1994 –1998
1994 –1996
1991 –1993
1988 –1991
1989 –1991
1987 –1988
Advisory Board, YouthCo AIDS Society, Vancouver
Scientific Review Committee, Oak Tree Women and Family HIV Clinic, Vancouver
Scientific Advisory Committee, Community AIDS Treatment Information Exchange
Volunteer, Casey House AIDS Hospice, Toronto
President, Research Association of Toronto Epidemiology Students, University of
Toronto, Toronto
Vice President, Microbiology Undergraduate Students Association, University of Toronto,
Toronto
H ONORS AND A WARDS
Awards for Scholarship and Merit
2014
2014
2013
2012
2012
2010-2020
2010
2010
2009
2009
2008
2007
1999
1997 –2003
1995 –1997
1997
1996
1994
1993
1991 –1993
1989 –1990
Personal profile in Lancet , July 22, 2014
Honoree, “My Sister’s Voice” (photo-exhibit, 40 women making a difference in the world)
Mentoring Award, National Hispanic Science Network
Garnett-
Powers & Associates “What Powers You” Excellence in Postdoctoral Scholar
Mentoring Award, UC San Diego
UC San Diego, Campus Diversity Award, Division of Global Public Health
NIDA MERI T “Method to Extend Research in Time” Award for Outstanding Researchers
(2010-2020)
POZ Magazine –“Top 100 in the Fight Against AIDS”
Women Who Mean Business Award, San Diego Women in Business Journal
Award for Leadership in International Collaboration, National Institute on Drug Abuse
Nominee, San Diego Health Care Champion
National Institute on Drug Abuse, International Leadership Award (nominee)
Accol-AIDS, Award for Best Science/Research Project in Vancouver (awarded to the
Vancouver Injection Drug User Study; Strathdee- Founding PI)
Delta Omega Honorary Society in Public Health
National Health Research Developmental Program, Health Canada National Health
Scholar Award (1998-2003 deferred upon recruitment to Johns Hopkins)
National Health Research Developmental Program, Health Canada Post-Doctoral
Fellowship
Dean’s Award, Faculty of Medicine, University of British Columbia
11th International Conference on AIDS Young Investigators Award (International, highest scoring abstract, Epidemiology and Public Health)
Canadian Association for HIV Research, Young Investigators Award in HIV/AIDS
Research (National, highest scoring abstract, Epidemiology and Public Health)
Department of Preventive Medicine & Biostatistics, University of Toronto, Randall Coates
Epidemiology Prize (Infectious Disease Epidemiology)
National Health Research Developmental Program, Health and Welfare Canada, PhD
Training Fellowship
National Health Research Developmental Program, Health and Welfare Canada, MSc
Training Fellowship
P UBLICATIONS
Peer-reviewed Publications (Total: 518)
1. Sukhdeo MV, Strathdee SA (nee Keith) , Mettrick DF. The effects of bile on the locomotory cycle of
Fasciola hepatica. J Parasitol. 1988;74(3):493-495. PMID: 3379530.
2. Murrant G, Strathdee SA. AIDS, hospice and volunteers. the Casey House volunteer program. a case study. J Volunt Adm. 1992;10(4):11-17. PMID: 10122388.
3. Hanvelt RA, Ruedy NS, Hogg RS, Strathdee SA, Montaner JS, O'Shaughnessy MV, Schechter MT.
Indirect costs of HIV/AIDS mortality in Canada. AIDS. 1994;8(10):F7-11. PMID: 7818806.
6

4. Hogg RS, Strathdee SA, Craib KJ, O'Shaughnessy MV, Montaner JS, Schechter MT. Lower socioeconomic status and shorter survival following HIV infection. Lancet. 1994;344(8930):1120-
1124. PMID: 7934494.
5. Montaner JS, Le T, Hogg R, Ricketts M, Sutherland D, Strathdee SA, O'Shaughnessy M, Schechter
MT. The changing spectrum of AIDS index diseases in Canada. AIDS. 1994;8(5):693-696. PMID:
8060550.
6. Strathdee SA, Flannery J, Graydon D. Stressors in the AIDS hospice environment. Aids Patient
Care. 1994;8(2):82-89.
7. Strathdee SA, Schechter MT, Hogg RS, O'Shaughnessy MV. Trends in the epidemiology of
HIV/AIDS in British Columbia. B C Med J. 1994;36(2):98-114.
8. Veugelers PJ, Strathdee SA, Tindall B, Page KA, Moss AR, Schechter MT, Montaner JS, van
Griensven GJ. Increasing age is associated with faster progression to neoplasms but not opportunistic infections in HIV-infected homosexual men. AIDS. 1994;8(10):1471-1475. PMID:
7818819.
9. Craib KJ, Meddings DR, Strathdee SA, Hogg RS, Montaner JS, O'Shaughnessy MV, Schechter MT.
Rectal gonorrhoea as an independent risk factor for HIV infection in a cohort of homosexual men.
Genitourin Med. 1995;71(3):150-154. PMCID: PMC1195487.
10. Hogg RS, Schechter MT, Schilder A, Le R, Strathdee SA, Goldstone IL, O'Shaughnessy MV. Access to health care and geographic mobility of HIV/AIDS patients. AIDS Patient Care. 1995;9(6):297-302.
PMID: 11361439.
11. Millson P, Myers T, Rankin J, McLaughlin B, Major C, Mindell W, Coates R, Rigby J, Strathdee SA.
Prevalence of human immunodeficiency virus and associated risk behavior in injection drug users in
Toronto. Can J Public Health. 1995;86(3):176-180. PMID: 7671202.
12. Murrant G, Strathdee SA. Motivations for service volunteer involvement at Casey House AIDS
Hospice. Hosp J. 1995;10(3):27-38. PMID: 8606049.
13. Myers T, Millson M, Rigby J, Ennis M, Rankin J, Mindell W, Strathdee SA. A comparison of the determinants of safe injecting and condom use among injecting drug users. Addiction.
1995;90(2):217-226. PMID: 7703815.
14. Sherlock CH, Strathdee SA, Le T, Sutherland D, O'Shaughnessy MV, Schechter MT. Use of pooling and outpatient laboratory specimens in an anonymous seroprevalence survey of HIV infection in
British Columbia, Canada. AIDS. 1995;9(8):945-950. PMID: 7576331.
15. Strathdee SA, Frank JW, McLaughlin J, Leblanc M, Major C, O'Shaughnessy MV, Read SE.
Quantitative measures of human immunodeficiency virus-specific antibodies predict progression to
AIDS. J Infect Dis. 1995;172(5):1375-1379. PMID: 7594682.
16. Strathdee SA, Hogg RS, Schechter MT. Current trends in the epidemiology of HIV/AIDS in British
Columbia. B C Med J. 1995;37(10):702-704.
17. Strathdee SA, Schechter MT. The epidemiology of AIDS in Canada: 1995. Int Arch Allergy Immunol.
1995;10(5):172-178.
18. Veugelers PJ, Strathdee SA, Moss AR, Page KA, Tindall B, Schechter MT, Coutinho RA, van
Griensven GJ. Is the human immunodeficiency virus-related Kaposi's sarcoma epidemic coming to an end? Insights from the Tricontinental Seroconverter Study. Epidemiology. 1995;6(4):382-386.
PMID: 7548345.
19. Coutinho RA, Prins M, Spijkerman IJ, Geskus RB, Keet RP, Fennema HS, Strathdee SA. Summary of track C: epidemiology and public health. AIDS. 1996;10 Suppl 3:S115-121. PMID: 8970718.
20. Hogg RS, Heath KV, Strathdee SA, Montaner JS, O'Shaughnessy MV, Schechter MT. HIV/AIDS mortality in Canada: evidence of gender, regional and local area differentials. AIDS. 1996;10(8):889-
894. PMID: 8828746.
21. Strathdee SA, Hogg RS, O'Shaughnessy MV, Montaner JS, Schechter MT. A decade of research on the natural history of HIV infection: Part 2. Cofactors. Clin Invest Med. 1996;19(2):121-130. PMID:
8697671.
22. Strathdee SA, O'Shaughnessy MV, Montaner JS, Schechter MT. A decade of research on the natural history of HIV infection: Part 1. Markers. Clin Invest Med. 1996;19(2):111-120. PMID:
8697670.
23. Strathdee SA, Veugelers PJ, Moore PS. The epidemiology of HIV-associated Kaposi's sarcoma: the unraveling mystery. AIDS. 1996;10 Suppl A:S51-57. PMID: 8883610.
7

24. Strathdee SA, Veugelers PJ, Page-Shafer KA, McNulty A, Moss AR, Schechter MT, van Griensven
GJ, Coutinho RA. Lack of consistency between five definitions of nonprogression in cohorts of HIVinfected seroconverters. AIDS. 1996;10(9):959-965. PMID: 8853728.
25. Craib KJ, Strathdee SA, Hogg RS, Leung B, Montaner JS, O'Shaughnessy MV, Schechter MT.
Serum levels of human immunodeficiency virus type 1 (HIV-1) RNA after seroconversion: a predictor of long-term mortality in HIV infection. J Infect Dis. 1997;176(3):798-800. PMID: 9291337.
26. Hogg RS, Strathdee SA, Craib KJ, O'Shaughnessy MV, Montaner JS, Schechter MT. Modeling the impact of HIV disease on mortality in gay and bisexual men. Int J Epidemiol. 1997;26(3):657-661.
PMID: 9222793.
27. Jackson LA, Millson P, Calzavara L, Rachlis A, Rowe C, Strathdee SA, Wagner C, Walmsley S. HIVpositive women living in the metropolitan Toronto area: their experiences and perceptions related to
HIV testing. the HIV Women's Study Group. Can J Public Health. 1997;88(1):18-22. PMID: 9094799.
28. Page-Shafer K, Veugelers PJ, Moss AR, Strathdee SA, Kaldor JM, van Griensven GJ. Sexual risk behavior and risk factors for HIV-1 seroconversion in homosexual men participating in the
Tricontinental Seroconverter Study, 1982-1994. Am J Epidemiol. 1997;146(7):531-542. PMID:
9326430.
29. Patrick DM, Strathdee SA, Archibald CP, Ofner M, Craib KJ, Cornelisse PG, Schechter MT, Rekart
ML, O'Shaughnessy MV. Determinants of HIV seroconversion in injection drug users during a period of rising prevalence in Vancouver. Int J STD AIDS. 1997;8(7):437-445. PMID: 9228591.
30. Rothon DA, Strathdee SA, Cook D, Cornelisse PG. Determinants of HIV-related high risk behaviors among young offenders: a window of opportunity. Can J Public Health. 1997;88(1):14-17. PMID:
9094798.
31. Strathdee SA, Patrick DM. Escalating rates of HIV infection among injection drug users in British
Columbia: the role of physicians. B C Med J. 1997;39(9):483-485.
32. Strathdee SA, Patrick DM, Archibald CP, Ofner M, Cornelisse PG, Rekart M, Schechter MT,
O'Shaughnessy MV. Social determinants predict needle-sharing behavior among injection drug users in Vancouver, Canada. Addiction. 1997;92(10):1339-1347. PMID: 9489050.
33. Strathdee SA, Patrick DM, Currie SL, Cornelisse PG, Rekart ML, Montaner JS, Schechter MT,
O'Shaughnessy MV. Needle exchange is not enough: lessons from the Vancouver injecting drug use study. AIDS. 1997;11(8):F59-65. PMID: 9223727.
34. Strathdee SA, Schechter MT. One step forward, two steps back. CMAJ. 1997;157(12):1699-1700.
PMCID: PMC1228651.
35. Veugelers PJ, Kaldor JM, Strathdee SA, Page-Shafer KA, Schechter MT, Coutinho RA, Keet IP, van
Griensven GJ. Incidence and prognostic significance of symptomatic primary human immunodeficiency virus type 1 infection in homosexual men. J Infect Dis. 1997;176(1):112-117.
PMID: 9207356.
36. Veugelers PJ, Strathdee SA, Kaldor JM, Shafer KA, Moss AR, Schechter MT, Schellekens PT,
Coutinho RA, van Griensven GJ. Associations of age, immunosuppression, and AIDS among homosexual men in the Tricontinental Seroconverter Study. J Acquir Immune Defic Syndr Hum
Retrovirol. 1997;14(5):435-441. PMID: 9170418.
37. Archibald CP, Ofner M, Strathdee SA, Patrick DM, Sutherland D, Rekart ML, Schechter MT,
O'Shaughnessy MV. Factors associated with frequent needle exchange program attendance in injection drug users in Vancouver, Canada. J Acquir Immune Defic Syndr Hum Retrovirol.
1998;17(2):160-166. PMID: 9473018.
38. *Harvey E, Strathdee SA, Patrick DM, Ofner M, Archibald CP, Eades G, O'Shaughnessy MV. A qualitative investigation into an HIV outbreak among injection drug users in Vancouver, British
Columbia. AIDS Care. 1998;10(3):313-321. PMID: 9828974.
39. Strathdee SA, Hogg RS, Martindale SL, Cornelisse PG, Craib KJ, Montaner JS, O'Shaughnessy MV,
Schechter MT. Determinants of sexual risk-taking among young HIV-negative gay and bisexual men.
J Acquir Immune Defic Syndr Hum Retrovirol. 1998;19(1):61-66. PMID: 9732071.
40. Strathdee SA, Palepu A, Cornelisse PG, Yip B, O'Shaughnessy MV, Montaner JS, Schechter MT,
Hogg RS. Barriers to use of free antiretroviral therapy in injection drug users. JAMA.
1998;280(6):547-549. PMID: 9707146.
41. Strathdee SA, van Ameijden EJ, Mesquita F, Wodak A, Rana S, Vlahov D. Can HIV epidemics among injection drug users be prevented? AIDS. 1998;12 Suppl A:S71-79. PMID: 9632987.
8

42. van Benthem BH, Veugelers PJ, Cornelisse PG, Strathdee SA, Kaldor JM, Shafer KA, Coutinho RA, van Griensven GJ. Is AIDS a floating point between HIV seroconversion and death? Insights from the Tricontinental Seroconverter Study. AIDS. 1998;12(9):1039-1045. PMID: 9662201.
43. Veugelers PJ, Cornelisse PG, Craib KJ, Marion SA, Hogg RS, Strathdee SA, Montaner JS,
O'Shaughnessy MV, Schechter MT. Models of survival in HIV infection and their use in the quantification of treatment benefits. Am J Epidemiol. 1998;148(5):487-496. PMID: 9737561.
44. Alexander CS, Dong W, Schechter MT, O'Shaughnessy MV, Strathdee SA, Mo T, Montaner JS,
Harrigan PR. Prevalence of primary HIV drug resistance among seroconverters during an explosive outbreak of HIV infection among injecting drug users. AIDS. 1999;13(8):981-985. PMID: 10371180.
45. Bastos FI, Strathdee SA, Derrico M, Pina MD. Drug use and the spread of HIV/AIDS in South
America and the Caribbean. Drugs (Abingdon Engl). 1999;6(1):29-49.
46. FitzGerald JM, Patrick DM, Strathdee SA, Rekart M, Elwood RK, Schecter MT, Montaner J,
O'Shaughnessy M. Use of incentives to increase compliance for TB screening in a population of intravenous drug users. Vancouver Injection Drug Use Study Group. Int J Tuberc Lung Dis.
1999;3(2):153-155. PMID: 10091882.
47. Heath KV, Cornelisse PG, Strathdee SA, Palepu A, Miller ML, Schechter MT, O'Shaughnessy MV,
Hogg RS. HIV-associated risk factors among young Canadian Aboriginal and non-Aboriginal men who have sex with men. Int J STD AIDS. 1999;10(9):582-587. PMID: 10492424.
48. Palepu A, Strathdee SA, Hogg RS, Anis AH, Rae S, *Cornelisse PGA, Patrick DM, O'Shaughnessy
MV, Schechter MT. The social determinants of emergency department and hospital use by injection drug users in Canada. J Urban Health. 1999;76(4):409-418. PMID: 10609591.
49. Patrick DM, Rekart ML, Cook D, Strathdee SA, Spencer D, Rees AD. Non-nominal HIV surveillance: preserving privacy while tracking an epidemic. Can J Public Health. 1999;90(3):164-167. PMID:
10401165.
50. Schechter MT, Strathdee SA, Cornelisse PG, Currie S, Patrick DM, Rekart ML, O'Shaughnessy MV.
Do needle exchange programmes increase the spread of HIV among injection drug users? an investigation of the Vancouver outbreak. AIDS. 1999;13(6):F45-51. PMID: 10397556.
51. Schilder AJ, Kennedy C, Strathdee SA, Goldstone I L, Hogg RS, O'Shaughnessy MV. ‘A lot of things I hide:’ understanding disclosure in the care of HIV-positive bisexual men. J Gay Lesbian Med Assoc.
1999;3(4):119-125.
52. Strathdee SA, Celentano DD, Shah N, Lyles C, Stambolis VA, Macalino G, Nelson K, Vlahov D.
Needle-exchange attendance and health care utilization promote entry into detoxification. J Urban
Health. 1999;76(4):448-460. PMID: 10609594.
53. Bastos FI, Strathdee SA. Evaluating effectiveness of syringe exchange programmes: current issues and future prospects. Soc Sci Med. 2000;51(12):1771-1782. PMID: 11128265.
54. *Brahmbhatt H, Bigg D, Strathdee SA. Characteristics and utilization patterns of needle-exchange attendees in Chicago: 1994-1998. J Urban Health. 2000;77(3):346-358. PMID: 10976609.
55. Craib KJ, Weber AC, Cornelisse PG, Martindale SL, Miller ML, Schechter MT, Strathdee SA,
Schilder A, Hogg RS. Comparison of sexual behaviors, unprotected sex, and substance use between two independent cohorts of gay and bisexual men. AIDS. 2000;14(3):303-311. PMID:
10716507.
56. Jackson LA, Millson M, Calzavara L, Strathdee SA, Walmsley S, Rachlis A, Rowe C, Wagner C.
Community HIV prevention efforts: what can we learn from the experiences and perceptions of HIVpositive women in metropolitan Toronto? Int Quart Comm Health Education. 2000;18(3):307-330.
57. *Marx MA, Crape B, Brookmeyer RS, Junge B, Latkin C, Vlahov D, Strathdee SA. Trends in crime and the introduction of a needle exchange program. Am J Public Health. 2000;90(12):1933-1936.
PMCID: PMC1446444.
58. *Mehta SH, Brancati FL, Sulkowski MS, Strathdee SA, Szklo M, Thomas DL. Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States. Ann Intern
Med. 2000;133(8):592-599. PMID: 11033586.
59. Riley ED, Safaeian M, Strathdee SA, *Marx MA, Huettner S, Beilenson P, Vlahov D. Comparing new participants of a mobile versus a pharmacy-based needle exchange program. J Acquir Immune Defic
Syndr. 2000;24(1):57-61. PMID: 10877496.
9

60. Shah NG, Celentano DD, Vlahov D, Stambolis V, Johnson L, Nelson KE, Strathdee SA. Correlates of enrollment in methadone maintenance treatment programs differ by HIV-serostatus. AIDS.
2000;14(13):2035-2043. PMID: 10997409.
61. *Shrestha S, Strathdee SA, *Brahmbhatt H, Farzadegan H, Vlahov D, Smith MW. Short tandem repeat methodology for genotypic identification of single-person versus multi-person use of syringes.
AIDS. 2000;14(11):1507-1513. PMID: 10983637.
62. Song JY, Safaeian M, Strathdee SA, Vlahov D, Celentano DD. The prevalence of homelessness among injection drug users with and without HIV infection. J Urban Health. 2000;77(4):678-687.
PMID: 11194310.
63. Strathdee SA, Hogg RS, *Cornelisse PGA, Martindale SL, Currie SL, O'Shaughnessy MV, Schechter
MT. Factors associated with willingness to participate in HIV vaccine trials among HIV-negative injection drug users and young gay and bisexual men. AIDS Behav. 2000;4(3):271-278.
64. Strathdee SA, Martindale SL, Cornelisse PG, Miller ML, Craib KJ, Schechter MT, O'Shaughnessy
MV, Hogg RS. HIV infection and risk behaviors among young gay and bisexual men in Vancouver.
CMAJ. 2000;162(1):21-25. PMCID: PMC1232225.
65. Thomas DL, Astemborski J, Rai RM, Anania FA, Schaeffer M, Galai N, Nolt K, Nelson KE, Strathdee
SA, Johnson L, Laeyendecker O, Boitnott J, Wilson LE, Vlahov D. The natural history of hepatitis C virus infection: host, viral, and environmental factors. JAMA. 2000;284(4):450-456. PMID: 10904508.
66. Thomas DL, Astemborski J, Vlahov D, Strathdee SA, Ray SC, Nelson KE, Galai N, Nolt KR,
Laeyendecker O, Todd JA. Determinants of the quantity of hepatitis C virus RNA. J Infect Dis.
2000;181(3):844-851. PMID: 10720503.
67. Thomas DL, Strathdee SA, Vlahov D. Long-term Prognosis of Hepatitis C Virus Infection. JAMA.
2000;284(20):2592. PMID: 11086358.
68. Celentano DD, Galai N, Sethi AK, Shah NG, Strathdee SA, Vlahov D, Gallant JE. Time to initiating highly active antiretroviral therapy among HIV-infected injection drug users. AIDS. 2001;15(13):1707-
1715. PMID: 11546947.
69. Fuller CM, Vlahov D, Arria AM, Ompad DC, Garfein R, Strathdee SA. Factors associated with adolescent initiation of injection drug use. Public Health Rep. 2001;116 Suppl 1:136-145. PMCID:
PMC1913680.
70. Jacobson LP, Gore ME, Strathdee SA, Phair JP, Riddler S, Detels R. Therapy naivete in the era of potent antiretroviral therapy. J Clin Epidemiol. 2001;54(2):149-156. PMID: 11166530.
71. Kleeberger CA, Phair JP, Strathdee SA, Detels R, Kingsley L, Jacobson LP. Determinants of heterogeneous adherence to HIV-antiretroviral therapies in the Multicenter AIDS Cohort Study. J
Acquir Immune Defic Syndr. 2001;26(1):82-92. PMID: 11176272.
72. Mao Q, Ray SC, Laeyendecker O, Ticehurst JR, Strathdee SA, Vlahov D, Thomas DL. Human immunodeficiency virus seroconversion and evolution of the hepatitis C virus quasispecies. J Virol.
2001;75(7):3259-3267. PMCID: PMC114119.
73. *Marx MA, *Brahmbhatt H, Beilenson P, Brookmeyer RS, Strathdee SA, Alexander CS, Vlahov D.
Impact of needle exchange programs on adolescent perceptions about illicit drug use. AIDS Behav.
2001;5(4):379-386.
74. *Mehta SH, Strathdee SA, Thomas DL. Association between hepatitis C virus infection and diabetes mellitus. Epidemiol Rev. 2001;23(2):302-312. PMID: 12192739.
75. Palepu A, Yip B, Miller C, Strathdee SA, O'Shaughnessy MV, Montaner JS, Hogg RS. Factors associated with the response to antiretroviral therapy among HIV-infected patients with and without a history of injection drug use. AIDS. 2001;15(3):423-424. PMID: 11273228.
76. Patrick DM, Tyndall MW, Cornelisse PG, Li K, Sherlock CH, Rekart ML, Strathdee SA, Currie SL,
Schechter MT, O'Shaughnessy MV. Incidence of hepatitis C virus infection among injection drug users during an outbreak of HIV infection. CMAJ. 2001;165(7):889-895. PMCID: PMC81496.
77. Piaseczna MA, Craib KJ, Li K, Chan K, Weber AE, Strathdee SA, Martindale S, Schechter MT, Hogg
RS. Longitudinal patterns of sexual behavior and condom use in a cohort of HIV-negative gay and bisexual men in Vancouver, British Columbia, Canada, 1995-2000. J Acquir Immune Defic Syndr.
2001;28(2):187-193. PMID: 11588514.
78. Riley ED, Chaisson RE, Robnett TJ, Vertefeuille J, Strathdee SA, Vlahov D. Use of audio computerassisted self-interviews to assess tuberculosis-related risk behaviors. Am J Respir Crit Care Med.
2001;164(1):82-85. PMID: 11435243.
10

79. Schroeder JR, Latkin CA, Hoover DR, Knowlton AR, Zenilman J, Strathdee SA, Celentano DD.
Social factors related to antiretroviral therapy use in injection drug users. AIDS Behav.
2001;5(4):363-369.
80. Strathdee SA, Galai N, *Safaiean M, Celentano DD, Vlahov D, Johnson L, Nelson KE. The difference between men and women drug users in seroconversion risk factors. Sidahora. 2001:25-
26. PMID: 11681272.
81. Strathdee SA, Galai N, *Safaiean M, Celentano DD, Vlahov D, Johnson L, Nelson KE. Sex differences in risk factors for HIV seroconversion among injection drug users: a 10-year perspective.
Arch Intern Med. 2001;161(10):1281-1288. PMID: 11371255.
82. Strathdee SA, Vlahov D. The effectiveness of needle exchange programs: a review of the science and policy. AIDScience. 2001;1(16):1-33.
83. Vlahov D, Des Jarlais DC, Goosby E, Hollinger PC, Lurie PG, Shriver MD, Strathdee SA. Needle exchange programs for the prevention of human immunodeficiency virus infection: epidemiology and policy. Am J Epidemiol. 2001;154(12 Suppl):S70-77. PMID: 11744532.
84. Vlahov D, Safaien M, Lai S, Strathdee SA, Johnson L, Sterling T, Celentano DD. Sexual and drug risk-related behaviors after initiating highly active antiretroviral therapy among injection drug users.
AIDS. 2001;15(17):2311-2316. PMID: 11698705.
85. Wilson LE, Umemura T, Astemborski J, Ray SC, Alter HJ, Strathdee SA, Vlahov D, Thomas DL.
Dynamics of SEN virus infection among injection drug users. J Infect Dis. 2001;184(10):1315-1319.
PMID: 11679921.
86. Arria AM, Fuller C, Strathdee SA, Latkin C, Vlahov D. Drug dependence among young recently initiated injection drug users. J Drug Issues. 2002;32(4):1089-1102.
87. Botnick MR, Heath KV, Cornelisse PG, Strathdee SA, Martindale SL, Hogg RS. Correlates of suicide attempts in an open cohort of young men who have sex with men. Can J Public Health.
2002;93(1):59-62. PMID: 11925703.
88. Burris S, Vernick JS, Ditzler A, Strathdee SA. The legality of selling or giving syringes to injection drug users. J Am Pharm Assoc (Wash). 2002;42(6 Suppl 2):S13-18. PMID: 12489604.
89. Fuller CM, Vlahov D, Ompad DC, Shah N, Arria A, Strathdee SA. High-risk behaviors associated with transition from illicit non-injection to injection drug use among adolescent and young adult drug users: a case-control study. Drug Alcohol Depend. 2002;66(2):189-198. PMID: 11906806.
90. Hankins CA, Friedman SR, Zafar T, Strathdee SA. Transmission and prevention of HIV and sexually transmitted infections in war settings: implications for current and future armed conflicts. AIDS.
2002;16(17):2245-2252. PMID: 12441795.
91. Kapadia F, Vlahov D, Des Jarlais DC, Strathdee SA, Ouellet L, Kerndt P, Morse EE, Williams I,
Garfein RS. Does bleach disinfection of syringes protect against hepatitis C infection among young adult injection drug users? Epidemiology. 2002;13(6):738-741. PMID: 12410020.
92. Lai S, Lai H, Meng Q, Tong W, Vlahov D, Celentano D, Strathdee SA, Nelson K, Fishman EK, Lima
JA. Effect of cocaine use on coronary calcium among black adults in Baltimore, Maryland. Am J
Cardiol. 2002;90(3):326-328. PMID: 12127624.
93. Macalino GE, Celentano DD, Latkin C, Strathdee SA, Vlahov D. Risk behaviors by audio computerassisted self-interviews among HIV-seropositive and HIV-seronegative injection drug users. AIDS
Educ Prev. 2002;14(5):367-378. PMID: 12413183.
94. *Mehta SH, Cox A, Hoover DR, Wang XH, Mao Q, Ray S, Strathdee SA, Vlahov D, Thomas DL.
Protection against persistence of hepatitis C. Lancet. 2002;359(9316):1478-1483. PMID: 11988247.
95. Meng Q, Lima JA, Lai H, Vlahov D, Celentano DD, Strathdee SA, Nelson KE, Tong W, Lai S. Use of
HIV protease inhibitors is associated with left ventricular morphologic changes and diastolic dysfunction. J Acquir Immune Defic Syndr. 2002;30(3):306-310. PMID: 12131567.
96. Meng Q, Lima JA, Lai H, Vlahov D, Celentano DD, Strathdee SA, Nelson KE, Wu KC, Chen S, Tong
W, Lai S. Coronary artery calcification, atherogenic lipid changes, and increased erythrocyte volume in black injection drug users infected with human immunodeficiency virus-1 treated with protease inhibitors. Am Heart J. 2002;144(4):642-648. PMID: 12360160.
97. Nelson KE, Galai N, Safaeian M, Strathdee SA, Celentano DD, Vlahov D. Temporal trends in the incidence of human immunodeficiency virus infection and risk behavior among injection drug users in
Baltimore, Maryland, 1988-1998. Am J Epidemiol. 2002;156(7):641-653. PMID: 12244033.
11

98. O'Connell JM, Hogg RS, Chan K, Strathdee SA, McLean N, Martindale SL, Willoughby B, Remis R.
Willingness to participate and enroll in a phase 3 preventive HIV-1 vaccine trial. J Acquir Immune
Defic Syndr. 2002;31(5):521-528. PMID: 12473841.
99. Ompad DC, Fuller CM, Vlahov D, Thomas D, Strathdee SA. Lack of behavior change after disclosure of hepatitis C virus infection among young injection drug users in Baltimore, Maryland.
Clin Infect Dis. 2002;35(7):783-788. PMID: 12228813.
100. Ostrow DE, Fox KJ, Chmiel JS, Silvestre A, Visscher BR, Vanable PA, Jacobson LP, Strathdee SA.
Attitudes towards highly active antiretroviral therapy are associated with sexual risk taking among
HIV-infected and uninfected homosexual men. AIDS. 2002;16(5):775-780. PMID: 11964534.
101. Rai R, Wilson LE, Astemborski J, Anania F, Torbenson M, Spoler C, Vlahov D, Strathdee SA,
Boitnott J, Nelson KE, Thomas DL. Severity and correlates of liver disease in hepatitis C virusinfected injection drug users. Hepatology. 2002;35(5):1247-1255. PMID: 11981775.
102. Riley ED, Safaeian M, Strathdee SA, Brooner RK, Beilenson P, Vlahov D. Drug user treatment referrals and entry among participants of a needle exchange program. Subst Use Misuse.
2002;37(14):1869-1886. PMID: 12511056.
103. Riley ED, Wu AW, Junge B, *Marx M, Strathdee SA, Vlahov D. Health services utilization by injection drug users participating in a needle exchange program. Am J Drug Alcohol Abuse. 2002;28(3):497-
511. PMID: 12211362.
104. *Safaeian M, Brookmeyer R, Vlahov D, Latkin C, *Marx M, Strathdee SA. Validity of self-reported needle exchange attendance among injection drug users: implications for program evaluation. Am J
Epidemiol. 2002;155(2):169-175. PMID: 11790681.
105. Semba RD, Shah N, Strathdee SA, Vlahov D. High prevalence of iron deficiency and anemia among female injection drug users with and without HIV infection. J Acquir Immune Defic Syndr.
2002;29(2):142-144. PMID: 11832682.
106. Sherman SG, Smith L, Laney G, Strathdee SA. Social influences on the transition to injection drug use among young heroin sniffers: a qualitative analysis. Int J Drug Policy. 2002;13(2):113-120.
107. Vertefeuille J, Strathdee SA, Huettner S, Brown M, Vlahov D. Factors associated with HIV seroprevalence among participants enrolling at a Needle Exchange Program. J Drug Issues.
2002;32(4):1125-1138.
108. Wiley DJ, Grosser S, Qi K, Visscher BR, Beutner K, Strathdee SA, Calhoun B, Palella F, Detels R.
Validity of self-reporting of episodes of external genital warts. Clin Infect Dis. 2002;35(1):39-45.
PMID: 12060873.
109. *Ahmed MA, Zafar T, *Brahmbhatt H, Imam G, Ul-Hassan S, Bareta JC, Strathdee SA. HIV/AIDS risk behaviors and correlates of injection drug use among drug users in Pakistan. J Urban Health.
2003;80(2):321-329. PMID: 12791807.
110. Burris S, Strathdee SA, Vernick JS. Lethal injections: the law, science, and politics of syringe access for injection drug users. Univ San Francisco Law Rev. 2003;37(4):813-885. PMID: 15457636.
111. Duggal P, An P, Beaty TH, Strathdee SA, Farzadegan H, Markham RB, Johnson L, O'Brien SJ,
Vlahov D, Winkler CA. Genetic influence of CXCR6 chemokine receptor alleles on PCP-mediated
AIDS progression among African Americans. Genes Immun. 2003;4(4):245-250. PMID: 12761559.
112. Fuller CM, Vlahov D, Latkin CA, Ompad DC, Celentano DD, Strathdee SA. Social circumstances of initiation of injection drug use and early shooting gallery attendance: implications for HIV intervention among adolescent and young adult injection drug users. J Acquir Immune Defic Syndr.
2003;32(1):86-93. PMID: 12514419.
113. *Golub ET, Astemborski JA, Hoover DR, Anthony JC, Vlahov D, Strathdee SA. Psychological distress and progression to AIDS in a cohort of injection drug users. J Acquir Immune Defic Syndr.
2003;32(4):429-434. PMID: 12640202.
114. Henderson LA, Vlahov D, Celentano DD, Strathdee SA. Readiness for cessation of drug use among recent attenders and non-attenders of a needle exchange program. J Acquir Immune Defic Syndr.
2003;32(2):229-237. PMID: 12571535.
115. *Kuo I, Brady J, Butler C, Schwartz R, Brooner R, Vlahov D, Strathdee SA. Feasibility of referring drug users from a needle exchange program into an addiction treatment program: experience with a mobile treatment van and LAAM maintenance. J Subst Abuse Treat. 2003;24(1):67-74. PMID:
12646332.
12

116. *Malta M, Carneiro-da-Cunha C, Kerrigan D, Strathdee SA, Monteiro M, Bastos FI. Case management of human immunodeficiency virus-infected injection drug users: a case study in Rio de
Janeiro, Brazil. Clin Infect Dis. 2003;37 Suppl 5:S386-391. PMID: 14648453.
117. *Mehta SH, Brancati FL, Strathdee SA, Pankow JS, Netski D, Coresh J, Szklo M, Thomas DL.
Hepatitis C virus infection and incident type 2 diabetes. Hepatology. 2003;38(1):50-56. PMID:
12829986.
118. Modi WS, Goedert JJ, Strathdee SA, Buchbinder S, Detels R, Donfield S, O'Brien SJ, Winkler C.
MCP-1-MCP-3-Eotaxin gene cluster influences HIV-1 transmission. AIDS. 2003;17(16):2357-2365.
PMID: 14571188.
119. *Shrestha S, Strathdee SA, Galai N, Thomas D, Vlahov D, O'Brien SJ, Smith MW. CCR5 pathway candidate genes susceptible to HIV-infection. Am J Hum Genet. 2003;73(5):1259.
120. Strathdee SA, Sherman SG. The role of sexual transmission of HIV infection among injection and non-injection drug users. J Urban Health. 2003;80(4 Suppl 3):iii7-14. PMID: 14713667.
121. Strathdee SA, Zafar T, *Brahmbhatt H, Baksh A, Ul-Hassan S. Rise in needle sharing among injection drug users in Pakistan during the Afghanistan war. Drug Alcohol Depend. 2003;71(1):17-24.
PMID: 12821202.
122. Thio CL, Thomas DL, Karacki P, Gao X, Marti D, Kaslow RA, Goedert JJ, Hilgartner M, Strathdee
SA, Duggal P, O'Brien SJ, Astemborski J, Carrington M. Comprehensive analysis of class I and class
II HLA antigens and chronic hepatitis B virus infection. J Virol. 2003;77(22):12083-12087. PMCID:
PMC254245.
123. Tun W, Celentano DD, Vlahov D, Strathdee SA. Attitudes toward HIV treatments influence unsafe sexual and injection practices among injecting drug users. AIDS. 2003;17(13):1953-1962. PMID:
12960828.
124. Vernick JS, Burris S, Strathdee SA. Public opinion about syringe exchange programs in the USA: an analysis of national surveys. Int J Drug Policy. 2003;14(5):431-435.
125. Wood E, Montaner JS, Bangsberg DR, Tyndall MW, Strathdee SA, O'Shaughnessy MV, Hogg RS.
Expanding access to HIV antiretroviral therapy among marginalized populations in the developed world. AIDS. 2003;17(17):2419-2427. PMID: 14600512.
126. Zafar T, *Brahmbhatt H, Imam G, Ul-Hassan S, Strathdee SA. HIV knowledge and risk behaviors among Pakistani and Afghani drug users in Quetta, Pakistan. J Acquir Immune Defic Syndr.
2003;32(4):394-398. PMID: 12640197.
127. Buxton MB, Vlahov D, Strathdee SA, Des Jarlais DC, Morse EV, Ouellet L, Kerndt P, Garfein RS.
Association between injection practices and duration of injection among recently initiated injection drug users. Drug Alcohol Depend. 2004;75(2):177-183. PMID: 15276223.
128. Frangakis CE, Brookmeyer RS, Varadhan R, Safaeian M, Vlahov D, Strathdee SA. Methodology for evaluating a partially controlled longitudinal treatment using principal stratification, with application to a needle exchange program. J Am Stat Assoc. 2004;99(465):239-249.
129. *Golub ET, Latka M, Hagan H, *Havens JR, Hudson SM, Kapadia F, Campbell JV, Garfein RS,
Thomas DL, Strathdee SA. Screening for depressive symptoms among HCV-infected injection drug users: examination of the utility of the CES-D and the Beck Depression Inventory. J Urban Health.
2004;81(2):278-290. PMID: 15136661.
130. *Haque N, Zafar T, *Brahmbhatt H, Imam G, Ul-Hassan S, Strathdee SA. High-risk sexual behaviors among drug users in Pakistan: implications for prevention of STDs and HIV/AIDS. Int J STD AIDS.
2004;15(9):601-607. PMID: 15339368. (re-printed as J Pak Med Assoc. 2006;56(1 Suppl 1):S65-72.
PMID: 16689489)
131. *Havens JR, Strathdee SA, Fuller CM, Ikeda R, Friedman SR, Des Jarlais DC, Morse PS, Bailey S,
Kerndt P, Garfein RS. Correlates of attempted suicide among young injection drug users in a multisite cohort. Drug Alcohol Depend. 2004;75(3):261-269. PMID: 15283947.
132. Karacki PS, Gao X, Thio CL, Thomas DL, Goedert JJ, Vlahov D, Kaslow RA, Strathdee SA,
Hilgartner MW, O'Brien SJ, Carrington M. MICA and recovery from hepatitis C virus and hepatitis B virus infections. Genes Immun. 2004;5(4):261-266. PMID: 15029237.
133. *Kuo I, Mudrick DW, Strathdee SA, Thomas DL, Sherman SG. Poor validity of self-reported hepatitis
B virus infection and vaccination status among young drug users. Clin Infect Dis. 2004;38(4):587-
590. PMID: 14765355.
13

134. *Kuo I, Sherman SG, Thomas DL, Strathdee SA. Hepatitis B virus infection and vaccination among young injection and non-injection drug users: missed opportunities to prevent infection. Drug Alcohol
Depend. 2004;73(1):69-78. PMID: 14687961.
135. *Loughlin A, Metsch L, Gardner L, Anderson-Mahoney P, Barrigan M, Strathdee SA. Provider barriers to prescribing HAART to medically-eligible HIV-infected drug users. AIDS Care.
2004;16(4):485-500. PMID: 15203416.
136. *Loughlin A, Strathdee SA. Hepatitis C infection among drug users enrolled in methadone maintenance program. Int J Drug Policy. 2004;15:93-101.
137. Metsch LR, Pereyra M, del Rio C, Gardner L, Duffus WA, Dickinson G, Kerndt P, Anderson-
Mahoney P, Strathdee SA, Greenberg AE. Delivery of HIV prevention counseling by physicians at
HIV medical care settings in 4 US cities. Am J Public Health. 2004;94(7):1186-1192. PMID:
15226141; PMCID: PMC1448419.
138. *Poundstone KE, Strathdee SA, Celentano DD. The social epidemiology of human immunodeficiency virus/acquired immunodeficiency syndrome. Epidemiol Rev. 2004;26:22-35.
PMID: 15234945.
139. Thio CL, Goedert JJ, Mosbruger T, Vlahov D, Strathdee SA, O'Brien SJ, Astemborski J, Thomas DL.
An analysis of tumor necrosis factor alpha gene polymorphisms and haplotypes with natural clearance of hepatitis C virus infection. Genes Immun. 2004;5(4):294-300. PMID: 15071492.
140. Thio CL, Mosbruger TL, Kaslow RA, Karp CL, Strathdee SA, Vlahov D, O'Brien SJ, Astemborski J,
Thomas DL. Cytotoxic T-lymphocyte antigen 4 gene and recovery from hepatitis B virus infection. J
Virol. 2004;78(20):11258-11262. PMID: 15452244; PMCID: PMC521829.
141. Torbenson M, Kannangai R, Astemborski J, Strathdee SA, Vlahov D, Thomas DL. High prevalence of occult hepatitis B in Baltimore injection drug users. Hepatology. 2004;39(1):51-57. PMID:
14752822.
142. Tun W, Gange SJ, Vlahov D, Strathdee SA, Celentano DD. Increase in sexual risk behavior associated with immunologic response to highly active antiretroviral therapy among HIV-infected injection drug users. Clin Infect Dis. 2004;38(8):1167-1174. PMID: 15095224.
143. Vlahov D, Wang CL, Galai N, Bareta J, *Mehta SH, Strathdee SA, Nelson KE. Mortality risk among new onset injection drug users. Addiction. 2004;99(8):946-954. PMID: 15265091.
144. Wang C, Vlahov D, Galai N, Bareta J, Strathdee SA, Nelson KE, Sterling TR. Mortality in HIVseropositive versus - seronegative persons in the era of highly active antiretroviral therapy: implications for when to initiate therapy. J Infect Dis. 2004;190(6):1046-1054. PMID: 15319852.
145. Wood E, Kerr T, Montaner JS, Strathdee SA, Wodak A, Hankins CA, Schechter MT, Tyndall MW.
Rationale for evaluating North America's first medically supervised safer-injecting facility. Lancet
Infect Dis. 2004;4(5):301-306. PMID: 15120347.
146. Bucardo J, *Brouwer KC, Magis-Rodriguez C, Ramos R, Fraga M, *Perez SG, Patterson TL,
Strathdee SA. Historical trends in the production and consumption of illicit drugs in Mexico: implications for the prevention of blood borne infections. Drug Alcohol Depend. 2005;79(3):281-293.
PMID: 16102372; PMCID: PMC2196212.
147. Cox AL, Netski DM, Mosbruger T, Sherman SG, Strathdee SA, Ompad D, Vlahov D, Chien D,
Shyamala V, Ray SC, Thomas DL. Prospective evaluation of community-acquired acute-phase hepatitis C virus infection. Clin Infect Dis. 2005;40(7):951-958. PMID: 15824985.
148. Fuller CM, Borrell LN, Latkin CA, Galea S, Ompad DC, Strathdee SA, Vlahov D. Effects of race, neighborhood, and social network on age at initiation of injection drug use. Am J Public Health.
2005;95(4):689-695. PMID: 15798131; PMCID: PMC1449242.
149. Gardner LI, Metsch LR, Anderson-Mahoney P, Loughlin AM, del Rio C, Strathdee SA, Sansom SL,
Siegal HA, Greenberg AE, Holmberg SD. Efficacy of a brief case management intervention to link recently diagnosed HIV-infected persons to care. AIDS. 2005;19(4):423-431. PMID: 15750396.
150. *Golub ET, Bareta JC, *Mehta SH, McCall LD, Vlahov D, Strathdee SA. Correlates of unsafe syringe acquisition and disposal among injection drug users in Baltimore, Maryland. Subst Use Misuse.
2005;40(12):1751-1764. PMID: 16419554.
151. *Golub ET, Purvis LA, Sapun M, Safaeian M, Beyrer C, Vlahov D, Strathdee SA. Changes in willingness to participate in HIV vaccine trials among HIV-negative injection drug users. AIDS Behav.
2005;9(3):301-309. PMID: 16088366.
14

152. *Havens JR, Ompad DC, Latkin CA, Fuller CM, Arria AM, Vlahov D, Strathdee SA. Suicidal ideation among African-American non-injection drug users. Ethn Dis. 2005;15(1):110-115. PMID: 15720057.
153. Hogg RS, Strathdee SA, Kerr T, *Wood E, Remis R. HIV prevalence among aboriginal British
Columbians. Harm Reduct J. 2005;2:26. PMCID: PMC1368971.
154. Lloyd JJ, Ricketts EP, Strathdee SA, Cornelius LJ, Bishai D, Huettner S, *Havens JR, Latkin C.
Social contextual factors associated with entry into opiate agonist treatment among injection drug users. Am J Drug Alcohol Abuse. 2005;31(4):555-570. PMCID: PMC2196226.
155. Magis-Rodriguez C, *Brouwer KC, Morales S, Gayet C, Lozada R, Ortiz-Mondragon R, Ricketts EP,
Strathdee SA. HIV prevalence and correlates of receptive needle sharing among injection drug users in the Mexican-U.S. border city of Tijuana. J Psychoactive Drugs. 2005;37(3):333-339. PMID:
16295018.
156. *Mehta SH, Netski D, Sulkowski MS, Strathdee SA, Vlahov D, Thomas DL. Liver enzyme values in injection drug users with chronic hepatitis C. Dig Liver Dis. 2005;37(9):674-680. PMID: 15951255.
157. *Mehta SH, Thomas DL, Sulkowski MS, Safaein M, Vlahov D, Strathdee SA. A framework for understanding factors that affect access and utilization of treatment for hepatitis C virus infection among HCV-mono-infected and HIV/HCV-co-infected injection drug users. AIDS. 2005;19 Suppl
3:S179-189. PMID: 16251816.
158. *Miller CL, Strathdee SA, Kerr T, Small W, Li K, *Wood E. Factors associated with willingness to participate in a heroin prescription program among injection drug users. J Opioid Manag.
2005;1(4):201-203. PMID: 17315547.
159. Novelli LA, Sherman SG, *Havens JR, Strathdee SA, Sapun M. Circumstances surrounding the first injection experience and their association with future syringe sharing behaviors in young urban injection drug users. Drug Alcohol Depend. 2005;77(3):303-309. PMID: 15734230.
160. *Ompad DC, Ikeda RM, Shah N, Fuller CM, Bailey S, Morse E, Kerndt P, Maslow C, Wu Y, Vlahov
D, Garfein R, Strathdee SA. Childhood sexual abuse and age at initiation of injection drug use. Am J
Public Health. 2005;95(4):703-709. PMID: 15798133; PMCID: PMC1449244.
161. Patterson TL, Semple SJ, Fraga M, Bucardo J, Davila-Fraga W, Strathdee SA. An HIV-prevention intervention for sex workers in Tijuana, Mexico: a pilot study. Hisp J Behav Sci. 2005;27(1):82-100.
162. Patterson TL, Semple SJ, Zians JK, Strathdee SA. Methamphetamine-using HIV-positive men who have sex with men: correlates of polydrug use. J Urban Health. 2005;82(1 Suppl 1):i120-126. PMID:
15738313.
163. Plitt SS, Garfein RS, Gaydos CA, Strathdee SA, Sherman SG, Taha TE. Prevalence and correlates of chlamydia trachomatis, neisseria gonorrhoeae, trichomonas vaginalis infections, and bacterial vaginosis among a cohort of young injection drug users in Baltimore, Maryland. Sex Transm Dis.
2005;32(7):446-453. PMID: 15976603.
164. Plitt SS, Sherman SG, Strathdee SA, Taha TE. Herpes simplex virus 2 and syphilis among young drug users in Baltimore, Maryland. Sex Transm Infect. 2005;81(3):248-253. PMCID: PMC1744972.
165. Rhodes T, Singer M, Bourgois P, Friedman SR, Strathdee SA. The social structural production of
HIV risk among injecting drug users. Soc Sci Med. 2005;61(5):1026-1044. PMID: 15955404.
166. *Rusch ML, Farzadegan H, Tarwater PM, Safaeian M, Vlahov D, Strathdee SA. Sexual risk behavior among injection drug users before widespread availability of highly active antiretroviral therapy. AIDS
Behav. 2005;9(3):289-299. PMID: 16133905.
167. Santibanez SS, Garfein RS, Swartzendruber A, Kerndt PR, Morse E, Ompad D, Strathdee SA,
Williams IT, Friedman SR, Ouellet LJ. Prevalence and correlates of crack-cocaine injection among young injection drug users in the United States, 1997-1999. Drug Alcohol Depend. 2005;77(3):227-
233. PMID: 15734222.
168. Sherman SG, Fuller CM, Shah N, Ompad DV, Vlahov D, Strathdee SA. Correlates of initiation of injection drug use among young drug users in Baltimore, Maryland: the need for early intervention. J
Psychoactive Drugs. 2005;37(4):437-443. PMID: 16480171.
169. *Shrestha S, Smith MW, Beaty TH, Strathdee SA. Theory and methodology for utilizing genes as biomarkers to determine potential biological mixtures. Ann Epidemiol. 2005;15(1):29-38. PMID:
15571991.
170. Stachowiak JA, Sherman SG, Peryshkina A, Konakova A, Krushkova I, Strathdee SA, Beyrer C.
Health risks and power among female sex workers in Moscow. SIECUS Rep. 2005;33(2):18-25.
15

171. Strathdee SA, Fraga WD, Case P, *Firestone M, *Brouwer KC, *Perez SG, Magis C, Fraga MA.
"Vivo para consumirla y la consumo para vivir" ["I live to inject and inject to live"]: high-risk injection behaviors in Tijuana, Mexico. J Urban Health. 2005;82(3 Suppl 4):iv58-73. PMCID: PMC2196210.
172. Strathdee SA, Latka M, Campbell J, O'Driscoll PT, *Golub ET, Kapadia F, *Pollini RA, Garfein RS,
Thomas DL, Hagan H. Factors associated with interest in initiating treatment for hepatitis C Virus
(HCV) infection among young HCV-infected injection drug users. Clin Infect Dis. 2005;40 Suppl
5:S304-312. PMCID: PMC2196220.
173. *Todd CS, Safi N, Strathdee SA. Drug use and harm reduction in Afghanistan. Harm Reduct J.
2005;2:13. PMCID: PMC1262742.
174. Azim T, Chowdhury EI, Reza M, *Ahmed MA, Uddin MT, Khan R, Ahmed G, Rahman M, Khandakar
I, Khan SI, Sack DA, Strathdee SA. Vulnerability to HIV infection among sex worker and non-sex worker female injecting drug users in Dhaka, Bangladesh: evidence from the baseline survey of a cohort study. Harm Reduct J. 2006;3:33. PMCID: PMC1665448.
175. *Brouwer KC, Case P, Ramos R, Magis-Rodriguez C, Bucardo J, Patterson TL, Strathdee SA.
Trends in production, trafficking, and consumption of methamphetamine and cocaine in Mexico.
Subst Use Misuse. 2006;41(5):707-727. PMCID: PMC2757051.
176. *Brouwer KC, Strathdee SA, Magis-Rodriguez C, Bravo-Garcia E, Gayet C, Patterson TL, Bertozzi
SM, Hogg RS. Estimated numbers of men and women infected with HIV/AIDS in Tijuana, Mexico. J
Urban Health. 2006;83(2):299-307. PMCID: PMC2527171.
177. Campbell JV, Hagan H, Latka MH, Garfein RS, *Golub ET, Coady MH, Thomas DL, Strathdee SA.
High prevalence of alcohol use among hepatitis C virus antibody positive injection drug users in three US cities. Drug Alcohol Depend. 2006;81(3):259-265. PMCID: PMC2196223.
178. Cornelius JL, Lloyd JJ, Bishai D, Latkin CA, Huettner S, Brown M, *Havens JR, Ricketts EP, Rapp
CA, Strathdee SA. The treatment retention intervention: A case study of an evaluation of a case management intervention to improve treatment outcomes for injecting drug users. J Assoc Acad
Minority Physicians 2006;17:44-53.
179. *Drumright LN, Little SJ, Strathdee SA, Slymen DJ, Araneta MR, Malcarne VL, Daar ES, Gorbach
PM. Unprotected anal intercourse and substance use among men who have sex with men with recent HIV infection. J Acquir Immune Defic Syndr. 2006;43(3):344-350. PMID: 16980913.
180. *Drumright LN, Patterson TL, Strathdee SA. Club drugs as causal risk factors for HIV acquisition among men who have sex with men: a review. Subst Use Misuse. 2006;41(10-12):1551-1601. PMID:
17002993.
181. Evans L, Strathdee SA. A roof is not enough: unstable housing, vulnerability to HIV infection and the plight of the SRO. Int J Drug Policy. 2006;17(2):115-117.
182. Frost SD, *Brouwer KC, Firestone Cruz MA, Ramos R, Ramos ME, Lozada RM, Magis-Rodriguez C,
Strathdee SA. Respondent-driven sampling of injection drug users in two U.S.-Mexico border cities: recruitment dynamics and impact on estimates of HIV and syphilis prevalence. J Urban Health.
2006;83(6 Suppl):i83-97. PMCID: PMC1705507.
183. Hagan H, Campbell J, Thiede H, Strathdee SA, Ouellet L, Kapadia F, Hudson S, Garfein RS. Selfreported hepatitis C virus antibody status and risk behavior in young injectors. Public Health Rep.
2006;121(6):710-719. PMCID: PMC1781913.
184. Hagan H, Latka MH, Campbell JV, *Golub ET, Garfein RS, Thomas DA, Kapadia F, Strathdee SA.
Eligibility for treatment of hepatitis C virus infection among young injection drug users in 3 US cities.
Clin Infect Dis. 2006;42(5):669-672. PMID: 16447112.
185. *Havens JR, Sherman SG, Sapun M, Strathdee SA. Prevalence and correlates of suicidal ideation among young injection vs. noninjection drug users. Subst Use Misuse. 2006;41(2):245-254. PMID:
16393745.
186. Kaida A, Andia I, Maier M, Strathdee SA, Bangsberg DR, Spiegel J, Bastos FI, Gray G, Hogg R. The potential impact of antiretroviral therapy on fertility in sub-Saharan Africa. Curr HIV/AIDS Rep.
2006;3(4):187-194. PMID: 17032579.
187. Kerr T, Stoltz JA, Strathdee SA, Li K, Hogg RS, Montaner JS, *Wood E. The impact of sex partners'
HIV status on HIV seroconversion in a prospective cohort of injection drug users. J Acquir Immune
Defic Syndr. 2006;41(1):119-123. PMID: 16340484.
188. Kerrigan D, Bastos FI, *Malta M, Carneiro-da-Cunha C, Pilotto JH, Strathdee SA. The search for social validation and the sexual behavior of people living with HIV in Rio de Janeiro, Brazil:
16

understanding the role of treatment optimism in context. Soc Sci Med. 2006;62(10):2386-2396.
PMID: 16310301.
189. *Kuo I, Ul-Hassan S, Galai N, Thomas DL, Zafar T, *Ahmed MA, Strathdee SA. High HCV seroprevalence and HIV drug use risk behaviors among injection drug users in Pakistan. Harm
Reduct J. 2006;3:26. PMID: 16914042; PMCID: PMC1564387.
190. *Malta M, Bastos FI, Pereira-Koller EM, Cunha MD, Marques C, Strathdee SA. A qualitative assessment of long distance truck drivers' vulnerability to HIV/AIDS in Itajai, southern Brazil. AIDS
Care. 2006;18(5):489-496. PMID: 16777641.
191. *Mehta SH, Galai N, Astemborski J, Celentano DD, Strathdee SA, Vlahov D, Nelson KE. HIV incidence among injection drug users in Baltimore, Maryland (1988-2004). J Acquir Immune Defic
Syndr. 2006;43(3):368-372. PMID: 16980912.
192. *Miller CL, Strathdee SA, Kerr T, Li K, *Wood E. Factors associated with early adolescent initiation into injection drug use: implications for intervention programs. J Adolesc Health. 2006;38(4):462-464.
PMID: 16549314.
193. *Miller CL, Strathdee SA, Spittal PM, Kerr T, Li K, Schechter MT, *Wood E. Elevated rates of HIV infection among young Aboriginal injection drug users in a Canadian setting. Harm Reduct J.
2006;3:9. PMCID: PMC1431516.
194. *Ompad DC, Strathdee SA, Celentano DD, Latkin C, Poduska JM, Kellam SG, Ialongo NS.
Predictors of early initiation of vaginal and oral sex among urban young adults in Baltimore,
Maryland. Arch Sex Behav. 2006;35(1):53-65. PMID: 16502153.
195. Patterson TL, Semple SJ, Fraga M, Bucardo J, de la Torre A, Salazar J, Orozovich P, Staines H,
Amaro H, Magis-Rodriguez C, Strathdee SA. Comparison of sexual and drug use behaviors between female sex workers in Tijuana and Ciudad Juarez, Mexico. Subst Use Misuse. 2006;41(10-12):1535-
1549. PMID: 17002992.
196. *Pollini RA, McCall L, *Mehta SH, Celentano DD, Vlahov D, Strathdee SA. Response to overdose among injection drug users. Am J Prev Med. 2006;31(3):261-264. PMID: 16905039.
197. *Pollini RA, McCall L, *Mehta SH, Vlahov D, Strathdee SA. Non-fatal overdose and subsequent drug treatment among injection drug users. Drug Alcohol Depend. 2006;83(2):104-110. PMID: 16310322.
198. Shah NG, Galai N, Celentano DD, Vlahov D, Strathdee SA. Longitudinal predictors of injection cessation and subsequent relapse among a cohort of injection drug users in Baltimore, MD, 1988-
2000. Drug Alcohol Depend. 2006;83(2):147-156. PMID: 16364568.
199. *Shrestha S, Smith MW, Broman KW, Farzadegan H, Vlahov D, Strathdee SA. Multiperson use of syringes among injection drug users in a needle exchange program: a gene-based molecular epidemiologic analysis. J Acquir Immune Defic Syndr. 2006;43(3):335-343. PMID: 16980914.
200. *Shrestha S, Strathdee SA, Broman KW, Smith MW. Unknown biological mixtures evaluation using
STR analytical quantification. Electrophoresis. 2006;27(2):409-415. PMID: 16437418.
201. *Shrestha S, Strathdee SA, Galai N, Oleksyk T, Fallin MD, *Mehta S, Schaid D, Vlahov D, O'Brien
SJ, Smith MW. Behavioral risk exposure and host genetics of susceptibility to HIV-1 infection. J
Infect Dis. 2006;193(1):16-26. PMID: 16323127.
202. Stachowiak JA, Tishkova FK, Strathdee SA, Stibich MA, *Latypov A, Mogilnii V, Beyrer C. Marked ethnic differences in HIV prevalence and risk behaviors among injection drug users in Dushanbe,
Tajikistan, 2004. Drug Alcohol Depend. 2006;82 Suppl 1:S7-14. PMID: 16769449.
203. Strathdee SA, Patterson TL. Behavioral interventions for HIV-positive and HCV-positive drug users.
AIDS Behav. 2006;10(2):115-130. PMID: 16463006.
204. Strathdee SA, Ricketts EP, Huettner S, Cornelius L, Bishai D, *Havens JR, Beilenson P, Rapp C,
Lloyd JJ, Latkin CA. Facilitating entry into drug treatment among injection drug users referred from a needle exchange program: Results from a community-based behavioral intervention trial. Drug
Alcohol Depend. 2006;83(3):225-232. PMCID: PMC2196224.
205. Strathdee SA, Stachowiak JA, *Todd CS, Al-Delaimy WK, Wiebel W, Hankins C, Patterson TL.
Complex emergencies, HIV, and substance use: no "big easy" solution. Subst Use Misuse.
2006;41(10-12):1637-1651. PMID: 17002996.
206. *Washington TA, Galai N, Cohn S, Celentano DD, Vlahov D, Strathdee SA. The relationship between self-reported sexual orientation and behavior in a sample of middle-aged male injection drug users. Arch Sex Behav. 2006;35(1):67-74. PMCID: PMC2749680.
17

207. Winstanley EL, Gust SW, Strathdee SA. Drug abuse and HIV/AIDS: international research lessons and imperatives. Drug Alcohol Depend. 2006;82 Suppl 1:S1-5. PMID: 16769437.
208. Wood E, Kerr T, Hogg RS, Palepu A, Zhang R, Strathdee SA, Montaner JS. Impact of HIV testing on uptake of HIV therapy among antiretroviral naive HIV-infected injection drug users. Drug Alcohol
Rev. 2006;25(5):451-454. PMID: 16939941.
209. Wood E, Kerr T, Palepu A, Zhang R, Strathdee SA, Tyndall MW, Montaner JS, Hogg RS. Slower uptake of HIV antiretroviral therapy among Aboriginal injection drug users. J Infect. 2006;52(4):233-
236. PMID: 16169594.
210. Cruz MF, *Mantsios A, Ramos R, Case P, *Brouwer KC, Ramos ME, Fraga WD, Latkin CA, *Miller
CL, Strathdee SA. A qualitative exploration of gender in the context of injection drug use in two US-
Mexico border cities. AIDS Behav. 2007;11(2):253-262. PMCID: PMC2733528.
211. Davey MA, Latkin CA, Hua W, Tobin KE, Strathdee SA. Individual and social network factors that predict entry to drug treatment. Am J Addict. 2007;16(1):38-45. PMID: 17364420.
212. Dhalla S, Woods R, Strathdee SA, Patrick DM, Hogg RS. HIV vaccine preparedness studies in the organization for economic co-operation and development (OECD) countries. AIDS Care.
2007;19(9):1118-1127. PMID: 17851989.
213. *Drumright LN, Strathdee SA, Little SJ, Araneta MR, Slymen DJ, Malcarne VL, Daar ES, Gorbach
PM. Unprotected anal intercourse and substance use before and after HIV diagnosis among recently
HIV-infected men who have sex with men. Sex Transm Dis. 2007;34(6):401-407. PMID: 17091117.
214. Eyzaguirre L, *Brouwer KC, Nadai Y, Patterson TL, Ramos R, Firestone Cruz M, Orozovich P,
Strathdee SA, Carr JK. First molecular surveillance report of HIV type 1 in injecting drug users and female sex workers along the U.S.-Mexico border. AIDS Res Hum Retroviruses. 2007;23(2):331-
334. PMCID: PMC2734975.
215. Garfein RS, *Golub ET, Greenberg AE, Hagan H, Hanson DL, Hudson SM, Kapadia F, Latka MH,
Ouellet LJ, Purcell DW, Strathdee SA, Thiede H. A peer-education intervention to reduce injection risk behaviors for HIV and hepatitis C virus infection in young injection drug users. AIDS.
2007;21(14):1923-1932. PMID: 17721100.
216. Garfein RS, Swartzendruber A, Ouellet LJ, Kapadia F, Hudson SM, Thiede H, Strathdee SA,
Williams IT, Bailey SL, Hagan H, *Golub ET, Kerndt P, Hanson DL, Latka MH. Methods to recruit and retain a cohort of young-adult injection drug users for the Third Collaborative Injection Drug
Users Study/Drug Users Intervention Trial (CIDUS III/DUIT). Drug Alcohol Depend. 2007;91 Suppl
1:S4-17. PMID: 17582705.
217. *Golub ET, Strathdee SA, Bailey SL, Hagan H, Latka MH, Hudson SM, Garfein RS. Distributive syringe sharing among young adult injection drug users in five U.S. cities. Drug Alcohol Depend.
2007;91 Suppl 1:S30-38. PMID: 17398039.
218. Hagan H, Campbell JV, Thiede H, Strathdee SA, Ouellet L, Latka M, Hudson S, Garfein RS.
Injecting alone among young adult IDUs in five US cities: evidence of low rates of injection risk behavior. Drug Alcohol Depend. 2007;91 Suppl 1:S48-55. PMCID: PMC2128771.
219. *Havens JR, Cornelius LJ, Ricketts EP, Latkin CA, Bishai D, Lloyd JJ, Huettner S, Strathdee SA. The effect of a case management intervention on drug treatment entry among treatment-seeking injection drug users with and without comorbid antisocial personality disorder. J Urban Health.
2007;84(2):267-271. PMCID: PMC2231639.
220. Kapadia F, Latka MH, Hagan H, *Golub ET, Campbell JV, Coady MH, Garfein RS, Thomas DL,
Bonner S, Thiel T, Strathdee SA. Design and feasibility of a randomized behavioral intervention to reduce distributive injection risk and improve health-care access among hepatitis C virus positive injection drug users: the Study to Reduce Intravenous Exposures (STRIVE). J Urban Health.
2007;84(1):99-115.; PMCID: PMC2078252.
221. *Kuo I, Ul-Hasan S, Zafar T, Galai N, Sherman SG, Strathdee SA. Factors associated with recentonset injection drug use among drug users in Pakistan. Subst Use Misuse. 2007;42(5):853-870.
PMID: 17613949.
222. Lloyd JJ, Ricketts EP, *Havens JR, Cornelius LJ, Bishai D, Huettner S, Latkin C, Strathdee SA. The relationship between lifetime abuse and suicidal ideation in a sample of injection drug users. J
Psychoactive Drugs. 2007;39(2):159-166. PMCID: PMC2258230.
223. *Malta M, Bastos FI, Strathdee SA, Cunnigham SD, Pilotto JH, Kerrigan D. Knowledge, perceived stigma, and care-seeking experiences for sexually transmitted infections: a qualitative study from the
18

perspective of public clinic attendees in Rio de Janeiro, Brazil. BMC Public Health. 2007;7:18.
PMCID: PMC1797160.
224. Mausbach BT, Semple SJ, Strathdee SA, Zians J, Patterson TL. Efficacy of a behavioral intervention for increasing safer sex behaviors in HIV-negative, heterosexual methamphetamine users: results from the Fast-Lane Study. Ann Behav Med. 2007;34(3):263-274. PMID: 18020936.
225. Mausbach BT, Semple SJ, Strathdee SA, Zians J, Patterson TL. Efficacy of a behavioral intervention for increasing safer sex behaviors in HIV-positive MSM methamphetamine users: results from the
EDGE study. Drug Alcohol Depend. 2007;87(2-3):249-257. PMCID: PMC1904343.
226. *Miller CL, Kerr T, Strathdee SA, Li K, *Wood E. Factors associated with premature mortality among young injection drug users in Vancouver. Harm Reduct J. 2007;4:1. PMCID: PMC1769365.
227. *Miller CL, Strathdee SA, Li K, Kerr T, *Wood E. A longitudinal investigation into excess risk for blood-borne infection among young injection drug users (IUDs). Am J Drug Alcohol Abuse.
2007;33(4):527-536. PMID: 17668338.
228. Plitt SS, Sherman SG, Viscidi RP, Strathdee SA, Fuller CM, Taha TE. Human papillomavirus seroprevalence among young male and female drug users. Sex Transm Dis. 2007;34(9):676-680.
PMID: 17847165.
229. *Pollini RA, Strathdee SA. Indicators of methamphetamine use and abuse in San Diego County,
California: 2001-2005. J Psychoactive Drugs. 2007;Suppl 4:319-325. PMID: 18284098.
230. Sanders-Buell E, Saad MD, Abed AM, Bose M, *Todd CS, Strathdee SA, Botros BA, Safi N, Earhart
KC, Scott PT, Michael N, McCutchan FE. A nascent HIV type 1 epidemic among injecting drug users in Kabul, Afghanistan is dominated by complex AD recombinant strain, CRF35_AD. AIDS Res Hum
Retroviruses. 2007;23(6):834-839. PMID: 17604548.
231. Semple SJ, Zians J, Strathdee SA, Patterson TL. Psychosocial and behavioral correlates of depressed mood among female methamphetamine users. J Psychoactive Drugs. 2007;Suppl 4:353-
366. PMID: 18284102.
232. Thiede H, Hagan H, Campbell JV, Strathdee SA, Bailey SL, Hudson SM, Kapadia F, Garfein RS.
Prevalence and correlates of indirect sharing practices among young adult injection drug users in five U.S. cities. Drug Alcohol Depend. 2007;91 Suppl 1:S39-47. PMID: 17466464.
233. *Todd CS, Abed AM, Strathdee SA, Scott PT, Botros BA, Safi N, Earhart KC. HIV, hepatitis C, and hepatitis B infections and associated risk behavior in injection drug users, Kabul, Afghanistan. Emerg
Infect Dis. 2007;13(9):1327-1331. PMCID: PMC2857281.
234. *Todd CS, Abed AM, Strathdee SA, Scott PT, Botros BA, Safi N, Earhart KC. Association between expatriation and HIV awareness and knowledge among injecting drug users in Kabul, Afghanistan: A cross-sectional comparison of former refugees to those remaining during conflict. Confl Health.
2007;1:5. PMCID: PMC1847809.
235. *White EF, Garfein RS, *Brouwer KC, Lozada R, Ramos R, Firestone-Cruz M, *Perez SG, Magis-
Rodriguez C, Conde-Glez CJ, Strathdee SA. Prevalence of hepatitis C virus and HIV infection among injection drug users in two Mexican cities bordering the U.S. Salud Publica Mex.
2007;49(3):165-172. PMCID: PMC2743977.
236. Wood E, Hogg RS, Kerr T, Bonner S, Strathdee SA, Palepu A, Montaner JS. Rates of inappropriate antiretroviral prescription among injection drug users. Harm Reduct J. 2007;4:2. PMCID:
PMC1769364.
237. Wood E, Lloyd-Smith E, Li K, Strathdee SA, Small W, Tyndall MW, Montaner JS, Kerr T. Frequent needle exchange use and HIV incidence in Vancouver, Canada. Am J Med. 2007;120(2):172-179.
PMID: 17275459.
238. *Zuniga ML, Blanco E, Martinez P, Strathdee SA, Gifford AL. Perceptions of barriers and facilitators to participation in clinical trials in HIV-positive Latinas: a pilot study. J Womens Health (Larchmt).
2007;16(9):1322-1330. PMID: 18001189.
239. Amon JJ, Garfein RS, Ahdieh-Grant L, Armstrong GL, Ouellet LJ, Latka MH, Vlahov D, Strathdee
SA, Hudson SM, Kerndt P, Des Jarlais D, Williams IT. Prevalence of hepatitis C virus infection among injection drug users in the United States, 1994-2004. Clin Infect Dis. 2008;46(12):1852-1858.
PMID: 18462109.
240. Azim T, Chowdhury EI, Reza M, Faruque MO, Ahmed G, Khan R, Rahman M, Pervez MM, Jana S,
Strathdee SA. Prevalence of infections, HIV risk behaviors and factors associated with HIV infection
19

among male injecting drug users attending a needle/syringe exchange program in Dhaka,
Bangladesh. Subst Use Misuse. 2008;43(14):2124-2144. PMID: 19085439.
241. Baumbach JP, Foster LN, Mueller M, Cruz MF, Arbona S, Melville S, Ramos R, Strathdee SA.
Seroprevalence of select bloodborne pathogens and associated risk behaviors among injection drug users in the Paso del Norte region of the United States-Mexico border. Harm Reduct J. 2008;5:33.
PMCID: PMC2615419.
242. Bishai D, Sindelar J, Ricketts EP, Huettner S, Cornelius L, Lloyd JJ, *Havens JR, Latkin CA,
Strathdee SA. Willingness to pay for drug rehabilitation: implications for cost recovery. J Health
Econ. 2008;27(4):959-972. PMCID: PMC2601723.
243. Case P, Ramos R, *Brouwer KC, Firestone-Cruz M, *Pollini RA, Fraga MA, Patterson TL, Strathdee
SA. At the borders, on the edge: use of injected methamphetamine in Tijuana and Ciudad Juarez,
Mexico. J Immigr Minor Health. 2008;10(1):23-33. PMCID: PMC2716800.
244. *Deiss RG, *Brouwer KC, *Loza O, Lozada RM, Ramos R, Cruz MA, Patterson TL, Heckathorn DD,
Frost SD, Strathdee SA. High-risk sexual and drug using behaviors among male injection drug users who have sex with men in 2 Mexico-US border cities. Sex Transm Dis. 2008;35(3):243-249. PMCID:
PMC2391275.
245. Gardner LI, Metsch L, Strathdee SA, del Rio C, Mahoney P, Holmberg SD. Frequency of discussing
HIV prevention and care topics with patients with HIV: influence of physician gender, race/ethnicity, and practice characteristics. Gend Med. 2008;5(3):259-269. PMID: 18727992.
246. Hogg RS, Druyts EF, Burris S, Drucker E, Strathdee SA. Years of life lost to prison: racial and gender gradients in the United States of America. Harm Reduct J. 2008;5:4.; PMCID: PMC2265700.
247. Kaida A, Gray G, Bastos FI, Andia I, Maier M, McIntyre J, Grinsztejn B, Strathdee SA, Bangsberg
DR, Hogg R. The relationship between HAART use and sexual activity among HIV-positive women of reproductive age in Brazil, South Africa, and Uganda. AIDS Care. 2008;20(1):21-25. PMID:
18278611.
248. Lampinen TM, Chan K, Anema A, Miller ML, Schilder AJ, Schechter MT, Hogg RS, Strathdee SA.
Incidence of and risk factors for sexual orientation-related physical assault among young men who have sex with men. Am J Public Health. 2008;98(6):1028-1035. PMCID: PMC2377287.
249. Latka MH, Hagan H, Kapadia F, *Golub ET, Bonner S, Campbell JV, Coady MH, Garfein RS, Pu M,
Thomas DL, Thiel TK, Strathdee SA. A randomized intervention trial to reduce the lending of used injection equipment among injection drug users infected with hepatitis C. Am J Public Health.
2008;98(5):853-861. PMCID: PMC2374802.
250. Lloyd JJ, Strathdee SA, Pu M, *Havens JR, Cornelius LJ, Huettner S, Latkin CA. The impact of opiate agonist maintenance therapy on drug use within social networks of injecting drug users. Am J
Addict. 2008;17(5):414-421. PMID: 18770085.
251. *Malta M, Monteiro S, Lima RM, Bauken S, Marco A, Zuim GC, Bastos FI, Singer M, Strathdee SA.
HIV/AIDS risk among female sex workers who use crack in Southern Brazil. Rev Saude Publica.
2008;42(5):830-837. PMID: 18833383.
252. *Malta M, Strathdee SA, Magnanini MM, Bastos FI. Adherence to antiretroviral therapy for human immunodeficiency virus/acquired immune deficiency syndrome among drug users: a systematic review. Addiction. 2008;103(8):1242-1257. PMID: 18855813.
253. Mathers BM, Degenhardt L, Phillips B, Wiessing L, Hickman M, Strathdee SA, Wodak A, Panda S,
Tyndall M, Toufik A, Mattick RP. Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review. Lancet. 2008;372(9651):1733-1745. PMID: 18817968.
254. *Mehta SH, Genberg BL, Astemborski J, Kavasery R, Kirk GD, Vlahov D, Strathdee SA, Thomas DL.
Limited uptake of hepatitis C treatment among injection drug users. J Community Health.
2008;33(3):126-133. PMID: 18165889.
255. Metsch LR, Pereyra M, Messinger S, Del Rio C, Strathdee SA, Anderson-Mahoney P, Rudy E,
Marks G, Gardner L. HIV transmission risk behaviors among HIV-infected persons who are successfully linked to care. Clin Infect Dis. 2008;47(4):577-584. PMID: 18624629.
256. *Miller CL, *Firestone M, Ramos R, Burris S, Ramos ME, Case P, *Brouwer KC, Fraga MA,
Strathdee SA. Injecting drug users' experiences of policing practices in two Mexican-U.S. border cities: public health perspectives. Int J Drug Policy. 2008;19(4):324-331. PMCID: PMC2546504.
20

257. *Moyer LB, *Brouwer KC, Brodine SK, Ramos R, Lozada R, Cruz MF, Magis-Rodriguez C, Strathdee
SA. Barriers and missed opportunities to HIV testing among injection drug users in two Mexico--US border cities. Drug Alcohol Rev. 2008;27(1):39-45. PMCID: PMC2196215.
258. *Ojeda VDD, Patterson TL, Strathdee SA. The influence of perceived risk to health and immigrationrelated characteristics on substance use among Latino and other immigrants. Am J Public Health.
2008;98(5):862-868. PMCID: PMC2374816.
259. Patterson TL, Mausbach B, Lozada R, Staines-Orozco H, Semple SJ, Fraga-Vallejo M, Orozovich P,
Abramovitz DA, de la Torre A, Amaro H, Martinez G, Magis-Rodriguez C, Strathdee SA. Efficacy of a brief behavioral intervention to promote condom use among female sex workers in Tijuana and
Ciudad Juarez, Mexico. Am J Public Health. 2008;98(11):2051-2057. PMCID: PMC2633868.
260. Patterson TL, Semple SJ, Staines H, Lozada R, Orozovich P, Bucardo J, *Philbin MM, Pu M, Fraga
M, Amaro H, Torre Ade L, Martinez G, Magis-Rodriguez C, Strathdee SA. Prevalence and correlates of HIV infection among female sex workers in 2 Mexico-US border cities. J Infect Dis.
2008;197(5):728-732. PMCID: PMC2872174.
261. *Philbin M, *Pollini RA, Ramos R, Lozada R, *Brouwer KC, Ramos ME, Firestone-Cruz M, Case P,
Strathdee SA. Shooting gallery attendance among IDUs in Tijuana and Ciudad Juarez, Mexico: correlates, prevention opportunities, and the role of the environment. AIDS Behav. 2008;12(4):552-
560. PMCID: PMC2733534.
262. *Philbin MM, Lozada R, *Zuniga de Nuncio ML, *Mantsios A, Case P, Magis-Rodriguez C, Latkin CA,
Strathdee SA. A qualitative assessment of stakeholder perceptions and socio-cultural influences on the acceptability of harm reduction programs in Tijuana, Mexico. Harm Reduct J. 2008;5:36. PMCID:
PMC2613137.
263. *Pollini RA, *Brouwer KC, Lozada RM, Ramos R, Cruz MF, Magis-Rodriguez C, Case P, Burris S,
Pu M, Frost SD, Palinkas LA, Miller C, Strathdee SA. Syringe possession arrests are associated with receptive syringe sharing in two Mexico-US border cities. Addiction. 2008;103(1):101-108. PMID:
18028520; PMCID: PMC2214830.
264. *Rodwell TC, Moore M, Moser KS, Brodine SK, Strathdee SA. Tuberculosis from Mycobacterium bovis in binational communities, United States. Emerg Infect Dis. 2008;14(6):909-916. PMCID:
PMC2600278.
265. Schilder AJ, Orchard TR, Buchner CS, Miller ML, Fernandes KA, Hogg RS, Strathdee SA. 'It's like the treasure:" beliefs associated with semen among young HIV-positive and HIV-negative gay men.
Cult Health Sex. 2008;10(7):667-679. PMID: 18821350.
266. Schwarz K, Garrett B, Lee J, Thompson D, Thiel T, Alter MJ, Strathdee SA. Positive impact of a shelter-based hepatitis B vaccine program in homeless Baltimore children and adolescents. J Urban
Health. 2008;85(2):228-238. PMCID: PMC2430122.
267. Schwarz KB, Garrett B, Alter MJ, Thompson D, Strathdee SA. Seroprevalence of HCV infection in homeless Baltimore families. J Health Care Poor Underserved. 2008;19(2):580-587. PMID:
18469428.
268. Semple SJ, Zians J, Strathdee SA, Patterson TL. Methamphetamine-using felons: psychosocial and behavioral characteristics. Am J Addict. 2008;17(1):28-35. PMID: 18214720; PMCID: PMC2819148.
269. *Shannon K, Kaida A, Rachlis B, Lloyd-Smith E, Gray G, Strathdee SA. Reconsidering the impact of conflict on HIV infection among women in the era of antiretroviral treatment scale-up in sub-Saharan
Africa: a gender lens. AIDS. 2008;22(14):1705-1707. PMID: 18753938.
270. Strathdee SA, Case P, Lozada R, *Mantsios AR, Alvelais J, Pu M, *Brouwer KC, *Miller CL,
Patterson TL. The color of meth: is it related to adverse health outcomes? an exploratory study in
Tijuana, Mexico. Am J Addict. 2008;17(2):111-115. PMID: 18393053.
271. Strathdee SA, Lozada R, *Ojeda VDD, *Pollini RA, *Brouwer KC, Vera A, Cornelius W, Nguyen L,
Magis-Rodriguez C, Patterson TL. Differential effects of migration and deportation on HIV infection among male and female injection drug users in Tijuana, Mexico. PLoS One. 2008;3(7):e2690.
PMCID: PMC2467493.
272. Strathdee SA, Lozada R, *Pollini RA, *Brouwer KC, *Mantsios A, Abramovitz DAA, Rhodes T, Latkin
CA, *Loza O, Alvelais J, Magis-Rodriguez C, Patterson TL. Individual, social, and environmental influences associated with HIV infection among injection drug users in Tijuana, Mexico. J Acquir
Immune Defic Syndr. 2008;47(3):369-376. PMCID: PMC2752692.
21

273. Strathdee SA, Lozada R, Semple SJ, Orozovich P, Pu M, Staines-Orozco H, Fraga-Vallejo M, Amaro
H, Delatorre A, Magis-Rodriguez C, Patterson TL. Characteristics of female sex workers with US clients in two Mexico-US border cities. Sex Transm Dis. 2008;35(3):263-268. PMCID: PMC2737364.
274. Strathdee SA, Magis-Rodriguez C. Mexico's evolving HIV epidemic. JAMA. 2008;300(5):571-573.
PMCID: PMC2717701.
275. Strathdee SA, *Philbin MM, Semple SJ, Pu M, Orozovich P, Martinez G, Lozada R, Fraga M, de la
Torre A, Staines H, Magis-Rodriguez C, Patterson TL. Correlates of injection drug use among female sex workers in two Mexico-U.S. border cities. Drug Alcohol Depend. 2008;92(1-3):132-140. PMCID:
PMC2213538.
276. *Todd CS, Abed AM, Scott PT, Botros BA, Safi N, Earhart KC, Strathdee SA. Correlates of receptive and distributive needle sharing among injection drug users in Kabul, Afghanistan. Am J Drug Alcohol
Abuse. 2008;34(1):91-100. PMID: 18161647.
277. *Todd CS, Ahmadzai M, Atiqzai F, Miller S, Smith JM, Ghazanfar SA, Strathdee SA. Seroprevalence and correlates of HIV, syphilis, and hepatitis B and C virus among intrapartum patients in Kabul,
Afghanistan. BMC Infect Dis. 2008;8:119. PMCID: PMC2557011.
278. *Todd CS, Ahmadzai M, Smith JM, Siddiqui H, Ghazanfar SA, Strathdee SA. Attitudes and practices of obstetric care providers in Kabul, Afghanistan regarding antenatal testing for sexually transmitted infection. J Obstet Gynecol Neonatal Nurs. 2008;37(5):607-615. PMID: 18811781.
279. *Todd CS, Isley MM, Ahmadzai M, Azfar P, Atiqzai F, Smith JM, Ghazanfar SA, Strathdee SA, Miller
S. Cross-sectional analysis of factors associated with prior contraceptive use among hospitalized obstetric patients in Kabul, Afghanistan. Contraception. 2008;78(3):249-256. PMCID: PMC2585412.
280. Werb D, *Wood E, Small W, Strathdee SA, Li K, Montaner J, Kerr T. Effects of police confiscation of illicit drugs and syringes among injection drug users in Vancouver. Int J Drug Policy. 2008;19(4):332-
338. PMCID: PMC2529170.
281. Wood E, Montaner JS, Li K, Zhang R, Barney L, Strathdee SA, Tyndall MW, Kerr T. Burden of HIV infection among aboriginal injection drug users in Vancouver, British Columbia. Am J Public Health.
2008;98(3):515-519. PMCID: PMC2253561.
282. Wood E, Stoltz JA, Zhang R, Strathdee SA, Montaner JS, Kerr T. Circumstances of first crystal methamphetamine use and initiation of injection drug use among high-risk youth. Drug Alcohol Rev.
2008;27(3):270-276. PMID: 18368608.
283. *Zuniga de Nuncio ML, Brennan J, Scolari R, Strathdee SA. Barriers to HIV care in the context of cross-border health care utilization among HIV-positive persons living in the California/Baja
California US-Mexico border region. J Immigr Minor Health. 2008;10(3):219-227. PMID: 17653865.
284. Abramovitz DA, Volz EM, Strathdee SA, Patterson TL, Vera A, Frost SD. Using respondent-driven sampling in a hidden population at risk of HIV infection: who do HIV-positive recruiters recruit? Sex
Transm Dis. 2009;36(12):750-756. PMCID: PMC2788103.
285. Beyrer C, Patel Z, Stachowiak JA, Tishkova FK, Stibich MA, Eyzaguirre LM, Carr JK, Mogilnii V,
Peryshkina A, *Latypov A, Strathdee SA. Characterization of the emerging HIV type 1 and HCV epidemics among injecting drug users in Dushanbe, Tajikistan. AIDS Res Hum Retroviruses.
2009;25(9):853-860. PMCID: PMC2858926.
286. *Brouwer KC, Lozada R, Cornelius WA, Firestone Cruz M, Magis-Rodriguez C, *Zuniga de Nuncio
ML, Strathdee SA. Deportation along the U.S.-Mexico border: its relation to drug use patterns and accessing care. J Immigr Minor Health. 2009;11(1):1-6. PMID: 18247117.
287. *Burgos JL, Kahn JG, Strathdee SA, Valencia-Mendoza A, Bautista-Arredondo S, Laniado-Laborin
R, Castaneda R, *Deiss R, Garfein RS. Targeted screening and treatment for latent tuberculosis infection using QuantiFERON-TB Gold is cost-effective in Mexico. Int J Tuberc Lung Dis.
2009;13(8):962-968. PMCID: PMC2763545.
288. Cheng WS, Garfein RS, Semple SJ, Strathdee SA, Zians JK, Patterson TL. Differences in sexual risk behaviors among male and female HIV-seronegative heterosexual methamphetamine users. Am J
Drug Alcohol Abuse. 2009;35(5):295-300. PMCID: PMC2913870.
289. *Deiss R, Garfein RS, Lozada R, *Burgos JL, *Brouwer KC, Moser KS, *Zuniga ML, *Rodwell TC,
*Ojeda VDD, Strathdee SA. Influences of cross-border mobility on tuberculosis diagnoses and treatment interruption among injection drug users in Tijuana, Mexico. Am J Public Health.
2009;99(8):1491-1495. PMCID: PMC2707467.
22

290. *Drumright LN, Gorbach PM, Little SJ, Strathdee SA. Associations between substance use, erectile dysfunction medication and recent HIV infection among men who have sex with men. AIDS Behav.
2009;13(2):328-336. PMID: 18064558.
291. Druyts EF, Rachlis BS, Lima VD, Harvard SS, Zhang W, Brandson EK, Strathdee SA, Montaner JS,
Hogg RS. Mortality is influenced by locality in a major HIV/AIDS epidemic. HIV Med. 2009;10(5):274-
281. PMID: 19210694.
292. Gardner LI, Marks G, Craw J, Metsch L, Strathdee SA, Anderson-Mahoney P, del Rio C.
Demographic, psychological, and behavioral modifiers of the Antiretroviral Treatment Access Study
(ARTAS) intervention. AIDS Patient Care STDS. 2009;23(9):735-742. PMID: 19645619.
293. Garfein RS, Lozada R, Liu L, Laniado-Laborin R, *Rodwell TC, *Deiss R, Alvelais J, Catanzaro A,
Chiles PG, Strathdee SA. High prevalence of latent tuberculosis infection among injection drug users in Tijuana, Mexico. Int J Tuberc Lung Dis. 2009;13(5):626-632. PMCID: PMC2744313.
294. *Havens JR, Latkin CA, Pu M, Cornelius LJ, Bishai D, Huettner S, Rapp C, Ricketts EP, Lloyd JJ,
Strathdee SA. Predictors of opiate agonist treatment retention among injection drug users referred from a needle exchange program. J Subst Abuse Treat. 2009;36(3):306-312. PMID: 18835681.
295. *Iniguez-Stevens E, *Brouwer KC, Hogg RS, Patterson TL, Lozada R, Magis-Rodriguez C, Elder JP,
Viani RM, Strathdee SA. Estimating the 2006 prevalence of HIV by gender and risk groups in
Tijuana, Mexico. Gac Med Mex. 2009;145(3):189-195. PMCID: PMC3071654.
296. Kerr T, Stoltz JA, Marshall BD, Lai C, Strathdee SA, *Wood E. Childhood trauma and injection drug use among high-risk youth. J Adolesc Health. 2009;45(3):300-302. PMCID: PMC2731692.
297. Larios SE, Lozada R, Strathdee SA, Semple SJ, Roesch S, Staines H, Orozovich P, Fraga M, Amaro
H, de la Torre A, Magis-Rodriguez C, Patterson TL. An exploration of contextual factors that influence HIV risk in female sex workers in Mexico: the Social Ecological Model applied to HIV risk behaviors. AIDS Care. 2009;21(10):1335-1342. PMCID: PMC2861919.
298. *Malta M, Bastos FI, da Silva CM, Pereira GF, Lucena FF, Fonseca MG, Strathdee SA. Differential survival benefit of universal HAART access in Brazil: a nation-wide comparison of injecting drug users versus men who have sex with men. J Acquir Immune Defic Syndr. 2009;52(5):629-635.
PMCID: PMC2787684.
299. Mausbach BT, Semple SJ, Strathdee SA, Patterson TL. Predictors of safer sex intentions and protected sex among heterosexual HIV-negative methamphetamine users: an expanded model of the Theory of Planned Behavior. AIDS Care. 2009;21(1):17-24. PMCID: PMC2631418.
300. Nakamura N, Semple SJ, Strathdee SA, Patterson TL. Methamphetamine initiation among HIVpositive gay and bisexual men. AIDS Care. 2009;21(9):1176-1184. PMCID: PMC3044642.
301. *Ojeda VDD, Strathdee SA, Lozada R, *Rusch ML, Fraga M, Orozovich P, Magis-Rodriguez C, De
La Torre A, Amaro H, Cornelius W, Patterson TL. Associations between migrant status and sexually transmitted infections among female sex workers in Tijuana, Mexico. Sex Transm Infect.
2009;85(6):420-426. PMCID: PMC2819150.
302. Patterson TL, *Goldenberg S, Gallardo M, Lozada R, Semple SJ, Orozovich P, Abramovitz DA,
Strathdee SA. Correlates of HIV, sexually transmitted infections, and associated high-risk behaviors among male clients of female sex workers in Tijuana, Mexico. AIDS. 2009;23(13):1765-1771.
PMCID: PMC2804438.
303. *Philbin MM, *Mantsios A, Lozada R, Case P, *Pollini RA, Alvelais J, Latkin CA, Magis-Rodriguez C,
Strathdee SA. Exploring stakeholder perceptions of acceptability and feasibility of needle exchange programmes, syringe vending machines and safer injection facilities in Tijuana, Mexico. Int J Drug
Policy. 2009;20(4):329-335. PMCID: PMC2727467.
304. *Pollini RA, Alvelais J, Gallardo M, Vera A, Lozada R, Magis-Rodriquez C, Strathdee SA. The harm inside: injection during incarceration among male injection drug users in Tijuana, Mexico. Drug
Alcohol Depend. 2009;103(1-2):52-58.; PMCID: PMC2693031.
305. Poon AF, *Brouwer KC, Strathdee SA, Firestone-Cruz M, Lozada RM, Pond SL, Heckathorn DD,
Frost SD. Parsing social network survey data from hidden populations using stochastic context-free grammars. PLoS One. 2009;4(9):e6777. PMCID: PMC2734164.
306. Ramos R, Ferreira-Pinto JB, *Brouwer KC, Ramos ME, Lozada RM, Firestone-Cruz M, Strathdee
SA. A tale of two cities: social and environmental influences shaping risk factors and protective behaviors in two Mexico-US border cities. Health Place. 2009;15(4):999-1005. PMCID:
PMC2735581.
23

307. Rondinelli AJ, Ouellet LJ, Strathdee SA, Latka MH, Hudson SM, Hagan H, Garfein RS. Young adult injection drug users in the United States continue to practice HIV risk behaviors. Drug Alcohol
Depend. 2009;104(1-2):167-174. PMID: 19559543.
308. *Rusch ML, Lozada R, *Pollini RA, Vera A, Patterson TL, Case P, Strathdee SA. Polydrug use among IDUs in Tijuana, Mexico: correlates of methamphetamine use and route of administration by gender. J Urban Health. 2009;86(5):760-775. PMCID: PMC2729865.
309. Semple SJ, Amaro H, Strathdee SA, Zians J, Patterson TL. Ethnic differences in substance use, sexual risk behaviors, and psychosocial factors in a sample of heterosexual methamphetamine users. Subst Use Misuse. 2009;44(8):1101-1120. PMCID: PMC2905044.
310. Semple SJ, Strathdee SA, Zians J, Patterson TL. Family conflict and depression in HIV-negative heterosexuals: the role of methamphetamine use. Psychol Addict Behav. 2009;23(2):341-347.
PMCID: PMC2777754.
311. Semple SJ, Strathdee SA, Zians J, Patterson TL. Sexual risk behavior associated with coadministration of methamphetamine and other drugs in a sample of HIV-positive men who have sex with men. Am J Addict. 2009;18(1):65-72. PMCID: PMC3044646.
312. Semple SJ, Zians J, Strathdee SA, Patterson TL. Sexual marathons and methamphetamine use among HIV-positive men who have sex with men. Arch Sex Behav. 2009;38(4):583-590. PMCID:
PMC2695846.
313. *Shannon K, Kerr T, Strathdee SA, Shoveller J, Montaner JS, Tyndall MW. Prevalence and structural correlates of gender based violence among a prospective cohort of female sex workers. BMJ.
2009;339:b2939. PMCID: PMC2725271.
314. *Shannon K, Strathdee SA, Shoveller J, Rusch M, Kerr T, Tyndall MW. Structural and environmental barriers to condom use negotiation with clients among female sex workers: implications for HIVprevention strategies and policy. Am J Public Health. 2009;99(4):659-665. PMCID: PMC2661482.
315. Strathdee SA, Mausbach B, Lozada R, Staines-Orozco H, Semple SJ, Abramovitz DA, Fraga-Vallejo
M, Torre Ade L, Amaro H, Martinez-Mendizabal G, Magis-Rodriguez C, Patterson TL. Predictors of sexual risk reduction among Mexican female sex workers enrolled in a behavioral intervention study.
J Acquir Immune Defic Syndr. 2009;51 Suppl 1:S42-46. PMCID: PMC2734908.
316. *Todd CS, Abed AM, Scott PT, Safi N, Earhart KC, Strathdee SA. A cross-sectional assessment of utilization of addiction treatment among injection drug users in Kabul, Afghanistan. Subst Use
Misuse. 2009;44(3):416-430. PMID: 18979391.
317. *Todd CS, Ahmadzai M, Atiqzai F, Smith JM, Miller S, Azfar P, Siddiqui H, Ghazanfar SA, Strathdee
SA. Prevalence and correlates of HIV, syphilis, and hepatitis knowledge among intrapartum patients and health care providers in Kabul, Afghanistan. AIDS Care. 2009;21(1):109-117. PMID: 19085227.
318. *Todd CS, Stibich MA, Stanekzai MR, Rasuli MZ, Bayan S, Wardak SR, Strathdee SA. A qualitative assessment of injection drug use and harm reduction programmes in Kabul, Afghanistan: 2006-
2007. Int J Drug Policy. 2009;20(2):111-120. PMID: 18207381.
319. *Ulibarri MD, Semple SJ, Rao S, Strathdee SA, Fraga-Vallejo MA, Bucardo J, De la Torre A,
Salazar-Reyna J, Orozovich P, Staines-Orozco HS, Amaro H, Magis-Rodriguez C, Patterson TL.
History of abuse and psychological distress symptoms among female sex workers in two Mexico-
U.S. border cities. Violence Vict. 2009;24(3):399-413. PMCID: PMC2777761.
320. Volkow P, *Brouwer KC, *Loza O, Ramos R, Lozada R, Garfein RS, Magis-Rodriguez C, Firestone-
Cruz M, Strathdee SA. Cross-border paid plasma donation among injection drug users in two
Mexico-U.S. border cities. Int J Drug Policy. 2009;20(5):409-412. PMCID: PMC2955515.
321. *Wagner KD, Hudson SM, Latka MH, Strathdee SA, Thiede H, Mackesy-Amiti ME, Garfein RS. The effect of intimate partner violence on receptive syringe sharing among young female injection drug users: an analysis of mediation effects. AIDS Behav. 2009;13(2):217-224. PMID: 17876699.
322. Bautista CT, *Todd CS, Abed AM, Botros BA, Strathdee SA, Earhart KC, Safi N, Scott PT. Effects of duration of injection drug use and age at first injection on HCV among IDU in Kabul, Afghanistan. J
Public Health (Oxf). 2010;32(3):336-341. PMID: 20421237.
323. Beyrer C, Malinowska-Sempruch K, Kamarulzaman A, Kazatchkine M, Sidibe M, Strathdee SA. Time to act: a call for comprehensive responses to HIV in people who use drugs. Lancet.
2010;376(9740):551-563. PMID: 20650515.
324. Beyrer C, Malinowska-Sempruch K, Kamarulzaman A, Strathdee SA. 12 myths about HIV/AIDS and people who use drugs. Lancet. 2010;376(9737):208-211. PMID: 20650524.
24

325. *Burgos JL, Gaebler JA, Strathdee SA, Lozada R, Staines H, Patterson TL. Cost-effectiveness of an intervention to reduce HIV/STI incidence and promote condom use among female sex workers in the
Mexico-US border region. PLoS One. 2010;5(6):e11413. PMCID: PMC2894974.
326. Cheng WS, Garfein RS, Semple SJ, Strathdee SA, Zians JK, Patterson TL. Increased drug use and
STI risk with injection drug use among HIV-seronegative heterosexual methamphetamine users. J
Psych Drugs. 2010;42(1):11-18. PMCID: PMC2907747.
327. Cheng WS, Garfein RS, Semple SJ, Strathdee SA, Zians JK, Patterson TL. Binge use and sex and drug use behaviors among HIV(-), heterosexual methamphetamine users in San Diego. Subst Use
Misuse. 2010;45(1-2):116-133. PMCID: PMC2861916.
328. Degenhardt L, Mathers B, Guarinieri M, Panda S, Phillips B, Strathdee SA, Tyndall M, Wiessing L,
Wodak A, Howard J. Meth/amphetamine use and associated HIV: implications for global policy and public health. Int J Drug Policy. 2010;21(5):347-358. PMID: 20117923.
329. Garfein RS, Laniado-Laborin R, *Rodwell TC, Lozada R, *Deiss R, *Burgos JL, Cuevas-Mota J,
Cerecer P, Moser K, Volker ML, Strathdee SA. Latent tuberculosis among persons at risk for infection with HIV, Tijuana, Mexico. Emerg Infect Dis. 2010;16(5):757-763. PMID: 20409363;
PMCID: PMC2953999.
330. *Goldenberg SM, Gallardo Cruz M, Strathdee SA, Nguyen L, Semple SJ, Patterson TL. Correlates of unprotected sex with female sex workers among male clients in Tijuana, Mexico. Sex Transm Dis.
2010;37(5):319-324. PMCID: PMC2861913.
331. Hagan H, Pouget ER, Williams IT, Garfein RL, Strathdee SA, Hudson SM, Latka MH, Ouellet LJ.
Attribution of hepatitis C virus seroconversion risk in young injection drug users in 5 US cities. J
Infect Dis. 2010;201(3):378-385. PMID: 20053137.
332. Kaida A, Laher F, Strathdee SA, Money D, Janssen PA, Hogg RS, Gray G. Contraceptive use and method preference among women in Soweto, South Africa: the influence of expanding access to HIV care and treatment services. PLoS One. 2010;5(11):e13868. PMCID: PMC2974641.
333. *Loza O, Patterson TL, Rusch M, Martinez GA, Lozada R, Staines-Orozco H, Magis-Rodriguez C,
Strathdee SA. Drug-related behaviors independently associated with syphilis infection among female sex workers in two Mexico-US border cities. Addiction. 2010;105(8):1448-1456. PMCID:
PMC3285983.
334. *Loza O, Strathdee SA, Lozada R, Staines H, *Ojeda VDD, Martinez GA, Amaro H, Patterson TL.
Correlates of early versus later initiation into sex work in two Mexico-U.S. border cities. J Adolesc
Health. 2010;46(1):37-44. PMCID: PMC2818024.
335. *Loza O, Strathdee SA, Martinez GA, Lozada R, *Ojeda VDD, Staines-Orozco H, Patterson TL. Risk factors associated with chlamydia and gonorrhoea infection among female sex workers in two
Mexico-USA border cities. Int J STD AIDS. 2010;21(7):460-465. PMID: 20852194; PMCID:
PMC3069918.
336. *Malta M, Magnanini MM, Strathdee SA, Bastos FI. Adherence to antiretroviral therapy among HIVinfected drug users: a meta-analysis. AIDS Behav. 2010;14(4):731-747. PMID: 19020970.
337. Mathers BM, Degenhardt L, Ali H, Wiessing L, Hickman M, Mattick RP, Myers B, Ambekar A,
Strathdee SA. 2009 Reference Group to the UN on HIV and Injecting Drug Use. HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage. Lancet. 2010;375(9719):1014-1028. PMID: 20189638.
338. Mehta SR, Delport W, *Brouwer KC, Espitia S, Patterson TL, Pond SK, Strathdee SA, Smith DM.
The relatedness of HIV epidemics in the United States-Mexico border region. AIDS Res Hum
Retroviruses. 2010;26(12):1273-1277. PMCID: PMC3011998.
339. Munoz FA, *Pollini RA, *Zuniga ML, Strathdee SA, Lozada R, Martinez GA, Valles-Medina AM,
*Sirotin N, Patterson TL. Condom access: associations with consistent condom use among female sex workers in two northern border cities of Mexico. AIDS Educ Prev. 2010;22(5):455-465. PMCID:
PMC3069917.
340. *Pollini RA, Gallardo M, Hasan S, Minuto J, Lozada R, Vera A, *Zuniga ML, Strathdee SA. High prevalence of abscesses and self-treatment among injection drug users in Tijuana, Mexico. Int J
Infect Dis. 2010;14 Suppl 3:e117-122. PMCID: PMC2917477.
341. *Pollini RA, Lozada R, Gallardo M, Rosen P, Vera A, Macias A, Palinkas LA, Strathdee SA. Barriers to pharmacy-based syringe purchase among injection drug users in Tijuana, Mexico: a mixed methods study. AIDS Behav. 2010;14(3):679-687. PMCID: PMC2865643.
25

342. *Robertson AM, Vera AY, Gallardo M, *Pollini RA, Patterson TL, Case P, Nguyen L, Strathdee SA.
Correlates of seeking injection assistance among injection drug users in Tijuana, Mexico. Am J
Addict. 2010;19(4):357-363. PMCID: PMC2911636.
343. *Rodwell TC, Barnes RF, Moore M, Strathdee SA, Raich A, Moser KS, Garfein RS. HIV-tuberculosis coinfection in Southern California: evaluating disparities in disease burden. Am J Public Health.
2010;100 Suppl 1:S178-185. PMCID: PMC2837460.
344. *Rodwell TC, Kapasi AJ, Moore M, Milian-Suazo F, Harris B, Guerrero LP, Moser K, Strathdee SA,
Garfein RS. Tracing the origins of Mycobacterium bovis tuberculosis in humans in the USA to cattle in Mexico using spoligotyping. Int J Infect Dis. 2010;14 Suppl 3:e129-135. PMCID: PMC2920372.
345. *Rodwell TC, *Robertson AM, Aguirre N, Vera A, Anderson CM, Lozada R, Chait L, Schooley RT,
Zhang XQ, Strathdee SA. Pandemic (H1N1) 2009 Surveillance in Marginalized Populations, Tijuana,
Mexico. Emerg Infect Dis. 2010;16(8):1292-1295. PMCID: PMC3298300.
346. *Rusch ML, *Brouwer KC, Lozada R, Strathdee SA, Magis-Rodriguez C, Patterson TL. Distribution of sexually transmitted diseases and risk factors by work locations among female sex workers in
Tijuana, Mexico. Sex Transm Dis. 2010;37(10):608-614. PMID: 20585278.
347. Sanders-Buell E, Bose M, Nasir A, *Todd CS, Stanekzai MR, Tovanabutra S, Scott PT, Strathdee
SA, Tjaden J, Michael NL, McCutchan FE. Distinct circulating recombinant HIV-1 strains among injecting drug users and sex workers in Afghanistan. AIDS Res Hum Retroviruses. 2010;26(5):605-
608.; PMCID: PMC2933162.
348. Semple SJ, Strathdee SA, Gallardo Cruz M, *Robertson A, *Goldenberg S, Patterson TL.
Psychosexual and social-cognitive correlates of sexual risk behavior among male clients of female sex workers in Tijuana, Mexico. AIDS Care. 2010;22(12):1473-1480. PMCID: PMC3082496.
349. Semple SJ, Strathdee SA, Zians J, Patterson TL. Social and behavioral characteristics of HIVpositive MSM who trade sex for methamphetamine. Am J Drug Alcohol Abuse. 2010;36(6):325-331.
PMCID: PMC3383823.
350. Semple SJ, Strathdee SA, Zians J, Patterson TL. Life events and sexual risk among HIV-negative, heterosexual, methamphetamine users. J Sex Res. 2010;47(4):355-363. PMCID: PMC2888692.
351. Semple SJ, Strathdee SA, Zians J, Patterson TL. Factors associated with sex in the context of methamphetamine use in different sexual venues among HIV-positive men who have sex with men.
BMC Public Health. 2010;10:178. PMCID: PMC2858118.
352. *Shannon K, Kerr T, Marshall B, Li K, Zhang R, Strathdee SA, Tyndall MW, Montaner JG, Wood E.
Survival sex work involvement as a primary risk factor for hepatitis C virus acquisition in drug-using youths in a canadian setting. Arch Pediatr Adolesc Med. 2010;164(1):61-65. PMID: 20048243.
353. *Sirotin N, Strathdee SA, Lozada R, Abramovitz DA, Semple SJ, Bucardo J, Patterson TL. Effects of government registration on unprotected sex amongst female sex workers in Tijuana; Mexico. Int J
Drug Policy. 2010;21(6):466-470. PMCID: PMC2991616.
354. *Sirotin N, Strathdee SA, Lozada R, Nguyen L, Gallardo M, Vera A, Patterson TL. A comparison of registered and unregistered female sex workers in Tijuana, Mexico. Public Health Rep. 2010;125
Suppl 4:101-109. PMCID: PMC2882980.
355. *Stockman JK, Strathdee SA. HIV among people who use drugs: a global perspective of populations at risk. J Acquir Immune Defic Syndr. 2010;55 Suppl 1:S17-22. PMID: 21045594; PMCID:
PMC3059238.
356. Strathdee SA, Hallett TB, Bobrova N, Rhodes T, Booth R, Abdool R, Hankins CA. HIV and risk environment for injecting drug users: the past, present, and future. Lancet. 2010;376(9737):268-284.
PMID: 20650523.
357. Strathdee SA, *Stockman JK. Epidemiology of HIV among injecting and non-injecting drug users: current trends and implications for interventions. Curr HIV/AIDS Rep. 2010;7(2):99-106. PMCID:
PMC2856849.
358. *Syvertsen J, *Pollini RA, Lozada R, Vera A, Rangel G, Strathdee SA. Managing la malilla: exploring drug treatment experiences among injection drug users in Tijuana, Mexico, and their implications for drug law reform. Int J Drug Policy. 2010;21(6):459-465. PMCID: PMC3444157.
359. *Todd CS, Nasir A, Raza Stanekzai M, Abed AM, Strathdee SA, Bautista CT, Scott PT, Botros BA,
Tjaden J. Prevalence and correlates of syphilis and condom use among male injection drug users in four Afghan cities. Sex Transm Dis. 2010;37(11):719-725. PMID: 20585276.
26

360. *Todd CS, Nasir A, Raza Stanekzai M, Scott PT, Strathdee SA, Botros BA, Tjaden J. Contraceptive utilization and pregnancy termination among female sex workers in Afghanistan. J Womens Health
(Larchmt). 2010;19(11):2057-2062. PMCID: PMC2971650.
361. *Todd CS, Nasir A, Stanekzai MR, Bautista CT, Botros BA, Scott PT, Strathdee SA, Tjaden J. HIV, hepatitis B, and hepatitis C prevalence and associated risk behaviors among female sex workers in three Afghan cities. AIDS. 2010;24 Suppl 2:S69-75. PMID: 20610952.
362. *Ulibarri MD, Strathdee SA, Lozada R, Magis-Rodriguez C, Amaro H, O'Campo P, Patterson TL.
Intimate partner violence among female sex workers in two Mexico-US Border cities: partner characteristics and HIV risk-behaviors as correlates of abuse. Psychol Trauma. 2010;2(4):318-325.
PMCID: PMC3083072.
363. *Ulibarri MD, Strathdee SA, Patterson TL. Sexual and drug use behaviors associated with HIV and other sexually transmitted infections among female sex workers in the Mexico-US border region.
Curr Opin Psychiatry. 2010;23(3):215-220. PMCID: PMC3412621.
364. Vlahov D, *Robertson AM, Strathdee SA. Prevention of HIV infection among injection drug users in resource-limited settings. Clin Infect Dis. 2010;50 Suppl 3:S114-121. PMCID: PMC3114556.
365. *Zuniga de Nuncio ML, Blanco E, Palinkas LA, Strathdee SA, Gifford AL. Cross-cultural considerations in the recruitment of Latinos of Mexican origin into HIV/AIDS Clinical Trials in the
U.S.-Mexico Border Region: clinician and patient perspectives. J Immigr Refug Stud. 2010;8(241-
260).
366. G oldenberg, S., Strathdee, S. A., Gallardo, M., & Patterson, T. L. (2010). “People Here Are Alone,
Using Drugs, Selling their Body”: Deportation and HIV Vulnerability among Clients of Female Sex
Workers in Tijuana. Field Actions Science Reports. The journal of field actions, (Special Issue 2).
367. *Drumright LN, Hagan H, Thomas DL, Latka MH, *Golub ET, Garfein RS, Clapp JD, Campbell JV,
Bonner S, Kapadia F, Thiel TK, Strathdee SA. Predictors and effects of alcohol use on liver function among young HCV-infected injection drug users in a behavioral intervention. J Hepatol.
2011;55(1):45-52. PMCID: PMC3094600.
368. *Goldenberg SM, Strathdee SA, Gallardo M, Nguyen L, Lozada R, Semple SJ, Patterson TL. How important are venue-based HIV risks among male clients of female sex workers? A mixed methods analysis of the risk environment in nightlife venues in Tijuana, Mexico. Health Place. 2011;17(3):748-
756. PMCID: PMC3092829.
369. *Goldenberg SM, Strathdee SA, Gallardo M, Rhodes T, *Wagner KD, Patterson TL. "Over here, it's just drugs, women and all the madness": the HIV risk environment of clients of female sex workers in
Tijuana, Mexico. Soc Sci Med. 2011;72(7):1185-1192. PMCID: PMC3075317.
370. Kaida A, Laher F, Strathdee SA, Janssen PA, Money D, Hogg RS, Gray G. Childbearing intentions of HIV-positive women of reproductive age in Soweto, South Africa: the influence of expanding access to HAART in an HIV hyperendemic setting. Am J Public Health. 2011;101(2):350-358.
PMCID: PMC3020203.
371. *Mehta SH, Astemborski J, Kirk GD, Strathdee SA, Nelson KE, Vlahov D, Thomas DL. Changes in blood-borne infection risk among injection drug users. J Infect Dis. 2011;203(5):587-594. PMCID:
PMC3072736.
372. *Morris MD, Case P, *Robertson AM, Lozada R, Vera A, Clapp JD, Medina-Mora ME, Strathdee SA.
Prevalence and correlates of 'agua celeste' use among female sex workers who inject drugs in
Ciudad Juarez, Mexico. Drug Alcohol Depend. 2011;117(2-3):219-25. PMCID: PMC3148352.
373. Nakamura N, Semple SJ, Strathdee SA, Patterson TL. HIV risk profiles among HIV-positive, methamphetamine-using men who have sex with both men and women. Arch Sex Behav.
2011;40(4):793-801. PMCID: PMC3114110.
374. Nasir A, *Todd CS, Stanekzai MR, Bautista CT, Botros BA, Scott PT, Kim JH, Strathdee SA, Tjaden
J. Implications of hepatitis C viremia vs. antibody alone on transmission among male injecting drug users in three Afghan cities. Int J Infect Dis. 2011;15(3):e201-205. PMID: 21190883.
375. Nasir A, *Todd CS, Stanekzai MR, Bautista CT, Botros BA, Scott PT, Strathdee SA, Tjaden J.
Prevalence of HIV, hepatitis B and hepatitis C and associated risk behaviors amongst injecting drug users in three Afghan cities. Int J Drug Policy. 2011;22(2):145-152. PMID: 21146392.
376. *Ojeda VD, *Robertson AM, Hiller SP, Lozada R, Cornelius W, Palinkas LA, Magis-Rodriguez C,
Strathdee SA. A qualitative view of drug use behaviors of Mexican male injection drug users deported from the United States. J Urban Health. 2011;88(1):104-117. PMCID: PMC3042081.
27

377. Semple SJ, Strathdee SA, Zians J, McQuaid J, Patterson TL. Psychosocial and behavioral correlates of anxiety symptoms in a sample of HIV-positive, methamphetamine-using men who have sex with men. AIDS Care. 2011;23(5):628-637. PMCID: PMC3388942.
378. Semple SJ, Strathdee SA, Zians J, McQuaid JR, Patterson TL. Drug assertiveness and sexual risktaking behavior in a sample of HIV-positive, methamphetamine-using men who have sex with men. J
Subst Abuse Treat. 2011;41(3):265-72. PMCID: PMC3154402.
379. *Shannon K, Strathdee SA, Shoveller J, Zhang R, Montaner J, Tyndall M. Crystal methamphetamine use among female street-based sex workers: Moving beyond individual-focused interventions. Drug
Alcohol Depend. 2011;113(1):76-81. PMCID: PMC3392206.
380. Strathdee SA, Lozada R, Martinez G, Vera A, Rusch M, Nguyen L, *Pollini RA, Uribe-Salas F,
Beletsky L, Patterson TL. Social and structural factors associated with HIV infection among female sex workers who inject drugs in the Mexico-US border region. PLoS One. 2011;6(4):e19048. PMCID:
PMC3081836.
381. *Todd CS, Nasir A, Stanekzai MR, Scott PT, Close NC, Botros BA, Strathdee SA, Tjaden J. HIV awareness and condom use among female sex workers in Afghanistan: implications for intervention.
AIDS Care. 2011;23(3):348-356. PMID: 21347898.
382. *Ulibarri MD, Strathdee SA, Ulloa EC, Lozada R, Fraga MA, Magis-Rodriguez C, De La Torre A,
Amaro H, O'Campo P, Patterson TL. Injection drug use as a mediator between client-perpetrated abuse and HIV status among female sex workers in two Mexico-US border cities. AIDS Behav.
2011;15(1):179-185. PMCID: PMC2889005.
383. *Volkmann T, Lozada R, Anderson CM, Patterson TL, Vera A, Strathdee SA. Factors associated with drug-related harms related to policing in Tijuana, Mexico. Harm Reduct J. 2011;8(1):7. PMCID:
PMC3080292.
384. *Wagner KD, *Pollini RA, Patterson TL, Lozada R, *Ojeda VDD, *Brouwer KC, Vera A, *Volkmann
TA, Strathdee SA. Cross-border drug injection relationships among injection drug users in Tijuana,
Mexico. Drug Alcohol Depend. 2011;113(2-3):236-241. PMCID: PMC3025041.
385. *Zuniga ML, Blanco E, Brennan JJ, Scolari R, Artamonova IV, Strathdee SA. Binational care-seeking behavior and health-related quality of life among HIV-infected Latinos in the U.S.-Mexico border region. J Assoc Nurses AIDS Care. 2011;22(3):162-172. PMCID: PMC3086322.
386. *Todd CS, Nasir A, Stanekzai MR, Fiekert K, Rasuli MZ, Vlahov D, Strathdee SA. Prevalence and correlates of HIV, syphilis, and hepatitis B and C infection and harm reduction program use among male injecting drug users in Kabul, Afghanistan: A cross-sectional assessment. Harm Reduct J.
2011;8:22. PMCID: PMC3180253.
387. Kapadia F, Latka MH, Wu Y, Strathdee SA, Mackesy-Amiti ME, Hudson SM, Thiede H, Garfein RS.
Longitudinal determinants of consistent condom use by partner type among young injection drug users: the role of personal and partner characteristics. AIDS Behav. 2011;15(7):1309-18. PMCID:
PMC3180628.
388. Semple SJ, Strathdee SA, Zians J, Patterson TL. Methamphetamine-using parents: the relationship between parental role strain and depressive symptoms. J Stud Alcohol Drugs. 2011;72(6):954-64.
PMCID: PMC3211966.
389. *Goldenberg SM, Rangel G, Vera A, Patterson TL, Abramovitz D, Silverman JG, Raj A, Strathdee
SA. Exploring the impact of underage sex work among female sex workers in two Mexico-US border cities. AIDS Behav. 2011. PMCID: PMC3319836.
390. Semple SJ, Strathdee SA, Volkmann T, Zians J, Patterson TL. "High on my own supply": correlates of drug dealing among heterosexually identified methamphetamine users. Am J Addict.
2011;20(6):516-24. PMCID: PMC3197264.
391. Stanekzai MR, Todd CS, Orr MG, Bayan S, Rasuli MZ, Wardak SR, Strathdee SA. Baseline assessment of community knowledge and attitudes toward drug use and harm reduction in Kabul,
Afghanistan. Drug Alcohol Rev. 2011. PMID: 21919980.
392. Semple SJ, Strathdee SA, Zians J, Patterson TL. Correlates of trading sex for methamphetamine in a sample of HIV-negative heterosexual methamphetamine users. J Psych Drugs. 2011;43(2):79-88.
PMID: 21858954.
393. Barnes RF, Moore ML, Garfein RS, Brodine S, Strathdee SA, Rodwell TC. Trends in mortality of tuberculosis patients in the United States: the long-term perspective. Ann Epidemiol.
2011;21(10):791-5. PMCID: PMC3166369.
28

394. Semple SJ, Strathdee SA, Zians J, McQuaid J, Patterson TL. Correlates of obsessive-compulsive disorder in a sample of HIV-positive, methamphetamine-using men who have sex with men. AIDS
Behav. 2011;15(6):1153-60. PMCID: PMC2978745.
395. *Angulo-Arreola IA, Bastos FI, Strathdee SA. Substance abuse and HIV/AIDS in the Caribbean: current challenges and the ongoing response. J Int Assoc Phys AIDS Care (Chic). 2011. PMID:
21852689.
396. *Deiss RG, Lozada RM, *Burgos JL, Strathdee SA, Gallardo M, Cuevas J, Garfein RS. HIV prevalence and sexual risk behavior among non-injection drug users in Tijuana, Mexico. Glob Public
Health. 2012;7(2):175-83. PMCID: PMC3163240.
397. *Urada LA, Morisky DE, Pimentel-Simbulan N, Silverman JG, Strathdee SA. Condom negotiations among female sex workers in the Philippines: environmental influences. PLoS One.
2012;7(3):e33282. PMCID: PMC3308968.
398. Syvertsen JL, Roberston AM, Abramovitz D, Rangel GM, Martinez G, Patterson TL, Ulibarri MD,
Vera A, El-Bassel N, Strathdee SA. Study protocol for the recruitment of female sex workers and their non-commercial partners into couple-based HIV research. BMC Public Health. 2012;12(1):136.
PMCID: PMC3359230
399. *Morris MD, Brouwer KC, Lozada RM, Gallardo M, Vera A, Strathdee SA . “Injection first”: a unique group of drug users in Tijuana, Mexico. Am J Addict, 2012(1) 23-30. PMID: 22211343.
400. Croff JM, Clapp JD, Chambers CD, Woodruff SI, Strathdee SA. Brief field-based intervention to reduce alcohol-related problems among men who have sex with men. J Stud Alcohol Drugs.
2012;73(2):285-9. PMID: 22333336.
401. *Brouwer KC, Lozada R, Weeks JR, MagisRodrÃguez C, Firestone M, Strathdee SA. Intraurban mobility and its potential impact on the spread of blood-borne infections among drug injectors in
Tijuana, Mexico. Substance Use Misuse. 2012;47(3):244-53. PMID: 22136446.
402. *Wagner KD, Davidson PJ, Pollini RA, Strathdee SA, Washburn R, Palinkas LA. Reconciling incongruous qualitative and quantitative findings in mixed methods research: exemplars from research with drug using populations. Int J Drug Policy. 2012;23(1):54-61. PMCID: PMC3210875.
403. *Volkmann T, Shin SS, Garfein RS, Patterson TL, Pollini RA, Wagner KD, Artamanova I, Strathdee
SA. Border crossing to inject drugs in Mexico among injection drug users in San Diego, California. J
Immigr Minor Health. 2012;14(2):281-6. PMCID: PMC3163238.
404. Hahm HC, Lee J, Rough K, Strathdee SA, Gender power control, sexual experiences, safer sex practices, and potential HIV risk behaviors among young Asian-American women. AIDS Behav.
2012;16(1):179-88. PMCID: PMC3389795.
405. Ulibarri MD, Strathdee SA, Lozada R, Staines-
Orozco HS, Abramovitz D, Semple S, Martínez GA,
Patterson TL. Condom use among female sex workers and their non-commercial partners: effects of a sexual risk intervention in two Mexican cities. Int J STD AIDS. 2012 Apr;23(4):229-34. PMCID:
PMC3353829.
406. *Goldenberg SM, Strathdee SA, Perez-Rosales MD, Sued O. Mobility and HIV in Central America and Mexico: a critical review. J Immigr Minor Health. 2012;14(1):48-64. PMID: 21789558.
407. Strathdee SA, Shoptaw S, Quan V, Penniman-Dyer T, Aramrattana A. for the substance use scientific committee of the HIV prevention trials network. Towards combination HIV prevention for injection drug users: addressing addictophobia, apathy and inattention. Curr Opin HIV AIDS. 2012
Jul;7(4):320-325.
PMID: 22498479
408. Strathdee SA, Magis-Rodriguez C, Mays VM, Jiminez R, Patterson TL. The emerging HIV epidemic on the Mexico-US border: an international case study characterizing the role of epidemiology in surveillance and response. Ann Epidemiol. 2012 Jun;22(6):426-38. PMCID: PMC3361703
409. Patterson TL, Volkmann T, Gallardo M, Goldenberg S, Lozada R, Semple SJ, Anderson CM,
Strathdee SA. Identifying the HIV transmission bridge: which men are having unsafe sex with female sex workers and with their own wives or steady partners? J Acquir Immune Defic Syndr. 2012. [Epub ahead of print] PMCID: PMC3392412
410. *Stockman JK, Morris MD, Martinez G, Lozada R, Patterson TL, Ulibarri MD, Vera A, Strathdee SA.
Prevalence and correlates of female condom use and interest among injection-drug using female sex workers in two Mexico-U.S. border cities. AIDS and Behavior. 2012;16(7):1877-86. PMCID:
PMC3461315
29

411. *Robertson AM, Ojeda VD, Nguyen L, Lozada R, Martinez AM, Strathdee SA, Patterson TL.
Reducing harm from HIV/AIDS misconceptions among female sex workers in Tijuana and Ciudad
Juarez, Mexico: a cross sectional analysis. Harm Reduction Journal. 2012;9(1):35. PMCID:
PMC3477120
412. *Vera AH, Abramovitz D, Lozada R, Martinez G, Rangel GM, Staines H, Patterson TL, Strathdee SA.
Mujer Mas Segura (Safer Women): a combination prevention intervention to reduce sexual and injection risks among female sex workers who inject drugs. BMC Public Health. 2012;12:653.
PMCID: PMC3490986
413. *Urada LA, Morisky DE, Hernandez LI, Strathdee SA. Social and structural factors associated with consistent condom use among female entertainment workers trading sex in the Philippines. AIDS
Behav. 2012. PMID: 22223297.
414. Semple SJ, Strathdee SA, Zians J, Patterson TL. Factors associated with experiences of stigma in a sample of HIV-positive, methamphetamine-using men who have sex with men. Drug Alcohol
Depend. 2012. PMCID: PMC3419298.
415. Krusi A, Chettiar J, Ridgeway A, Abbott J, Strathdee SA, Shannon K. Negotiating safety and sexual risk reduction with clients in unsanctioned safer indoor sex work environments: a qualitative study.
AM J Public Health. 2012:102(6):1154-1159. PMID: 22571708.
416. Beletsky L, Martinez G, Gaines T, Nguyen L, Lozada R, Rangel G, Vera A, McCauley HL, Sorensen
A, Strathdee SA . Mexico’s northern border conflict: collateral damage to health and human rights of vulnerable groups. Rev Panam Salud Publica. 2012;31(5):403-10. PMID: 22767041
417. Barrón Limón SA, Semple SJ, Strathdee SA, Lozada R, Vargas Ojeda AC, Patterson TL. Correlates of unprotected anal sex among men who have sex with men in Tijuana, Mexico. BMC Public Health.
2012;12(1):433. PMCID: PMC3419298
418. Serv in A, Muñoz FA, Strathdee SA, Kozo J, Zúñiga ML. Choosing sides: HIV health care practices among shared populations of HIV-positive Latinos living near the U.S.-Mexico border. J Int Assoc
Phys in AIDS Care. 2012;11(6):348-55. PMID:2293079
419. *Gaines TL, Rusch ML, Brouwer KC, Lozada R, Perkins EE, Strathdee SA, Patterson TL. The effect of geography on HIV and sexually transmitted infections in Tijuana’s red light district. J Urban Health.
2012. PMID: 2282579
420. Beletsky L, Lorada R, Gaines T, Abramovitz D, Staines H, Vera A, Rangel G, Arrendondo J,
Strathdee SA. Syringe confiscation as an HIV risk factor: the public health implications of arbitrary policing in Tijuana and Ciudad Juarez, Mexico. Journal of Urban Health. 2012. PMCID:
PMC3675719
421. Eluwa GI, Strathdee SA, Adebayo SB, Ahonsi B, Adebajo SB. A profile on HIV prevalence and risk behaviors among injecting drug users in Nigeria: should we be alarmed? Drug Alcohol Depend.
2012. PMID: 22776443
422. O'Shaughnessy MV, Hogg RS, Strathdee SA, Montaner JS. Deadly public policy: what the future could hold for the HIV epidemic among injection drug users in Vancouver. Curr HIV/AIDS Rep.
2012;9(4):394-400. PMID: 22773331
423. Semple SJ, Strathdee SA, Srikrishnan AK, Solomon S, Patterson TL. Social and behavioral characteristics of gharwalis who operate brothels in the Ganga-Jamuna area of Nagpur, India. AIDS
Care. 2012. PMCID: PMC3502656
424. Patterson TL, Semple SJ, Chavarin CV, Mendoza DV, Santos LE, Chaffin M, Palinkas LA, Strathdee
SA, Aaron GA. Implementation of an efficacious intervention for high risk women in Mexico: protocol for a multi-site randomized trial with a parallel study of organizational factors. BMC Public Health
2012;7(1):105. PMCID: PMC3503741
425. Shin S, Gallardo M, Lozada R, Abramovitz D, Burgos JL, Laniado-Laborin R, Rodwell T, Novotny T,
Strathdee SA, Garfein RS. Cigarette smoking and inteferon gamma release assay conversion among injection drug users: a cohort study. Pulmonary Med. 2012. PMCID: PMC3529865
426. Chen NE, Strathdee SA, Uribe-Salas FJ, Patterson TL, Rangel MG, Rosen P, Brouwer KC.
Correlates of STI symptoms among female sex workers with truck driver clients in two Mexican border towns. BMC Public Health. 2012 Nov 20;12:1000. PMCID: PMC3528625
427. *Wagner KD, Moynihan MJ, Strathdee SA, Cuevas-Mota J, Clark M, Zuniga ML, Volkmann TA,
Teshale E, Garfein RS. The social and environmental context of cross-border drug use in Mexico:
30

findings from a mixed methods study of young IDUs living in San Diego, CA. J Ethn Sub Abuse.
2012. PMCID: PMC3531810
428. Urada LA*, Strathdee SA, Morisky DE, Schilling RF, Pimentel-Simbulan N, Estacio (Jr) LR, Raj A.
Sex work and its associations with alcohol and methamphetamine use among female bar and spa workers in the Philippines. Asia-Pacific Journal of Public Health. 2012.
PMID: 23343641
429. Chen NE, Strathdee SA, Rangel Gudelia, Patterson TL, Uribe-Salas FJ, Rosen P, Villalobos J,
Brouwer KC. HIV risk behaviors differ by workplace stability among Mexican female sex workers with truck driver clientele. J Publ Health Res. 2012. 1(3):pii:e32. PMCID: PMC3979342.
430. Syvertsen JL*, Robertson AM*, Palinkas LA, Rangel MG, Martinez G, Strathdee SA.Where sex ends and emotions begin': love and HIV risk among female sex workers and their intimate, noncommercial partners along the Mexico-US border. Cult Health Sex. 2013 PMID: 23473586
431. Vickerman P, Martin NK, Roy A, Beattie T; EMCDDA Collaborative Group, Jarlais DD, Strathdee S,
Wiessing L, Hickman M. Is the HCV-HIV co-infection prevalence amongst injecting drug users a marker for the level of sexual and injection related HIV transmission? Drug Alcohol Depend. 2013
PMID: 23453261
432. Rolon ML, Syvertsen JL, Robertson AM, Rangel MG, Martinez G, Ulibarri MD, Servin A, Strathdee
SA. The influence of having children on HIV-related risk behaviors of female sex workers and their intimate male partners in two Mexico-US border cities. J Trop Pediatr. 2013 PMID: 23418131
433. Robertson AM*, Syvertsen JL*, Martinez G, Rangel MG, Palinkas LA, Stockman JK, Ulibarri MD,
Strathdee SA. Acceptability of vaginal microbicides among female sex workers and their intimate male partners in two Mexico-US border cities: A mixed methods analysis.Glob Public Health. 2013
PMID: 23398385
434. Robertson AM, Syvertsen JL, Rangel MG, Staines HS, Morris M, Patterson TL, Ulibarri MD,
Strathdee SA. Concurrent sexual partnerships among female sex workers and their non-commercial male partners in Tijuana and Ciudad Juarez, Mexico. Sex Transm Infect 2012 PMID: 23172036
435. Eluwa GI, Strathdee SA, Adebajo SB, Ahonsi B, Azeez A, Anyanti J. Sexual risk behaviors and HIV among female sex workers in Nigeria. J Acquir Immune Defic Syndr. 2012 Dec 1;61(4):507-14
PMID: 22918155
436. Collins SP, Goldenberg SM, Burke NJ, Bojorquez-Chapela I, Silverman JG, Strathdee SA. Situating
HIV risk in the lives of formerly trafficked female sex workers on the Mexico-US border. AIDS Care.
2013 Apr;25(4):459-65. PMCID: PMC3521850
437. Morris MD* , Lemus H, Wagner KD, Martinez G, Lozada R, Gómez RM, Strathdee SA. Factors associated with pathways toward concurrent sex work and injection drug use among female sex workers who inject drugs in northern Mexico. Addiction. 2013 Jan;108(1):161-70. PMCID:
PMC3481016
438. Pitpitan EV*, Kalichman SC, Eaton LA, Strathdee SA, Patterson TL. HIV/STI risk among venuebased female sex workers across the globe: a look back and the way forward. Current HIV/AIDS
Report. 2012. PMCID: PMC3567216
439. Strathdee SA, Wechsberg WM, Kerrigan DL, Patterson TL. HIV prevention among women in lower and middle income countries: intervening upon contexts of heightened HIV risk. Ann Rev Pub Health
2012. PMID: 23297666
440. Semple SJ, Strathdee SA, Zians J, Patterson TL. Mother-son relationship as a risk factor for depressive symptoms among methamphetamine users. J Subst Use. 2012 PMCID: PMC3609666
441. Syvertsen JL*, Robertson AM*, Noriega ML, Palinkas LA, Rangel GM, Martinez G, Strathdee SA. Eyes that don’t see, heart that doesn’t feel: coping with sex work in an intimate relationship context and its implications for HIV prevention. Soc Sci Med. 2013. PMCID: PMC3647366
442. Robertson AM*, Syvertsen JL*, Amaro H, Martinez G, Rangel MG, Patterson TL, Strathdee SA.
Can’t buy my love: a typology of female sex workers’ commercial relationships in the Mexico-US border region. J Sex Res. 2013. PMID:23659340
443. Pitpitan EV*, Wagner KD*, Goodman-Meza D, Semple SJ, Chavarin C, Strathdee SA, Patterson TL.
Context matters: the moderating role of bar context in the association between substance use during sex and condom use among male clients of female sex workers in Tijuana, Mexico. AIDS Behav.
2013. PMCID: PMC3778075
31

444. Goldenberg SM*, Rangel G, Staines H, Vera A, Lozada R, Nguyen L, Silverman JG, Strathdee SA.
Individual, interpersonal, and social-structural correlates of involuntary sex work among female sex workers in two Mexico-U.S. border cities. J Acquir Immune Defic Syndr. 2013. PMCID: PMC3805673
445. Gaines TL, Rusch ML, Brouwer KC, Goldenberg SM, Lozada R, Robertson AM, Perkins E,
Strathdee SA, Patterson TL. Venue-level correlates of female sex worker registration status: A multilevel analysis of bars in Tijuana, Mexico. Glob Public Health. 2013. PMID:23534477
446. Strathdee SA, Abramovitz D, Lozada R, Martinez G, Rangel G, Vera A, Staines H, Magis-Rodriguez
C, Patterson TL. Reductions in HIV/STI incidence and sharing of injection equipment among female sex workers who inject drugs: results from a randomized controlled trial. PLoS ONE.
2013. PMCID:
PMC3681783
447. Shin, SS, Laniado-Laborin R, Gonzalez-Moreno P, Novotny TE, Strathdee SA, Garfein RS. Dose response association between salivary cotinine levels and mycobacterium tuberculosis infection. Int
J Tuber Lung Dis. 2013. 17(11):1452-8. PMCID: PMC3801225
448. Werb D, Kerr T, Nosyk B, Strathdee SA, Montaner J, Wood E. The temporal relationship between drug supply indicators: an audit of international government surveillance systems. BMJ Open.
2013.
3(9):e003077. doi: 10.1136/bmjopen-2013-003077. PMCID: PMC3787412
449. Goldenberg SM*, Engstrom D, Rolon ML, Silverman JG, Strathdee SA. Sex Workers Perspectives on Strategies to Reduce Sexual Exploitation and HIV Risk: A Qualitative Study in Tijuana, Mexico.
PLoS One. 2013. 8(8):e72982. doi: 10.1371/journal.pone.0072982.
PMCID: PMC3758274
450. Mackey TK, Liang BA, Strathdee SA. Digital social media, youth, and nonmedical use of prescription drugs: the need for reform. J Med Internet Res. 2013. 15(7):e143. PMCID: PMC3742396
451. Robertson AM*, Syvertsen JL*, Palinkas LA, Vera A*, Rangel G, Martinez G, Strathdee SA. Sex workers’ noncommercial male partners who inject drugs report higher risk sexual behaviors. Sexually
Transmitted Diseases. 2013; 40(10):801-3. doi: 10.1097/OLQ.0000000000000016 PMCID:
PMC3890981
452. Boltaev AA, El-Bassel N, Deryabina AP, Terlikbaeva A, Gilbert L, Hunt T, Primbetova S, Strathdee
SA. Scaling up HIV prevention efforts targeting people who inject drugs in Central Asia: A review of key challenges and ways forward. Drug Alcohol Depend. 2013. 132 Suppl 1:S41-7. doi:
10.1016/j.drugalcdep.2013.07.033
453. McDougal L, Strathdee SA, Rangel G, Martinez G, Vera A, Sirotin N, Stockman JK, Ulibarri MD, Raj
A. Adverse pregnancy outcomes and sexual violence among female sex workers who inject drugs on the US-Mexico border. Violence and Victims. 2013;28(3):496-512. PMCID: PMC3963834
454. Gaines T*, Rusch M; Brouwer K; Rudolph A; Goldenberg S; Strathdee SA. The longitudinal association of venue stability with consistent condom use among female sex workers in two Mexico-
U.S. border cities. Int J STD & AIDS. 2013. Jul;24(7):523-9. doi: 10.1177/0956462412473890
455. Nosyk B, Bertrand A, Beyrer C, Pedro C, Rueben G, Havlir D, Katabira E, Lange J, Lima V,
Patterson T, Strathdee SA, Williams B, Montaner J. Examining the evidence on the causal effect of highly active antiretroviral therapy on transmission of HIV using the Bradford Hill criteria. AIDS. 2013.
27(7):1159-65. doi: 10.1097/QAD.0b013e32835f1d68
456. Shoptaw S, Montgomery B, Williams CT, El-Bassel N, Aramrattana A, Metsch L, Metzger DS, Kuo I,
Bastos FI, Strathdee SA. Not just the needle: the state of HIV prevention science among substance users and future directions. J Acquir Immune Defic Syndr. 2013. 63 Suppl 2:S174-8. doi:
10.1097/QAI.0b013e3182987028. PMCID: PMC3739052
457. Shin SS, Gonzalez-Moreno P, Rao S, Garfein RS, Novotny TE, Strathdee SA. Cigarette smoking and quit attempts among injection drug users in Tijuana, Mexico. Nicotine & Tobacco Research.
2013.
15(12):2060-8. doi: 10.1093/ntr/ntt099. PMCID: PMC3819980
458. Goldenberg SM*, Chettiar J, Simo A, Silverman JG, Strathdee SA, Montaner J, Shannon K. Early sex work initiation independently elevates odds of HIV infection and police arrest among adult sex workers in a Canadian setting. J Acquir Immune Defic Syndr. 2013. 65(1):122-8. doi:
10.1097/QAI.0b013e3182a98ee6
459. Pitpitan EV*, Strathdee SA, Semple SJ, Wagner KD, Chavarin CV, Earnshaw VA, Patterson TL.
Perceived stigma of purchasing sex among Latino and non-Latino male clients of female sex workers in Tijuana, Mexico. J Immigr Minor Health. 2013. PMCID: PMC3934939
32

Volkmann T*, Wagner KD*, Strathdee SA, Semple SJ, Ompad DC, Chavarin CV, Patterson TL.
Correlates of self-efficacy for condom use among male clients of female sex workers in Tijuana,
Mexico. Arch Sex Behav. 2013. PMCID: PMC3851585
460. Degenhardt L, Mathers BM, Wirtz AL, Wolfe D, Kamarulzaman A, Carrieri MP, Strathdee SA,
Malinowska-Sempruch K, Kazatchkine M, Beyrer C. What has been achieved in HIV prevention, treatment and care for people who inject drugs, 2010-2012? A review of the six highest burden countries. Int J Drug Policy.
2014. 25(1):53-63. doi: 10.1016/j.drugpo.2013.08.004
461. Robertson AM, Garfein RS, Wagner KD, Mehta SR, Magis-Rodriguez C, Cuevas-Mota J, Moreno-
Zuniga PG, Strathdee SA; Proyecto El Cuete IV and STAHR II. Evaluating the impact of Mexico's drug policy reforms on people who inject drugs in Tijuana, B.C., Mexico, and San Diego, CA, United
States: a binational mixed methods research agenda. Harm Reduct J. 2014. 11(1):4. doi:
10.1186/1477-7517-11-4. PMCID: PMC3944401
462. Palinkas LA, Robertson AM, Syvertsen JL, Hernandez DO, Ulibarri MD, Rangel MG, Martinex G,
Strathdee SA. Client perspectives on design and implementation of a couples-based intervention to reduce sexual and drug risk behaviors among female sex workers and their noncommercial partners in Tij uana and Ciudad Juárez, México. AIDS Behav. 2014. 18(3):583-94. doi: 10.1007/s10461-014-
0715-1. PMCID: PMC3990224
463. *Ulibarri MD, Strathdee SA, Lozada R, Magis-Rodriguez C, Amaro H, O'Campo P, Patterson TL.
Prevalence and correlates of client-perpetrated violence among female sex workers in two Mexico-
U.S. border cities. Violence Against Women. 2014. 29(4):427-45. PMCID: PMC3999240
464. Robertson AM, Syvertsen JL, Amaro H, Martinez G, Rangel MG, Patterson Tl, Strathdee SA . Can’t buy my love: A typology of female sex workers’ commercial relationships in the Mexico-U.S. Border
Region. J Sex Res. 2014. doi: 10.1080/00224499.2012.757283. PMCID: PMC3890374
465. Ojeda VD*, Eppstein A, Lozada R, Vargas-Ojeda AC, Strathdee SA, Goodman D, Burgos JL.
Establishing a Binational Student-Run Free-Clinic in Tijuana, Mexico: A Model for US-Mexico Border
States. J Immigr Minor Health. 2014. doi: 10.1007/s10903-012-9769-1. PMCID: PMC3710293
466. Goldenberg SM*, Bojorquez-Chapela I, Engstrom D, Silverman JS, Strathdee SA. Right here is the gateway: mobility, sex work entry and HIV risk along the Mexico-US Border. International Migration.
2013. doi: 10.111/imig.12104. PMCID: PMC4207057.
467. Robertson AM*, Syvertsen JL*, Ulibarri MD, Rangel G, Martinez G, Strathdee SA. Prevalence and correlates of HIV and sexually transmitted infections among female sex workers and their noncommercial male partners in two Mexico-U.S. border cities. Journal of Urban Health. 2014. doi:
10.1007/s11524-013-9855-2.
468. El-Bassel N, Shaw SA, Dasgupta A, Strathdee SA. People Who Inject Drugs in Intimate
Relationships: It Takes Two to Combat HIV. Curr HIV/AIDS Rep. 2014. 11(1):45-51. doi:
10.1007/s11904-013-0192-6. PMCID: PMC4096813
469. El-Bassel N, Shaw SA, Dasgupta A, Strathdee SA. Drug use as a driver of HIV risks: re-emerging and emerging issues. Curr Opin HIV AIDS. 2014. 9(2):150-5. PMCID: PMC4112554
470. Schilder AJ, Anema A, Pai J, Rich A, Miller CL, Chan K, Strathdee SA, Moore D, Montaner JS, Hogg
RS. Association between Childhood Physical Abuse, Unprotected Receptive Anal Intercourse and
HIV Infection among Young Men Who have Sex with Men in Vancouver, Canada. Plos One.
2014;9(6):e100501. doi: 10.137/journal.pone.0100501. PMCID: PMC4070929
471. *Syvertsen JL, Robertson AM, Strathdee SA, Martinez G, Rangel MG, Wagner KD. Rethinking risk: gender and injection drug-related HIV risk among female sex workers and their non-commercial partners along the Mexico-U.S. border. Int J Drug Policy. 2014. 25(5):836-44. PMCID: PMC4133300
472. Guerrero EG, Villatoro JA, Kong Y, Fleiz C, Vega WA, Strathdee SA, Medina Mora ME. Barriers to accessing substance abuse treatment in Mexico: national comparative analysis by migration status.
Journal of Substance Abuse Treatment. 2014. 30;9:30. doi: 10.1186/1747-597X-9-30. PMCID:
PMC4118628
473. *Pitpitan EV, Chavarin CV, Semple SJ, Magis C, Strathdee SA. Hombre Seguro (Safe Men): A sexual risk reduction intervention for male clients of female sex workers. BMC Public Health. PMCID:
PMC4045912
474. *Goodman-Meza D, Pitpitan EV, Strathdee SA, Semple SJ, Wagner KD, Chavarin CV, Patterson TL.
Hazardous drinking and HIV risk-related behavior among male clients of female sex workers in
Tijuana, Mexico. Am J Addict. 2014. doi: 10.1111/j.1521-0391.2014.12138.x. PMCID: PMC4427019.
33

475. Werb D, Medina-Mora EL, Arredondo J, Beletsky L, Patterso n T, Strathdee SA. Mexico’s drug policy reform: cutting edge success or crisis in the making? Int J Drug Policy. 2014. pii: S0955-
3959(14)00145-5. doi: 10.1016/j.drugpo.2014.05.014.
476. Beyrer C, Crago A-L, Bekker L-G, Butler J, Shannon K, Kerrigan D, Decker MR, Baral SD, Poteat T,
Wirtz A, Weir BW, Barre-Sinoussi F, Kazatchkine M, Sidibe M, Boily M-C, Strathdee SA. An Action
Agenda for HIV and sex workers. Lancet. PMCID: PMC4302059
477. Strathdee SA, Crago A-L, Butler J, Bekker L-G, Beyrer Rusakova C. Dispelling myths about sex work and HIV. Lancet. 2014. pii: S0140-6736(14)60980-6. doi: 10.1016/S0140-6736(14)60980-6.
478. Rusakova M, Rakhmetova A, Strathdee SA. Why are sex workers who use substances at risk for
HIV? Lancet. 2014 (In Press)
479. Shannon K, Goldenberg SM, Deering KN, Strathdee SA. HIV infection among female sex workers in concentrated and high prevalence epidemics: why a structural determinants framework is needed.
Curr Opin HIV AIDS. 2014. 9(2):174-82. doi: 10.1097/COH.0000000000000042. PMCID:
PMC4286412
480. *Ulibarri MD, Roesch S, Rangel GM, Staines H, Amaro H, Strathdee SA . “Amar te Duele” (“Love
Hurts”): Sexual relationship power, intimate partner violence, depression symptoms and HIV risk among female sex workers who use drugs and their non-commercial, steady partners in Mexico.
AIDS Behav. 2014. PMCID: PMC4201896
481. Shannon K, Strathdee SA, Goldenberg S, Duff P, Paul S, Lau J, Pickles M, Boily M-C. The Global
Epidemiology of HIV among female sex workers: the influence of structural determinants. Lancet.
2014. pii: S0140-6736(14)60931-4. doi: 10.1016/S0140-6736(14)60931-4. PMCID: PMC4297548
482. Pines HA, Patterson TL, Range G, Martinez G, Bazzi AR, Ulibarri MD, Syvertsen JL, Martin NK,
Strathdee SA. STI/HIV test result disclosure between female sex workers and their primary, noncommercial male partners in two Mexico-US border cities: a cross-sectional study. Sex Transm
Infect. 2014. pii: sextrans-2014-051663. doi: 10.1136/sextrans-2014-051663. PMCID: PMC4390518.
483. Azim T, Bontell I, Strathdee SA. Women, drugs and HIV. Int J Drug Policy. 2014. pii: S0955-
3959(14)00265-5. doi: 10.1016/j.drugpo.2014.09.003. PMCID: PMC4498573.
484. Strathdee SA, Beletsky L, Kerr T. HIV, drugs and the legal environment. Int J Drug Policy. 2014. pii:
S0955-3959(14)00263-1. doi: 10.1016/j.drugpo.2014.09.001. PMCID: PMC4346482
485. Servin AE, Strathdee S , Muñoz FA, Vera A, Rangel G, Silverman JG. Vulnerabilities faced by the children of sex workers in two Mexico-US border cities: a retrospective study on sexual violence, substance use and HIV risk. AIDS Care. 2014. PMCID: PMC4221409
486. Pitpitan E, Strathdee SA, Semple S, Chavarin C, Magis-Rodriguez C, Patterson TL. Buffering syndemic effects in a sexual risk reduction intervention for male clients of female sex workers:
Results from a randomized controlled trial. Am J Pub Health. 2014. (In Press)
487. Oza KK, Silverman JG, Bojorquez I, Strathdee, SA, Goldenberg SM. Examining negative effects of early life experiences on reproductive and sexual health among female sex workers in Tijuana,
Mexico. Int J Gynaecol Obstet. 2014 Oct 13 pii: S0020-7292(14)00527-X. doi:
10.1016/j.ijgo.2014.08.014. PMCID: PMC4300273
488. Deering KN, Montaner JS, Chettiar J, Jia J, Ogilvie G. Buchner C, Feng C, Strathdee SA, Shannon
K. Successes and gaps in uptake of regular, voluntary HIV testing for hidden street – and off-street sex workers in Vancouver, Canada. AIDS Care 2014 Nov 27: 1-8
489. Mackey TK, Werb D, Beletsky L, Rangel G, Arredondo J, Strathdee SA . Mexico’s “ley de narcomenudeo” drug policy reform and the international drug control regime. Harm Reduct J. 2014
Nov 14; 11(1):31. doi: 10.1186/1477-7517-11-31
490. Latypov A, Grund JP, ElBassel N, Platt L, Stöver H, Strathdee S. Illicit drugs in Central Asia: what we know, what we don’t know, and what we need to know. Int J Drug Policy. 2014. 25(6):1155-62.
(In Press)
491. Pitpitan EV, Patterson TL, Abramovitz D, Vera A, Martinez G, Staines H, Strathdee SA. Policing
Behaviors: Safe Injection Self-Efficacy, and Intervening on Injection Risks: Moderated Mediation
Results From a Randomized Trial. Health Psychol. 2014. (In Press)
492. Conners EE, Silverman JG, Ulibarri M, Magis-Rodriguez C, Strathdee SA, Staines-Orozco H,
Patterson TL, Brouwer KC. Structural Determinants of Client Perpetrated Violence Among Female
Sex Workers in Two Mexico-U.S. Border Cities. AIDS Behav. 2014. (In Press)
34

493. Syvertsen JL, Robertson Bazzi AM, Scheibe A, Adebajo S, Strathdee SA, Wechsberg WM. The promise and peril of pre-exposure prophylaxis (PrEP): using social science to inform prep interventions among female sex workers. Afr J Reprod Health. 2014. 18(3 Spec No):74-83. (In
Press)
494. Lindsay RP, Roesch S, Strathdee SA, Rangel G, Staines H, Abramovitz D, Ulibarri M, Rusch ML.
Correlates of unprotected sex by client type among female sex workers who inject drugs along the
Northern Mexico border. Int J Alcohol Drug Research (In Press)
495. Pines HA, Vera A, Ranagel G, Magis-Rodriguez C, Strathdee SA. Incident syphilis infection among people who inject drugs in Tijuana, Mexico. Inst J STD & AIDS. 2015. pii: 0956462414568394 (In
Press)
496. Pitpitan E, Goodman-Meza D, Chavarin C, Burgos JL, Abramovitz DA, Strathdee SA, Patterson TL.
Prevalence and correlates of HIV among men who have sex with men in Tijuana, Mexico. J Int AIDS
Society. 2015. 18(1):19304. doi: 10.7448/IAS.18.1.19304. PMCID: PMC4323407.
497. Armenta RF, Abramovitz D, Lozada R, Vera A, Garfein Rs, Magis-Rodriguez C, Strathdee SA.
Correlates of Perceived Risk of HIV infection among persons who inject drugs in Tijuana, Baja
California, Mexico. Salud Publica Mex (In Press)
498. Bazzi A, Syvertsen J, Bazzi S, Rangel G, Martinez G, Ulibarri M, Pines H, Strathdee SA. Incidence and predictors of HIV and sexually transmitted infections among female sex workers and their intimate male partners in Northern Mexico: a longitudinal, multilevel study. Am J Epidemiol.
2015.181(9):723-31. doi: 10.1093/aje/kwu340. PMCID: PMC4408950.
499. Meachem M, Rudolph AE, Strathdee SA, Brouwer KC, Rusch M, Roesch S. Polydrug use and HIV risk among people who inject heroin in Tijuana, Mexico: A latent class analysis. Substance Use and
Misuse (In Press)
500. Semple SJ, Strathdee SA, Pitpitan EV, Chavarin C, Patterson TL. Behavioral and psychosocial correlates of anal sex among male clients of female sex workers in Tijuana, Mexico. Arch Sex
Behav. 2015. 44(4):1025-33. doi: 10.1007/s10508-015-0514-4.
(In Press)
501. Goldenberg SM, Bojorquez-Chapela I, Malta M D, Silverman JG, Usita P, Rolon ML, Strathdee SA.
Exploring the context of trafficking and adolescent sex industry involvement in Tijuana, Mexico:
Consequences for HIV risk and prevention. Violence Against Women. 2015. 21(4):478-99. doi:
10.1177/1077801215569079. (In Press)
502. Werb D, Wagner KD, Beletsky L, Gonzalez-Zuniga P, Vera A, Strathdee SA. Police bribery and access to methadone maintenance therapy among injection drug users in Tijuana, Mexico. Drug Alc
Depend. PMCID: PMC4330115
503. Gaines TL, Urada L, Martinez G, Goldenberg SM, Rangel G, Reed E, Patterson TL, Strathdee SA.
Short-term cessation of sex work and injection drug use: Evidence from a recurrent event survival analysis. Addictive Behaviors. 2015. 45:63-9. doi: 10.1016/j.addbeh.2015.01.020. PMCID:
PMC4373980.
504. Rhodes T, Guise A, Strathdee SA, Ndimbii J, Ngugi E, Cleland C, Platt L, Kurth A, Vickerman P.
The promise of methadone: Kenya’s solution to managing HIV and addiction? BMJ Open. 2015.
5(3):e007198. doi: 10.1136/bmjopen-2014-007198. PMCID: PMC4360822.
505. Wagner, KD, Pitpitan EV, Velente TW, Strathdee SA, Rusch M, Magis-Rodriguez C, Chavarin CV,
Patterson TL. Place of Residence Moderates the Relationship Between Emotional Closeness and
Syringe Sharing Among Injection Drug Using Clients of Sex Workers in the US-Mexico Border
Region. AIDS and Behavior, 1-9. doi: 10.1007/s10461-015-1001-6. PMCID: PMC4475673.
506. Malta M, da Silva CM, Magnanini MM, Wirtz Al, Perissé AR, Beyrer C, Strathdee SA, Bastos FI.
Improvement of HAART in Brazil, 1998-2008: A nationwide assessment of survival times after AIDS diagnosis among men who have sex with men. BMC Public Health. 2015. 7;15:226. doi:
10.1186/s12889-015-1530-y. PMCID: PMC4369843.
507. Rafful C, Zule W, González-Zúñiga, Werb D, Medina-Mora ME, Magis-Rodriguez C, Strathdee SA.
High dead-space syringe use among people who inject drugs in Tijuana, Mexico. Am J Drug Alcohol
Abuse. 2015. 41(3):220-5. doi: 10.3109/00952990.2015.1011742. (In Press)
508. Mackey TK, Strathdee SA. Responding to the public health consequences of the Ukraine crisis: an opportunity for global health diplomacy. J Int AIDS Soc. 2015.18(1):19410. doi:
10.7448/IAS.18.1.19410.
PMCID: PMC4365104.
35

509. El-Bassel, Strathdee SA. Women Who Use or Inject Drugs: An Action Agenda for Women-Specific,
Multilevel, and Combination HIV Prevention and Research. J Acquir Immune Defic Syndr.
2015. 1;69
Suppl 2:S182-90. doi: 10.1097/QAI.0000000000000628. (In Press)
510. Strathdee SA, West BS, Reed E, Moazan B, Azim T, Dolan K. Substance Use and HIV Among
Female Sex Workers and Female Prisoners: Risk Environments and Implications for Prevention,
Treatment, and Policies. J Acquir Immune Defic Syndr. 2015. 1;69 Suppl 2:S110-7. doi:
10.1097/QAI.0000000000000624.
PMCID: PMC4493865.
511. Servin AE, Brouwer KC, Gordon L, Rocha-Jimenez T, Staines H, Vera-Monroy RB, Strathdee SA,
Silverman JG. Vulnerability Factors and Pathways Leading to Underage Entry into Sex Work in two
Mexican-US Border Cities. J Appl Res Child. 2015. 6(1). pii: 3. PMCID: PMC4412591.
512. Rafful C, Wagner KD, Werb D, González-Zúñiga PE, Verdugo S, Rangel G, Strathdee SA.
Prevalence and correlates of neck injection among people who inject drugs in Tijuana, Mexico. Drug
Alcohol Rev. 2015 Apr. doi: 10.1111/dar.12264.
(In Press)
513. Syvertsen JL, Agot K, Ohaga S, Strathdee SA, Camlin CS, Omanga E, Odonde P, Rota G, Akoth K,
Peng J, Wagner KD. Evidence of injection drug use in Kisumu, Kenya: Implications for HIV prevention. Drug Alcohol Depend. 2015.151:262-6. doi: 10.1016/j.drugalcdep.2015.02.037. PMCID:
PMC4447587.
514. Strathdee SA, Beyrer C. Threading the Needle - How to Stop the HIV Outbreak in Rural Indiana.
Threading the Needle - How to Stop the HIV Outbreak in Rural Indiana. N Engl J Med. 2015. (In
Press)
515. Burgos JL, Yee D, Csordas T, Vargas-Ojeda AC, Segovia LA, Strathdee SA, Olivares-Nevarez JA,
Ojeda VD. Supporting the minority physician pipeline: providing global health experiences to undergraduate students in the United States-Mexico border region. Med Educ Online. 2015.
17;20:27260. doi: 10.3402/meo.v20.27260. (In Press)
516. Syvertsen JL, Bazzi AR, Martinez G, Rangel MG, Ulibarri MD, Fergus KB, Amaro H, Strathdee SA.
Love, Trust, and HIV Risk Among Female Sex Workers and Their Intimate Male Partners. Am J
Public Health. 2015. 105(8):1667-74. doi: 10.2105/AJPH.2015.302620. (In Press)
517. Sou J, Shannon K, Li J, Nguyen P, Strathdee SA, Shoveller J, Goldenberg SM. Structural determinants of inconsistent condom use with clients among migrant sex workers: findings of longitudinal research in an urban canadian setting. Sex Transm Dis. 2015. 42(6):312-6. doi:
10.1097/OLQ.0000000000000276. PMCID: PMC4435818.
518. Steffanie SA, Arredondo J, RochaJimenez T, Rolon ML, Abramovitz DA, Patiño-Mandujano E,
Rangel G, Olivarria-Horcasitas O, Gaines TL, Patterson TL, Beletsky L. A Police Education Program to Integrate Occupational Safety and HIV Prevention: Protocol for a Modified Stepped-Wedge Study
Design with Parallel Prospective Cohorts to Assess Behavioral Outcomes. BMJOpen. 2015. (In
Press)
*Denotes student or fellow where Dr. Strathdee was the primary advisor
Book Chapters (Total: 11)
1. Strathdee SA, Bastos FI. Intertwining epidemics: injection drug use and HIV infection. In: Breslow L, editor. Encyclopedia of Public Health. New York, NY: Macmillian; 2001.
2. Strathdee SA, *Loughlin AM. Vaccines - past, present, and future. In: Nelson KE, Williams CM,
Graham NMH, Masters CF, editors. Infectious disease epidemiology: theory and practice. 1st ed.
Gaithersburg, MD: Aspen Publishers; 2001. p. 255-282.
3. Case P, Strathdee SA. Injection Drug Use. In: Pizer H, Mayer K, editors. The AIDS Pandemic:
Elsevier; 2005.
4. Strathdee SA, Newell ML, Bastos FI, Patterson TL. HIV prevention programs: an overview. In: Beck
E, Mays N, editors: Oxford University Press; 2005.
5. Strathdee SA, Patterson TLL. Behavioral Interventions for HIV-seopositive and HCV-seropositive drug users: new directions. In: Kalichman S, editor. HIV prevention for people living with HIV-AIDS:
Kluwer Academic/Plenum Publishing; 2005.
6. *Loughlin AM, Strathdee SA. Vaccines: past, present, and future. In: Graham NMH, Masters CF,
Nelson KE, editors. Infectious disease epidemiology: theory and practice. 2nd ed: Aspen Publishers;
36

2007. p. 345-382.
7. Hankins C, Strathdee SA, Karim SA. HIV transmission and its prevention in Africa. In: Volberding P, editor. Global HIV/AIDS medicine. Philadelphia, PA: Saunders/Elsevier; 2008.
8. *Zuniga de Nuncio ML, Strathdee SA, Blanco E, Patterson TL. Community HIV Preventive
Interventions. In: Suls J, Kaplan RM, Davidson RJ, editors. Handbook of Health Psychology. New
York, NY: Guilford Press; 2010.
9. Rhodes T, *Wagner KD, Strathdee SA, Shannon K, *Davidson PJ, Bourgois P. Structural violence and structural vulnerability within the risk environment: theoretical and methodological perspectives for a social epidemiology of HIV risk among injection drug users and sex workers. In: O'Campo P,
Dunn JR, editors. Rethinking social epidemiology: towards a science of change: Springer; 2011.
10. *Urada LA, Goldenberg SM, Shannon K, Strathdee SA.
Sex Work.
In D. L. Tolman and L. M.
Diamond (Eds.), APA Handbook of Sexuality and Psychology, Vol. 2. Contextual Approaches (pp.
37-76), Washington, D.C.: American Psychological Association, 2012 .
11. Deering K, Strathdee SA, Shannon K. Sex Workers. In: Michalos A, editor. Encyclopedia of Quality of Life and Well-Being Research: Springer Netherlands; 2014. p. 5871-7.
Non Peer-reviewed Publications, Reviews, Editorials and Letters (Total: 53)
1.
2.
3.
4.
5.
6.
7.
Strathdee SA. Epidemiology: editorial comment on papers of outstanding interest. Current AIDS
Literature, 1995;8(1):3-4 [Editorial].
Strathdee SA. Epidemiology: facing the realities of the overlapping HIV epidemics among women and children: editorial comment on papers of outstanding interest. Current AIDS
Literature,1995;8(6):243-44 [Editorial].
Strathdee SA, Patrick DM, Archibald CP, Ofner M, Cornelisse PGA, Rekart ML, Schechter MT,
O’Shaughnessy MV. Final report from the point project: an outbreak investigation of HIV infection among injection drug users in Vancouver. [Report for Health Canada. March 1996].
Strathdee SA, Hogg RSH, Hanvelt R. Evaluating HIV/AIDS prevention programs in Canada.
[Report to the research priorities workshop of the Canadian Policy Research Networks Inc. and the
AIDS Education and Prevention Unit, Health Canada, March 1996].
Strathdee SA. Epidemiology: modeling approaches for evaluating HIV interventions. Current AIDS
Literature 1996;9(1): 3-4. [Editorial].
Monitoring the AIDS Pandemic (MAP) Network. The status and trends of the global HIV/AIDS pandemic, AIDSCAP and Family Health International, July 1996. [Discussant].
Strathdee SA. Social determinants related to the risk of HIV infection and progression to AIDS. The
Clarion , 1997;4(1):2-4. [Editorial].
Strathdee SA .
1997: Another breakthrough year in the etiology of Kaposi’s sarcoma? Targeted 8.
9.
AIDS Literature, 1997;11(3):27-28. [Editorial].
Strathdee SA and Hogg RS. For the Canadian association for HIV research (CAHR). AIDS research in Canada: recommendations for research funding and infrastructure for phase III of the
National AIDS Strategy. [report to the National Health Research Development Program, Health
Canada].
10. Strathdee SA. Emerging HIV epidemics among injecting drug users. Targeted AIDS Literature,
December 1997;11(12):R135-R136. [Editorial].
11. Wodak A, Strathdee SA, Friedman SR, Byrne J. The global response to the threat of HIV infection among and from injecting drug users. Targeted AIDS Literature,12(6):R41-R44. [Editorial].
12. Strathdee SA, Hogg R. Consortium to characterize Injecting drug users in Canada. National
Health Research Development Program, Health Canada, 1998. [Report to Health Canada].
13. Tilson H, Strathdee SA, (session discussant) Session C. The role of patient databases in assessing treatment safety. Journal AIDS 1998;17(suppl 1):S48-52. [Conference Proceedings].
14. Lange J, Strathdee SA. (session discussant) Session A. Natural history of HIV disease and predictors of clinical outcome. Journal AIDS 1998;17(suppl 1):S43-45. [Conference Proceedings].
15. Strathdee SA, Palepu A. Use of antiretroviral therapy by injection drug users with HIV infection.
JAMA, February 1999;281(8):699-701. [Letter].
16. Thomas DL, Strathdee SA, Vlahov D. Long-term prognosis of hepatitis C virus infection. JAMA
2000;284(20):2592. [Letter].
37

17. Hoggs RS, Strathdee SA , Craib KJ, O’Shaughnessy MV, Montaner J, Schechter MT. Gay life expectancy revisited. Int Journal Epidemiology 2001;30(6):1499. [Letter].
18. *Mehta SH, Brancati FL, Sulkowski MS, Strathdee SA, Szklo M, Thomas DL. Prevalence of type 2 diabetes mellitus persons with hepatitis c virus infection in the United States. Hepatology
2001;33(6):1554. [Commentary].
19. Strathdee SA, Bastos FI. From risk environments to safe havens: understanding context in the development of harm reduction interventions for drug users. Int Journal of Drug Policy,
2002;13(2):81-83. [Editorial].
20. Strathdee SA, *Poundstone K. The international epidemiology and burden of disease of injection drug use and HIV/AIDS policy framework: reducing risks, harms and costs of injection drug use and HIV/AIDS. Health Canada and UNAIDS, 2002.
21. Strathdee SA, Burris S, Vernick JS. Syringe-access law in the United States: a state of the art assessment of law and policy; August 2002 [Report to the Robert Wood Johnson Foundation].
22. *Mehta SH, Cox A, Strathdee SA, Vlahov D, Thomas D. Immunity against hepatitis C virus infection. Lancet 2002;360(9338):1020. [Letter].
23. *Golub E, Strathdee SA. Syringe disposal: the law of diminishing returns? AIDS Read
2002;(12):530-1. [Editorial].
24. Burris S, Strathdee SA, Vernick JS. Lethal injections: the law, science and politics of syringe access for Injecting drug users. San Francisco Law Review, 2003;37:813.
25. Booth RE, Strathdee SA. Baseline findings from the third collaborative injection drug users study/drug users intervention trial (CIDUS III/DUIT). Drug Alcohol Depend. 2007;91 Suppl 1:S1-3.
PMID: 17889451.
26. Strathdee SA. Sexual HIV transmission in the context of injection drug use: implications for interventions. Int Journal of Drug Policy 2003;14:79-81. [Editorial].
27. Strathdee, SA. Needle-exchange programs and the prevention of HIV infection. AIDS Patient Care
STDs. 2004;18(7):373-378. [Interview]
28. *Havens JR, Strathdee SA. Antisocial personality disorder and opioid treatment outcomes: a review. Addict Dis Treatment 2005;4(3):85-97.
29. Patterson TL, Strathdee SA. From Don Giovanni to Magic Johnson: methodological conundrums in the measurement of sexual risk behavior. Ann Behavavior Med. 2005;29(2):83-5. [Invited editorial].
30. *Kuo I, Strathdee SA . After the flowers are gone…what happens next? Int Journal Drug Policy 16
2005;112-114. [Commentary].
31. Strathdee SA. Targeting HIV interventions to the most at risk: hindsight is 20/20. Int Journal
Epidemiology. 2005;34(1):158-9. [Commentary].
32. Nelson KE, Vlahov D, Wang CL, Strathdee SA, Sterling TR. J Inf Dis 2005;191(5):821-2. [Reply to
Phillips and Lampe].
33. Strathdee, SA. Patterns and trends of drug abuse in San Diego. Proceedings of the Community
Epidemiology Work Group. US Department of Health and Human Services. June 25, 2005.
[Technical report].
34. Strathdee SA, Patterson T. Cost-effectiveness of a brief behavioral intervention to reduce HIV/STI and promote condom use among female sex workers in the Mexico –US border region. New
England Journal of Medicine - 2006;10(2):115-30. PMID: 16463006.
35. Burris S, Strathdee SA. To serve and protect? toward a better relationship between drug control policy and public health. AIDS 2006;2(20):117-118. [Commentary].
36. Evans L, Strathdee SA. A roof is not enough: unstable housing, vulnerability to HIV infection, and the plight of the SRO. Int J Drug Policy 17:115-117. [Commentary].
37. Winstanley EL, Normand JL, Gust SW, Strathdee SA. Drug abuse and HIV/AIDS: international research lessons and imperatives. Drug Alcohol Depend 2006; 82 Suppl 1 :S1-5. [Commentary].
38. Strathdee, SA. Patterns and Trends of Drug Abuse in San Diego. Proceedings of the community epidemiology work group. US Department of Health and Human Services. January, 2006.
[Technical Report]
39. Strathdee SA, *Pollini RA. A 21st-century Lazarus: the role of safer injection sites in harm reduction and recovery. Addiction 2007;102(6):848-9. [Editorial].
38

40. *Wood E, Kerr T, Tyndall MW, Zhang R, Hogg RS, Strathdee SA, Montaner JS. Rates of
HIV/AIDS care and antiretroviral therapy response among active injection drug users. Addiction
2007;102(9):1503-1505. [Letter] PMID: 17697280
41. Vlahov D, Strathdee SA. The bottom line on cash incentives with drug users. Addiction.
2009;104(5):796-7. [Commentary] PMID: 19413791.
42. Strathdee SA, Patterson TL. Supply reduction’s hidden casualties: a view from the trenches.
Addiction [Commentary] Addiction. 2009;104(3):340-1; [Discussion] 345-6. PMID: 19207337.
43. *Ojeda VD, Strathdee SA. Sex work and the city: the social geography of health and safety in
Tijuana Mexico. Glob Public Health 2010;8:1-3 [Book review]. PMID: 20146132.
44. Strathdee SA. Commentary on 08-0617 Salmon et al. The case for safer inhalation facilities: waiting to inhale. Addiction. 2010;105(4):676-683. PMID: 20148794
45. Volkow P, *Brouwer KC, Garfein RS, Strathdee SA. The risk of using paid plasma. Int J Drug
Policy. 2010;21(5):345-346. [Letter].
46. Alegría M, Strathdee SA, Pantin H. Substance risk, prevention treatments and the role of the environmental and cultural context in addressing Latinos and other ethnic/racial populations. Drug
Alcohol Depend 2012 Sep;125 Suppl 1:S2-3 PMID: 2292052
47. Strathdee SA, Beletsky L and Kerr T. HIV, Drugs and the Legal Environment. Thematic Paper,
Office of National Drug Control Policy, March 2014.
48. Guise A, Kazatchkine M, Rhodes T, Strathdee SA. Successful methadone delivery in East Africa and its global implications. Clinical Infectious Disease. 2014.
49. El-Bassel N, Strathdee SA, Sadr WM. HIV and people who use drugs in central Asia: confronting the perfect storm. Drug Alcohol Depend. 2013. 132 Suppl 1:S2-6. doi:
10.1016/j.drugalcdep.2013.07.020
50. Guise A, Kazatchkine M, Rhodes T, Strathdee SA. Editorial commentary: successful methadone delivery in East Africa and its global implications. Clin Infect Dis. 2014 Sep 1;59(5):743-4. doi:
10.1093/cid/ciu387.
51. Beg M, Strathdee SA, Kazatchkine M. State of the art science addressing injecting drug use, HIV and harm reduction. Int J Policy. 2015. 26 Suppl 1:S1-4. doi: 10.1016/j.drugpo.2014.11.008.
(in press)
52. Mackey TK, Strathdee SA. Big events and risks to global substance using populations: Unique threats and common challenges. Subst Use Misuse. 2015. 50(7):885-90. doi:
10.3109/10826084.2015.983008. (in press)
53. El-Bassel, Strathdee SA. Bringing Female Substance Users to the Center of the Global HIV
Response. J Acquir Immune Defic Syndr. 2015. 69 Suppl 2:S94-5. doi:
10.1097/QAI.0000000000000625. (in press)
T EACHING
University of California, San Diego - Training Program Directorships
Training Program Principal
Investigator
Time
Period
Funder Number of
Students/Fellows
Cross-border HIV
Training Program in
HIV Prevention
HIV/AIDS and
Substance Use Border
Health Program
Training Program on
Prevention of
Substance Use, HIV and Co-occurring
Conditions (T32)
Strathdee
Strathdee/Zuniga
2005-2009
2007-2011
Strathdee/Patterson 2007-present
USAID/HED 300 Mexican and
120 American students
4 fellows per year Hispanic
Serving
Health
Professional
Schools
National
Institute on
Drug Abuse
5 predoctoral and 5 post-doctoral fellowship slots
39

Training Program Principal
Investigator
Time
Period
Funder Number of
Students/Fellows
Center for HIV/AIDS
Minority Pipeline in
Substance Abuse
Research
Binational Training
Program to improve health among
Substance Users
Strathdee
Strathdee
2008-2012
2010-2012
University of California, San Diego (current students/fellows)
National
Institute on
Drug Abuse
USAID/HED
Trainee Name
Heather Pines
Dan Werb
Meredith Meachem
Claudia Rafful
Type/Training
Period
Postdoctoral fellow,
UCSD
Postdoctoral fellow,
UCSD
PhD student in Public
Health, Global Health track
PhD student in Public
Health, Global Health
Thesis/Project Title
STD prevention among
MSM
Interventions to discourage initation to injection
Latent class transitions of poly drug use in
Mexico
Drug policy reform as an HIV prevention
Jaime Arredondo
Brooke West
Alicia Vera
Andy Guise track
PhD student in Public
Health, Global Health track
Postdoctoral fellow,
UCSD
Postdoctoral Fellow,
Universidad
Autonoma de Baja
California
NIDA-IAS Fellow intervention
Aligning Law enforcement with HIV prevention in Mexico
Venue characteristics predicting HIV/STI risk
HIV prevention among
Drug treatment programs in Tijuana,
Mexico
Methadone implementation science in Kenya
University of California, San Diego (completed students, 2004-present)
Trainee Name Thesis Title
Angela Robertson
Type/Training
Period
PhD, Global Health track of Joint Doctoral
Program in Public
Concurrency and
HIV/STI risk among
FSWs and their
Funding
Strathdee
4 postdoctoral fellows or junior faculty per year
120 Mexican students
T32 fellow, UCSD
(Fowler/Patterson)
T32 Fellow, UCSD
(Fowler/Patterson)
T32 DA 023356; PI. SA
AITRP fellowship, Fogarty
International Program,
CONAcYT fellowship
AITRP fellowship, Fogarty
International Program
T32 fellow, UCSD
AITRP fellowship, Fogarty
International Program
NIDA-IAS Fellowship
Current Position
Assistant Professor, Dept of
Epidemiology, Boston
University
40

Trainee Name
Tyson Volkmann
Shira Goldenberg
Meghan Morris
Oralia Loza
Esmeralda Iniguez
(co-advisor)
Francisco Manzano
Type/Training
Period
Health (UCSD/SDSU)
(2012)
PhD student in Public
Health, Global Health track
PhD, Global Health track of Joint Doctoral
Program in Public
Health (UCSD/SDSU)
(2011)
PhD, Global Health track of Joint Doctoral
Program in Public
Health (UCSD/SDSU)
(2011)
PhD, Epidemiology track of Joint Doctoral
Program in Public
Health (UCSD/SDSU)
(2009)
PhD, Epidemiology track of Joint Doctoral
Program in Public
Health (UCSD/SDSU)
(2009)
MA, Ethnic
Studies(2006-2007)
Thesis Title
Intimate Partners
(supported through T32 and an R36)
Substance abuse risk behavior in injection drug users in San
Diego and Tijuana,
Mexico
Human trafficking for sexual exploitation along the Mexico-U.S. border
Gender differences in predictors of injection drug use initiation
(supported by NIDA
Diversity supplement)
Associations between
Sex Work and Injection
Drug Use in Tijuana,
Mexico (Supported by
NIDA Diversity
Supplement)
Modeling HIV and
Prevention
Interventions in Mexico
Towards a Framework of Operationalizing
Border Health
Current Position
EIS Program Officer, CDC
(Completed T32 fellow)
Postdoctoral Fellow, Univ. of
British Columbia (completed
CIHR, Fullbright fellowships)
Postdoctoral Fellow, UCSF
(completed T32 and div supplement)
Assistant Professor,
University of Texas El Paso
Epidemiologist, Early
Warning Infectious Disease
Surveillance Program, CA
PhD student, UCSD
Lydia Drumright
Monica Malta
PhD, Epidemiology
(2004-2006)
Humphrey Fellow,
2005
Associations between
Viagra and High Risk
Sexual Behavior among
Gay Men
Risk Behaviors among
Truck Drivers and
CSWs in Brazil
Lecturer, University of
London, UK
Dean of Graduate Studies,
FIOCRUZ, Rio de Janeiro
Post-doctoral fellows (completed)
Trainee
Name
Lianne
Urada
Eileen
Pitpitan
Type/Training Period Previous Degree &
Institution
T32 NIDA fellow, UCSD
(2011-2013)
HIV prevention among
FSWs
T32 NIDA fellow, UCSD
(2011-2013)
PhD, University of
Connecticut
Current Position
Assistant Professor, Department of
Medicine,UCSD
Assistant Professor, Department of
Medicine,UCSD (K01, 1
Strathdee/Patterson) st year;
41

Jennifer
Syvertsen
David
Goodman
Kathleen
Deering
Melanie
Rusch
Lydia
Drumright
T32 NIDA fellow, UCSD
(2012-2013)
PhD, University of
Southern California
T32 Postdoctoral fellow,
UCSD and AITRP
(2012-2013)
CIHR Postdoctoral fellow, UBC (2012-
2013)
University of California
AIDS Research
Program (2007-2009) and K99 (Rusch)
T32 Postdoctoral
NIAID Training Award
(2006-2008)
HIV Prevalence and
Correlates among MSM
Modelling structural factors influencing HIV risks among sex workers
PhD, University of British
Columbia
Assistant Professor, Department of
Anthropology, OSU (completed T32 and GloCal fellowships)
Albert Einstein College, Internal
Medicine Residency Program
Canadian Institutes of Health
Research, Postdoctoral fellow
Senior Researcher, Vancouver
Island Coastal Health
K99/ROO- completed
PhD, Epidemiology,
SDSU/UCSD Joint
Doctoral Program
Lecturer, Centre for Infection
Prevention & Management, Division of Infectious Disease & Immunity,
London
Associate Professor, Department of
Medicine, UCSD
PhD, Molecular
Microbiology and
Immunology;
Johns Hopkins University
PhD, Epidemiology, Johns
Hopkins School of Public
Health
Senior Research Scientist, Pacific
Institute for Research and
Evaluation (PIRE)
Kimberly
Brouwer
T32 Postdoctoral
NIAID Training Award
(2004-2005) and K01
(Brouwer)
Robin
Pollini
Karla
Wagner
T32 Postdoctoral
NIAID Training Award and K01 (Pollini)
(2005-2010)
T32 DA023356; PI. SA
Strathdee and K01
(Wagner)
Victoria
Ojeda
Kate
Shannon
NIDA Diversity
Supplement and K01
(Ojeda)
Cari Miller CIHR Postdoctoral
Award
Monica
Ulibarri
NIDA Diversity
Supplement and K01
(Ulibarri)
Jamila
Stockman
T32 DA 023356; PI. SA
Strathdee and K01
(Stockman)
CIHR Postdoctoral
Fellow
PhD, University of
Southern California
PhD, UCLA
PhD, University of British
Columbia
PhD, Johns Hopkins
School of Public Health
PhD, University of British
Columbia
Assistant Professor, University of
Nevada at Reno
Associate Professor, Department of
Medicine,UCSD
Assistant Professor, Simon Fraser
University
PhD, University of Arizona Assistant Professor, Department of
Psychiatry, UCSD
Assistant Professor, Department of
Medicine, UCSD
Associate Professor, University of
British Columbia
Jose Luis
Burgos
Tommi
Gaines
Peter
Davidson
Abby
Rudolph
NIDA Diversity
Supplement and K01
(Burgos)
NIDA Diversity
Supplement and K01
(Gaines)
T32 DA 023356; PI. SA
Strathdee and K01
(Davidson)
T32 DA 023356; PI. SA
Strathdee and K01
(Rudolph)
MD, MPH, Universidad
Autonoma de Baja
California
Assistant Professor, Department of
Medicine,UCSD
DrPH, UCLA, Biostatistics Assistant Professor, Department of
Medicine, UCSD
PhD, UCSF, Medical
Sociology
PhD, Johns Hopkins
School of Public Health
Assistant Professor, Department of
Medicine, UCSD
Scientist, PIRE
42

PhD Students (completed during tenure at JHSPH)
Trainee Name Type/Training
Period
Thesis Title
Mauro Sanchez ScD, Epidemiology
(1998- 2002)
Anita Loughlin PhD,
Epidemiology,
(1998-2002)
Electronic Monitoring of
Adherence to HAART
Increasing access to HIV and HCV care among drug users
Most Recent Position
Faculty, Universidad de Brasilia,
Brazil
Senior Epidemiologist, OptimInsight
Shruti Mehta PhD,
Epidemiology
1998- 2002
Associations between
HCV and Type II diabetes
Professor, Department of
Epidemiology, Johns Hopkins
University
Danielle Ompad
Sadeep
Shrestha
Jennifer Havens
Rochussen
Irene Kuo
PhD,
Epidemiology
(1998-2002)
PhD,
Epidemiology
(2001-present)
PhD,
Epidemiology
(2001-present)
PhD,
Epidemiology
(1999-present)
ADHD & conduct disorder as antecedents to high risk sexual behaviors
Genotypic studies of multiperson syringe use among injection drug users
Psychopathology and its relationship to substance abuse treatment readiness and treatment entry
Viral Hepatitis among
Drug Users in the USA and Pakistan
Associate Professor, New York
University
Associate Professor, University of
Alabama at Birmingham (tenured)
Associate Professor, University of
Kentucky (tenured)
Assistant Professor, George
Washington University
Student Advisees (Completed, Advisor during tenure at JHSPH)
Trainee Name Type/Training
Period
Mahboobeh Safaiean PhD, Epidemiology
(2000-2003)
Thesis Title
HPV among HIV+
Women in Uganda
Funding
T32 predoctoral stipend (PI:
Zenilman)
Katherine Poundstone PhD, Epidemiology
(2002-2003)
Caroline Fichtenberg PhD, Epidemiology
(2001-2003)
Social determinants of
HIV Infection
N/A
Pamela Matson PhD, Epidemiology
(2002-2003)
N/A
Post-doctoral fellows (completed during tenure at JHSPH)
Trainee
Name
Elizabeth
Golub
Type/Training Period Previous Degree &
Institution
Postdoctoral
NIDA Training Award
Grantee (2001-2003)
PhD, Epidemiology
Johns Hopkins University
(2001)
R03 (pre-doctoral)
Mary Meyer Fellowship,
Department of Epidemiology
NIDA, Drug Dependence
Training Program
Current Position
Associate Professor, Department of Epidemiology, Johns Hopkins
University
43

Independent Study Project Students - UCSD
1. Robert Deiss
2. Emily White
3. Jamie Anderson
4. Amy Huang Eppstein
5. Sarah Gibson-Rojas
Thesis Committee Membership – UCSD/SDSU (completed)
1. Laura Moyer, MPH, Epidemiology
2. Sandra Larios, PhD, Clinical Psychology
3. Julie Ketchie-Croff, PhD Health Behavior, 2010
4. Susan Cheng, Joint Doctoral Program in Public Health, Epidemiology
5. Kirsten Aschbacher, Joint Doctoral Program in Clinical Psychology
6. Ryan Lindsay, Joint Doctoral Program in Public Health, Global Health
Thesis Committee Member (Completed Students- Johns Hopkins)
1. Laura Cheevers, MSc, Epidemiology, Johns Hopkins School of Public Health, 1999
2. Bryan Lau, MSc, Epidemiology, Johns Hopkins School of Public Health, 1999
3. Carolyn Masters, PhD, Epidemiology, Johns Hopkins School of Public Health, 1999
4. Kevin Mallinson, PhD, Nursing, Johns Hopkins School of Public Health, 2001
5. Robert Kelly, PhD, International Health, Johns Hopkins School of Public Health, 2001
6. Waimar Tun, PhD, Epidemiology, Johns Hopkins School of Public Health, 2002
7. Priya Duggal, PhD, Epidemiology, Johns Hopkins School of Public Health, 2002
8. Ruby Nguyen, PhD, Epidemiology, Johns Hopkins School of Public Health, 2002
9. Jonathan Golub, PhD., Epidemiology, Johns Hopkins School of Public Health, 2002
10. Jacky Jennings, PhD, Epidemiology, Johns Hopkins School of Public Health, 2002
11. Preeti Pathela, DrPH., Epidemiology, Johns Hopkins School of Public Health, 2002
12. Priya Patil, PhD, International Health, Johns Hopkins School of Public Health, 2002
13. Ajay Sethi PhD, Epidemiology, Johns Hopkins School of Public Health, 2003
14. Laura Novelli, MHS, Epidemiology, Johns Hopkins School of Public Health, 2003
15. Lindsay Jorgenson, MHS, Epidemiology, Johns Hopkins School of Public Health, 2003
MPH Students (Integrating Experience Mentor, completed-Johns Hopkins)
1. Robin Pollini (2001)
2. Jennifer Rochussen Havens (2001)
3. Sandra Hipzner (2002)
4. Mohammad Ahmed (2002)
5. Maria D’Amico (2002)
International Humphrey Fellow Scholar Program (Advisor-Johns Hopkins)
1. Evodia Mokoko (South Africa) (2000-01)
2. Monica Beg (Bangladesh) (2000-02)
3. Olga Toussova (Russia) (2001-02)
4. Alisher Latypov (Tajikistan) (2002-03)
Preliminary Oral Participation- Johns Hopkins
Department of Epidemiology
1. David Kaufman, PhD, 1998
2. Sonia Stoszek, PhD, 1999
3. Hector Velasco, PhD, 1999
4. Rosa Duran, PhD, 1999
44

5. Paivi Miskala, PhD, 1999
6. Rupa Basu, PhD, 1999
7. Paulo Chaves, PhD, 1999
8. Christine Arcari, PhD, 1999
9. Carolyn Masters, PhD, 1999
10. Terri Manolio, PhD, 2000
11. Narin Hiransuthikul, PhD, 2000
12. Pamela Scott, PhD, 2000
13. Dana Maher, PhD, 2000
14. John F. Vertefeuille, PhD, 2001
15. William Checkley, PhD, 2001
16. Karen F. Corsi, PhD, 2001
17. Cun Ling Wang, PhD, 2002
18. Fredrick Makumbi, PhD, 2002
19. Megan McSorley, PhD, 2002
20. Elizabeth Gillander, PhD, 2002
Course Instruction (University of California San Diego)
1. Lecturer: FPM 258B Graduate Epidemiology Seminar, Nov 18, 2004
2. Lecturer: FPM 280C Health Behavior Practicum. “Dissemination of Data to the Public and the
Press.” May 16, 2006.
Course Instruction (Johns Hopkins University )
1. Lecturer: Psychosocial Factors in Health and Illness, Summer Institute in Mental Hygiene.
“Epidemiology of HIV/AIDS among Injecting drug users.” 2002-2003.
2. Lecturer : Gender and Health. “Women and HIV/AIDS”, May 2, 2003.
3. Lecturer: Mini-symposium on drug dependence Epidemiology, NIDA drug dependence
Epidemiology training program. “Gender Differences in HIV seroconversion among drug users”.
March 20, 2000.
4. Course Instructor: 340.715, Problems in the Design of Epidemiologic Studies, 2000 – present.
5. Lecturer : Issues in International Health. Winter Intersession. “Epidemiology of Injection Drug Use and BloodBorne Diseases”, January 2000-2001.
6. Lecturer: 340.627, Publ ic Health Impact of HIV/AIDS. “The Epidemiology of HIV/AIDS”, 1999-2001.
7. Laboratory Instructor: 340.603, Design and Analysis of Prospective Studies. 1999-2001.
8. Laboratory Instructor: 340.604, Design and Analysis of Case Control Studies. 1999-2000.
9. Laboratory Instructor: 340.601, Principles of Epidemiology, 1998-1999.
Reviewer
MPH Public Health Symposium 2002
Other Universities
Lecturer: SDSU PH 726 Epidemiology of HIV/AIDS among high-risk populations in 2 Mexican-US border cities, April 24, 2006
Graduate Student Supervision
University of British Columbia
1. Dmitry Noel-Bentley, MA, Counseling Psychology, 1996 - 1999
2. Anthony Sallar, PhD, Epidemiology, 1996 - present
3. Katherine Heath, PhD, Epidemiology, 1997 – 1998
4. Mary Pilipenko, M.Sc., Clinical Nutrition, University of British Columbia, 1999 (completed)
Course Instruction
45

University of British Columbia
1. Course Instructor: Health of Human Populations (Introductory Epidemiology Course). Department of Health Care & Epidemiology, University of British Columbia, Toronto, Canada, (Co-instructor
1993-1995; Primary Instructor 1995 – 1998.
2. Tutor: Doctor, Patient, and Society (Problem Based Learning Course for Medical Students):
Department of Medicine, University of British Columbia, Toronto, 1997.
External Examiner
1. Jennifer Iverson, PhD, Epidemiology, University of New South Wales, Australia
2. Traci Craig Green, PhD, Epidemiology, 2002, McGill University, Montreal
3. Paul Veugelers, Ph.D, Epidemiology, 1995, University of Amsterdam
3. Annie Dufour, PhD, Epidemiology, 1999, U niversité de Laval, Quebec City
4. Miranda Langendam, PhD, Epidemiology, 2000, University of Amsterdam
5. Margaret McDonald, Ph.D, Epidemiology, 2001, University of New South Wales, Australia
R ESEARCH G RANT P ARTICIPATION (A CTIVE )
Project PI Co-Investigators Amount Period Agency
Modeling structural HIV determinants in substance users and related populations
Police training to reduce occupational needlesticks and HIV among substance users
Global Health Fellows
Training Program
Dr. S.A.
Strathdee
Dr. N.
Martin
Dr P.
Vickerman
Dr. S.A.
Strathdee
Dr L.
Beletsky
Dr. S.A.
Strathdee
Dr. C.
Cohen
Dr. S.A.
Strathdee
Impact of Drug Policy
Reform on the HIV Risk
Environment among IDUs in
Tijuana (R37)
AIDS
International
Training
Program in the
US Mexico
Border Region
(D43)
Proyecto Parejas:
HIV/STI Risks among
FSWs and their Non-
Commercial Partners
(R01)
Dr. S.A.
Strathdee
Dr. S.A.
Strathdee
Dr. Thomas
Patterson
Dr. Thomas
Patterson
Dr. Tommi Gaines
Dr. J. Klausner
Dr. P Conrad
Dr. T. Patterson
Dr. R. Garfein
Dr. V. Ojeda
Dr. L. Beletsky
Dr. L. Palinkas
Dr. K Wagner
Dr. R. Laniado-
Laborín (codirector)
Dr. T. Patterson
Dr. V. Ojeda
Dr. L. Palinkas
Dr. M. Rusch
Dr. D. Smith
Dr. M. Ulibarri
1,197,724
2,043,130 2015 - 2020 National
Institute on
Drug Abuse,
NIH
$4,000,000 2012-2017 NIH Fogarty
International
Center
$5,000,000
$1,390,000
$3,540,961
2015 - 2018 National
2010-2020
(MERIT
Award)
2010-2016
2009-2015
Institute on
Drug Abuse,
NIH
National
Institute on
Drug Abuse,
NIH
Fogarty
International
Center,
NIH
National
Institute on
Drug Abuse,
NIH
46

Project PI Co-Investigators Amount Period Agency
Training Program in
Substance Use, HIV and Related Infections
(T32)
Dr. S.A.
Strathdee
Dr. T. Patterson
(13 faculty mentors from
UCSD and SDSU)
$1,431,140 2007-2017 National
Institute on
Drug Abuse,
NIH
R ESEARCH G RANT P ARTICIPATION (C OMPLETED )
Project
Centers for AIDS
Research-UCSD
(international core) (P30)
Sex Trafficking and HIV vulnerability among female sex workers along the
Mexico-US border
Binational
Training
Program to
Improve
Social
Justice and Health in the
Mexico-US border
Region
Preventing
HIV/STIs in
Central Indian
Female Sex
Workers: A Pilot
Intervention (R34)
Center for
HIV/AIDS Minority
Pipeline in
Substance Abuse
Research (R25)
Principal
Investigator
Dr. D.
Richman
Dr. S.A.
Strathdee
Dr. S.A.
Strathdee
Dr. Tom
Patterson
(PI)
Dr. S.A.
Strathdee
Co-
Investigators
Dr. S.A.
Strathdee
Dr. R. Schooley
(co-directors)
Dr. Ietza
Boroquez (Co-
PI)
Shira
Goldenberg (Co-
I)
Dr. W. Cornelius
Dr. L. Beletsky
Dr. J.L. Burgos
Dr. T. Patterson
Amount
$8,721,357 2007-2012 NIAID, NIH
$50,000
$304,039
Period Agency
2011-2012 PIMSA
2010-2012 USAID/HED
Dr. S.A.
Strathdee
Dr. S. Solomon
Dr. T. Patterson
Dr. M. Zuniga
$616,718
$786,271
2009-2012 National Institute on
Mental Health, NIH
2008-2012 National Institute on
Drug Abuse,
NIH
47

Project
UC Center of
Expertise on
Migration and
Health, Southern
Hub
Drug market characteristics: antecedents and sequelae on the
U.S. Mexico border (R21)
Principal
Investigator
Dr. S.A.
Strathdee
Dr. S.A.
Strathdee
Co-
Investigators
Amount
Dr. W. Cornelius $180,000
Dr Robin Pollini
Dr Remedios
Lozada
$681,344
Global Health
Partnership at
UCSD and SDSU
(R25)
A Cross-Border
HIV/AIDS
Prevention
Training Program in Northwest
Mexican Border
Region
Epidemiology of
HIV and TB among Injecting drug users in
Tijuana (R01)
Dr. S.A.
Strathdee
Dr. S.A.
Strathdee
Dr. S.A.
Strathdee
50 Co-Is at
UCSD and
SDSU
$586,789
Dr. T. Patterson
Dr. A.
McCutchan
Dr. S. Brodine
Dr. R. Laniado-
Laborin
Dr. A.Vargas
Dr. G. Rangel
Dr. T. Patterson
Dr. K. Brouwer
Dr. R. Garfein
Dr. P. Case
Dr. C. Latkin
Dr. R. Lozada
Dr. M. Zuniga
$498,638
2,400,000
Dr. R. Lozada $100,000 A Mobile prevention program to reduce
HIV/AIDS among drug users in
Tijuana
The Vancouver
Injection Drug Use
Study
An Integrated
Program of
Needle Exchange and VCT in Kabul,
Afghanistan.
Dr. S.A.
Strathdee
Dr. Evan
Wood
Dr. S. Strathdee
Dr. T. Kerr
Dr. M.T.
Schechter
Dr. P. Spittal
Dr. C. Todd Dr. S.A.
Strathdee
$2,500,000
$300,000
Period Agency
2009-2011 Gates Foundation
2007-2011 National Institute on
Drug Abuse, NIH
2006-2010 NIH, Fogarty
International Center
2005-2008 United States
Agency for
International
Development/
HED
2005-2009 National Institute on
Drug Abuse,
NIH
2007-2008 Gilead Foundation
2004-2009 National Institute on
Drug Abuse, NIH
2006-2008 Doris Duke
Charitable
Foundation
48

Project
PreveTB:
Increasing
Capacity for
Diagnosis,
Treatment and
Referrals among
High Risk
Populations in
Tijuana
Intervention to
Reduce HIV Risk
Behaviors among
MSM
Behavioral
Intervention for
HIV- Heterosexual meth users
Movil Promotora
Program: A Harm
Reduction
Program in
Tijuana, Mexico
Support for A
Harm Reduction
Program in
Tijuana, Mexico
Centers for AIDS
Research-UCSD
(supplement for
International
Program)
Evaluation of a
Three Component
Intervention among injecting drug users in India
Baltimore Needle
Exchange
Program
Evaluation
Principal
Investigator
Dr. R. S.
Garfein
Dr. R. S.
Garfein
Dr. T.
Patterson
Dr. S.A.
Strathdee
Dr. S.A.
Strathdee
Dr. D.
Richman
Co-
Investigators
Dr. S.A.
Strathdee
Dr. S.A.
Strathdee
Dr. S.A.
Strathdee
Dr. R. Lozada
Dr. T. Rodwell
Dr. R. Lozada
Dr. S.A.
Strathdee
Dr. Sweat Dr. S.A.
Strathdee
Dr. H.
Brahmbhatt
L. Samson
Dr. S.A.
Strathdee
Dr. D. Bishai
Dr. R.
Brookmeyer
Dr. C. Latkin
Dr. R. Brooner
Dr. L. Cornelius
Dr. S.A.
Strathdee
T. Zafar HIV and HCV
Prevalence among Injecting drug users in
Pakistan
HIV and HCV
Prevalence among Injecting drug users in
Mexico
Dr. S.A.
Strathdee
Dr. R. Ramos
Dr. R. Lozada
Dr. C. Conde
Dr. T. Patterson
Dr. C. Magis
Amount
$450,000
$225,000
$575,468
$25,000
$20,000
1,367,896
$2,500,000
$2,420,208
$63,000
$58,000
Period Agency
2006-2008 USAID
2006-2008 U.S. Centers for
Disease Control and
Prevention
2006-2008 National Institute of
Mental Health, NIH
2006-2007 Alliance Health Care
Foundation
2007 San Diego AIDS
Walk Foundation
2006-2007 NIAID, NIH
2002-2006 National Institute on
Drug Abuse, NIH
2001-2006 National Institute on
Drug Abuse,
NIH
2003-2004 National Institute on
Drug Abuse, NIH
2004-2005 National Institute on
Drug Abuse, NIH
49

Project
HIV, HCV and
Risk Behaviors among Injecting drug users and
Sex workers in
Tijuana and Cd
Juarez, Mexico
Behavioral and
Molecular
Surveillance of
HIV among
Injecting drug users in Tajikistan
Baltimore Needle
Exchange
Program
Evaluation
(Admin.
Supplement)
Principal
Investigator
Dr. S.A.
Strathdee
Dr. S.A.
Strathdee
Dr. S.A.
Strathdee
Co-
Investigators
Dr. R. Ramos
Dr. R. Lozada
Dr. C. Conde
Dr. T. Patterson
Dr. C. Magis
Dr. C. Beyrer
Dr. J.
Stachowiak
Dr. D. Vlahov,
Dr. R. Brooner,
Dr. J. Brady
Dr. R. Schwartz
An Intervention
Study to Improve
Access to HIV
Care and
Treatment
(Baltimore Site)
A Peer Based
Intervention to
Reduce HIV Risk in Young Drug
Users
Incidence of HIV
Infection in a
Cohort of Injecting drug users (ALIVE
II)
Dr. S.A.
Strathdee
Dr. S.A.
Strathdee
Dr. S.A.
Strathdee
Dr. D. Vlahov
Dr. K.E. Nelson
Dr. D.L. Thomas
Dr. D. Celentano
$2,000,000
1999-2000 National Institute on
Drug Abuse, NIH
Dr. A. Loughlin $1,100, 000 1999-2004 CDC
Dr. E. Golub
Amount
$30,000
$350,000
$560,250
$1,200,000
Period
2004
Agency
UCSD Center for
AIDS Research
2002-2004 USAID
1999-2004 CDC
1999-2003 National Institute on
Drug Abuse, NIH
$200,000 1998-1999 National Institute on
Drug Abuse,
NIH
Evaluation of
Needle Exchange
Treatment Slot
Expansion through Mobile
LAAM Program
An Open Cohort
Investigation of
HIV Infection among Injecting drug users
Health Care
Utilization
Patterns of
Injecting drug users
Dr. S.A.
Strathdee
Dr. S.A.
Strathdee,
Dr. D.
Patrick,
Dr. M.V
O’Shaughnessy
Dr. A.
Palepu
Dr. D. Vlahov,
Dr. J. Brady,
Dr. R. Brooner
Dr. M.T.
Schechter
Dr. M.L. Rekart
Dr. J.S.G.
Montaner
Dr. S.A.
Strathdee
Dr. D. Patrick
Dr. A. Anis
$800,000
$160,000
(Cdn)
$61,600
$59,094
(Cdn)
1995-1998 B.C. Ministry of
Health;
Health Canada
1997-1998 B.C. Health
Research
Foundation
50

Project
Risk of
Tuberculosis
Infection and
Disease in a
Population of
Injecting drug users
Multi-Center
Capture-
Recapture Study to Estimate the
Injection Drug
User population in
Canada
Determinants of
Hospitalization among HIV+ persons
Determinants of
Hospitalization
During the Last
Year of Life
Risk of
Tuberculosis
Infection and
Disease in a
Population of
Injecting drug users
Dr. R. S.
Hogg
Multi-Center
Capture-
Recapture Study to Estimate the
IDU population in
Canada
Determinants of
Hospitalization among HIV+ persons
Determinants of
Hospitalization
During the Last
Year of Life
Principal
Investigator
Dr. M.
Fitzgerald
Dr. R. Remis
Dr. S.A.
Strathdee
Dr. M.
Millson
Dr. R.
Routledge
R. Palmer
Dr. R. S.
Hogg
Co-
Investigators
Dr. S.A.
Strathdee
Dr. D.A. Patrick
Dr. J. Montaner
Dr. M.V.
O’Shaughnessy
Dr. M.L. Rekart
Dr. M.T.
Schechter
Dr. R.S. Hogg
Dr. J. Bruneau
Dr. M. Alary
Dr. C. Archibald
P. Leclerc
Dr. S.A.
Strathdee
Dr. J. Raboud
Amount
$21, 600
(Cdn)
$110,000
(Cdn)
$13,000
(Cdn)
Dr. S. A.
Strathdee
Dr. A. Anis
Dr. M.
Fitzgerald
Dr. R. Remis
Dr. S.A.
Strathdee
Dr. M.
Millson
Dr. R.
Routledge
R. Palmer
Dr. R. S.
Hogg
Dr. S.A.
Strathdee
Dr. D.A. Patrick
Dr. J. Montaner
Dr. M.V.
O’Shaughnessy
Dr. M.L. Rekart
Dr. M.T.
Schechter
Dr. R.S. Hogg
Dr. J. Bruneau
Dr. M. Alary
Dr. C. Archibald
P. Leclerc
Dr. S.A.
Strathdee
Dr. J. Raboud
$21, 600
(Cdn)
$110,000
(Cdn)
$13,000
(Cdn)
Dr. R. S.
Hogg
Dr. S. A.
Strathdee
Dr. A. Anis
$22,700
(Cdn)
$22,700
(Cdn)
Period
1997
1997
1996
1997
1997
1996
Agency
1997-1999 B.C. Lung
Association
Laboratory Centers for Disease Control;
Health Canada
St. Paul’s Hospital
Foundation
NHRDP,
Health Canada
1997-1999 B.C. Lung
Association
Laboratory Centers for Disease Control;
Health Canada
St. Paul’s Hospital
Foundation
NHRDP,
Health Canada
51

Project
Health Care
Utilization of
Injecting drug users: Pilot Study
Principal
Investigator
Dr. A.
Palepu
Co-
Investigators
Dr. S.A.
Strathdee
Dr. D. Patrick
Dr. A. Anis
Dr. C. Latkin
Dr. A. Arria
Amount
$14,489
(Cdn)
Period
1996
Agency
St. Paul’s Hospital
Foundation
AIDS
Epidemiologic
Research Studies
(REACH II)
Dr. S.A.
Strathdee
$731,667
(US)
1996-1999 CDC
Baltimore Needle
Exchange
Program
Evaluation
Incidence HIV
Infections in a
Cohort of IV Drug
Users (ALIVE II)
A Socio-
Behavioral and
Psychological
Study of HIV-
Infected Women in Ontario
Evaluation of a
Harm Reduction
Program in New
Delhi
Epidemiologic
Study on
Changing HIV
Risks among
Female-Sex
Workers Injecting drugs on the
Mexico – U.S.
Border (R01)
Dr. S.A.
Strathdee
Dr. K.E.
Nelson
Dr. S.A.
Strathdee
Dr. L.
Calzavara
Dr. L.
Jackson
Dr. Michael
Sweat
Dr. S.A.
Strathdee
Dr. T. Valente
Dr. C. Latkin
Dr. R.
Brookmeyer
Dr. D. Vlahov,
Dr. C. Lyles, Dr.
D. Thomas, Dr.
A. Tang
Dr. D. Celentano
Dr. M.E. Millson
Dr. S.A.
Strathdee
S. Walmsley
C. Wagner
A. Rachlis
Dr. S.A.
Strathdee
Dr. Luke
Samson
Dr. Samaran
Panda
Dr. T. Patterson
Dr. K. Brouwer
Dr. R. Lozada
Dr. M. Zuniga
$736,228
(US)
$1,368,044
(TDC)
$15,000
$24,000
(Cdn)
$2,000,000
$2,500,000
1994-2000 National Institute on
Drug Abuse, NIH
1993-1999 National Institute on
Drug Abuse
1993-1994 Ontario Ministry of
Health; Glaxco
Wellcome
2002-2007 National Institute on
Drug Abuse, NIH
2008-2014 National Institute on
Drug Abuse,
NIH
Determinants of
HIV Transmission
(P01)
Dr. S. Little Dr. D. Richman
Dr. D. Smith
Dr. C. Benson
Dr. S. Morris
Dr. R. Garfein
Dr. S.
Strathdee*
Director, Project
$21,222,
343
2008-2013 National Institute on
1
*Dr. Strathdee transferred Project Director status to Dr. Garfein on March 1/08.
Allergy and
Infectious Diseases
P EER -R EVIEWED A BSTRACTS AND P RESENTATIONS AT S CHOLARLY M EETINGS (Total: 405)
*Denotes oral presentation
52

1.
2.
3.
4.
5.
6.
7.
*Millson ME, Myers T, Rankin J, Major C, Fearon M, Rigby J, Strathdee SA. Two and a half year follow-up of HIV seroprevalence and risk behavior among Injecting drug users in Toronto. 3 rd
Annual Canadian Conference on HIV/AIDS Research, Montreal, May 1993, Canadian Journal
Infectious Diseases 1993; 4(Suppl A):34b;e03.
Murrant G, Strathdee SA. Motivations for volunteer involvement at Casey House AIDS Hospice.
3 rd Annual Canadian Conference on HIV/AIDS research, Canadian Association for HIV research; Montreal, May 1993, Canadian Journal Infectious Diseases 1993; 4(Suppl A):49b; sp406.
*Strathdee SA, Flannery J, Graydon D. Stressors in the workplace at Casey House AIDS
Hospice. 3 rd Annual Canadian Conference on HIV/AIDS Research, Canadian Association for
HIV Research, Montreal, May 1993. Canadian Journal Infectious Diseases 1993, 4(Suppl
A):47b;s16.
Millson ME, Myers T, Rankin J, Major C, Fearon M, Rigby J, Strathdee SA. Trends in HIV seroprevalence and risk behaviors in Injecting drug users in Toronto. 9th International
Conference on AIDS Berlin, June 1993.
Montaner JSG, Phillips P, Craib KJP, Zala C, Strathdee SA , Schechter MT, O’Shaughnessy
MV. Prevention of respiratory disease within a cohort of gay men – improving compliance with current guidelines. 2 nd International Congress on Drug Therapy in HIV Infection, Washington,
1994.
Major C, Read SE, Coates R, Millson ME, Calzavara L, Rigby J, Strathdee SA, Fearon M,
O’Shaughnessy MV. Saliva in HIV field research. 8th International Conference on AIDS,
Amsterdam, 1992.
*Calzavara L, Jackson L, Walmsley S, Rachlis A, Millson ME, Schlossberg J, Wagner C, Rowe
C, Strathdee SA, Major C, Bullock S. How many HIV-positive women are there in Ontario? 4 th
8.
Annual Canadian Conference on HIV/AIDS Research, Toronto June 1994, Canadian Journal
Infectious Diseases 1994; 5(Suppl A):42d, #34.
Phillips P, Zala C, Montaner JSG, Craib KJP, Strathdee SA , Schechter MT, O’Shaughnessy
MV. Improving compliance with guidelines for prevention of respiratory disease within a cohort of gay men. 4 th Annual Canadian Conference on HIV/AIDS Research, Toronto June 1994,
Canadian Journal Infectious Diseases 1994; 5(Suppl A):11d, #109.
Voigt R, Donald KJ, Hogg RS, Craib KJP, Strathdee SA , O’Shaughnessy MV, Montaner JSG. 9.
Physician agreement with recommended therapeutic guidelines for the management of HIV disease. 4 th Annual Canadian Conference on HIV/AIDS Research, Toronto June 1994,
Canadian Journal Infectious Diseases 1994; 5(Suppl A):11d, #120.
10. Woodfall BJ, Hogg RS, Le R, Thomson A, Strathdee SA , Schechter MT, O’Shaughnessy MV,
Montaner JSG. Impact of hospital experience on HIV disease mortality. 4 th Annual Canadian
Conference on HIV/AIDS Research, Toronto June 1994, Canadian Journal Infectious Diseases s 1994; 5(Suppl A):46d, #113.
11. Montaner JSG, Mandigo K, Hogg RS, Strathdee SA , Le R, Campbell D, O’Shaughnessy MV.
The post-voncorde era: Current trends in zidovudine utilization. 4 th Annual Canadian
Conference on HIV/AIDS Research, Toronto, June 1994, Canadian Journal Infectious Diseases
1994; 5(Suppl A):9d, #114.
12. *Hanvelt R, Ruedy N, Hogg RS, Strathdee SA , O’Shaughnessy MV, Montaner JSG, Schechter
MT. Estimated production loss due to HIV/AIDS mortality in Canada, 1987-1991. 4 th Annual
Canadian Conference on HIV/AIDS Research, Toronto, June 1994, Canadian Journal Infectious
Diseases 1994; 5(Suppl A):43d, #57.
13. *Kirkham CM, Lobb DJ,Strathdee SA. Sociodemographic characteristics and attitudes towards medical care among HIVpositive women in the b.c. positive women’s network. 4 th Annual
Canadian Conference on HIV/AIDS Research, Toronto, June 1994, Canadian Journal Infectious
Diseases 1994; 5(Suppl A):34d, #59.
14. Zadra J, Hogg RS, Strathdee SA, Craib KJP, Montaner JSG, Schechter MT. Socioeconomic characteristics are associated with rate of weight loss in homosexual men. 4 th Annual Canadian
Conference on HIV/AIDS Research, Toronto, June 1994, Canadian Journal Infectious Diseases
1994; 5 ( Suppl A):46d, #61.
53

15. *Hogg RS, Strathdee SA , Le R, Montaner JSG, O’Shaughnessy MV, Schechter MT. HIV/AIDS now the leading cause of premature mortality in men in Toronto, Montreal, and Vancouver. 4 th
Annual Canadian Conference on HIV/AIDS Research, Toronto, June 1994, Canadian Journal
Infectious Diseases 1994 ; 5(Suppl A):45d, #58.
16. Hogg RS, Strathdee SA , Le R, Schechter MT, Montaner JSG, O’Shaughnessy MV. Predictors of hospitalization in persons with HIV disease. 4 th Annual Canadian Conference on HIV/AIDS
Research, Toronto, June 1994, Canadian Journal Infectious Diseases 1994; 5(Suppl A):42d,
#55.
17. *Hogg RS, Strathdee SA , Craib KJP, O’Shaughnessy MV, Schechter MT, Montaner JSG.
Modeling the impact of HIV disease on patterns of mortality in gay and bisexual men. 4 th
Annual Canadian Conference on HIV/AIDS Research, Toronto, June 1994, Canadian Journal
Infectious Diseases 1994; 5(Suppl A):43d, #51.
18. *Craib KJP, Strathdee SA , Hogg RS, Le TN, Montaner JSG, O’Shaughnessy MV, Schechter
MT. AIDS mortality rates and factors related to survival in a cohort of homosexual men. 4 th
Annual Canadian Conference on HIV/AIDS Research, Toronto, June 1994, Canadian Journal
Infectious Diseases 1994 ; 5(Suppl A):44d, #52.
19. *Strathdee SA, Frank J, Leblanc M, McLaughlin J, Major C, Le TN, Read SE. Quantitative measures of p24 and p24/gp41 antibody as predictors of progression to AIDS: Evidence for effect modification by zidovudine. 4 th Annual Canadian Conference on HIV/AIDS Research,
Toronto, June 1994, Canadian Journal Infectious Diseases 1994; 5(Suppl A):43d, #53.
20. *Strathdee SA , Sutherland D, Schechter MT, Hogg RS, Le TN, O’Shaughnessy MV, Montaner
JSG. The changing spectrum of AIDS index diseases in Canada. 4 th Annual Canadian
Conference on HIV/AIDS Research, Toronto, June 1994, Canadian Journal Infectious Diseases
1994; 5(Suppl A):40d, #112.
21. Strathdee SA, Hogg RS, Craib KJP, Zadra J, Montaner JSG, Schechter MT. Is low social support a risk factor for subsequent HIV disease progression? 4 th Annual Canadian Conference on HIV/AIDS Research, Toronto, June 1994 Canadian Journal Infectious Diseases 1994;
5(Suppl A):44d, #56.
22. *Strathdee SA, Craib KJP, Le TN, Hogg RS, Devlin BL, McLean T, Montaner JSG,
O’Shaughnessy MV, Schechter MT. Under-reporting of AIDS cases in British Columbia. 4 th
Annual Canadian Conference on HIV/AIDS Research, Toronto, June 1994; Canadian Journal
Infectious Diseases 4; 5(s):45d, #50.
23. Veugelers PJ, Strathdee SA, Moss AR, Page KA, Tindall B, Schechter MT, Coutinho RA, van
Griensven GJP. Is the cofactor associated with kaposi’s sarcoma in HIV-infected homosexual men declining over time? 10th International Conference on AIDS, Yokohama, Japan 1994;
10(1):128. Abstract number Pa0132.
24. O’Shaughnessy MV, Montaner JSG, Mandigo K, Hogg RS, Strathdee SA, Le R, Campbell D,
Schechter MT. The post-concorde era: current trends in zidovudine utilization. 10th
International Conference on AIDS, Yokohama, Japan 1994; 10(2):16. Abstract number 356b.
25. Sestak PM, Donald KJ, Hogg RS, Craib KJP, Strathdee SA , O’Shaughnessy MV, Montaner
JSG. Physician agreement with recommended therapeutic guidelines for the management of
HIV disease. 10th International Conference on AIDS, Yokohama, Japan 1994; 10(2):237.
Abstract number Pb0961.
26. Le R, Hogg RS, Thomson A, Strathdee SA , Schechter MT, O’Shaughnessy MV, Montaner JSG.
Impact of hospital experience on HIV disease mortality. 10th International Conference on AIDS,
Yokohama, Japan 1994; 10(1):447. Abstract number Pd0397.
27. *Hanvelt R, Ruedy N, Hogg RS, Strathdee SA , O’Shaughnessy MV, Montaner JSG, Schechter
MT. Estimated production loss due to HIV/AIDS mortality in Canada, 1987-1991. 10th
International Conference on AIDS, Yokohama, Japan 1994; 10(1):13. Abstract number 025d.
28. Voigt R, Zadra J, Hogg RS, Strathdee SA, Craib KJP, Montaner JSG, Schechter MT.
Socioeconomic characteristics are associated with rate of weight loss in homosexual men. 10th
International Conference on AIDS, Yokohama, Japan, 1994; 10(1):322. Abstract number
Pc0220.
54

29. Woodfall BJ, Hogg RS, Strathdee SA , Le R, Schechter MT, Montaner JSG, O’Shaughnessy
MV. Predictors of hospitalization in persons with HIV disease. 10th International Conference on
AIDS, Yokohama, Japan, 1994; 10(1):447. Abstract number Pd0396.
30. *Schechter MT, Strathdee SA , Sutherland D, Hogg RS, Le TN, O’Shaughnessy MV, Montaner
JSG. The changing spectrum of AIDS index diseases in Canada. 10th International
Conference on AIDS, Yokohama, Japan, 1994; 10(1):38. Abstract number 124c.
31. Le TN, Strathdee SA, Craib KJP, Hogg RS, Devlin BL, McLean T, Montaner JSG,
O’Shaughnessy MV, Schechter MT. Under-reporting of AIDS cases in British Columbia. 10th
International Conference on AIDS, Yokohama, Japan 1994; 10(1):325. Abstract number
Pc0230.
32. Craib KJP, Strathdee SA , Hogg RS, Le TN, Montaner JSG, O’Shaughnessy MV, Schechter MT.
AIDS mortality rates and factors related to survival in a cohort of homosexual men. 10th
International Conference on AIDS, Yokohama, Japan, 1994; 10(1):317. Abstract number
Pc0197.
33. Willoughby BC, Strathdee SA, Hogg RS, Craib KJP, Zadra J, Montaner JSG, Schechter MT. Is low social support a risk factor for subsequent HIV disease progression? 10th International
Conference on AIDS, Yokohama, Japan 1994 ; 10(1):322. Abstract number Pc0221.
34. Hogg RS, Strathdee SA , Craib KJP, O’Shaughnessy MV, Schechter MT, Montaner JSG.
Modeling the impact of HIV disease on patterns of mortality in gay and bisexual men. 10th
International Conference on AIDS, Yokohama, Japan 1994; 10(1):58. Abstract number 184c.
35. Strathdee SA, Frank J, Leblanc M, McLaughlin J, Major C, Le TN, Read SE. Quantitative measures of p24/gp41 and p24 HIV antibody as predictors of progression to AIDS: evidence for effect modification by zidovudine. 10th International Conference on AIDS, Yokohama, Japan,
1994; 10 ( 1):318. Abstract number Pc0204.
36. Zala C, Phillips P, Montaner JSG, Craib KJP, Strathdee SA , Schechter MT, O’Shaughnessy
MV. Improving compliance with guidelines for prevention of respiratory disease within a cohort of gay men. 10th International Conference on AIDS, Yokohama, Japan, 1994; 10(1):244.
Abstract number Pb0406.
37. Jackson L, Calzavara L, Strathdee SA, Millson ME, Rachlis A, Rowe C, Wagner C, Walmsley S and the HIV women’s study group, University of Toronto, Ontario, Canada. Social, behavioral and psychological issues related to HIV infection among women in Ontario, Canada. HIV infection in Women Conference, Washington, February 1995, p. 124.
38. Calzavara L, Jackson L, Strathdee SA, Millson ME, Rachlis A, Rowe C, Wagner C, Walmsley C and the HIV women’s study group, University of Toronto. A sociodemographic profile of known
HIV-positive women in Ontario. HIV Infection in Women Conference, Washington, February
1995.
39. *Montaner JSG, Strathdee SA , Hogg RS, Le R, O’Shaughnessy MV, Schechter MT. Baseline profile of women and men on antiretroviral therapy in British Columbia. HIV infection in Women
Conference, Washington, February 1995, p. 122.
40. Hogg RS, Strathdee SA , Le R, Woodfall B, Montaner JSG, O’Shaughnessy MV, Schechter MT.
Predictors of hospitalization in women and men with HIV disease. HIV Infection in Women
Conference, Washington, February 1995, p. 35.
41. Strathdee SA , Patrick D, Archibald C, Ofner M, Eades G, Rekart M, O’Shaughnessy MV. An outbreak investigation of HIV infection among injection drug users in a major Canadian epicenter. AIDS and Drug Abuse Conference, National Institute on Drug Abuse, Scottsdale,
June 1995.
42. Patrick DM, MacDougall RG, Rekart ML, Middleton PJ, Cook D, Strathdee SA, Archibald C,
Ofner M, Harvey E, O’Shaughnessy MV. Use of a non-nominal surveillance system to track an outbreak of HIV infection among a population of Injecting drug users who had early access to control measures. International Society for STD Research, New Orleans, June 1995.
43. Hogg RS, Schechter MT, Craib KJP, Strathdee SA , Montaner JSG, O’Shaughnessy MV.
Evidence for gender and regional differences. 5 th Annual Canadian Conference on HIV/AIDS
Research, Winnipeg, June 1995, Canadian Journal Infectious Diseases 1995; 6(Suppl B):32b,
#354. HIV/AIDS mortality in Canada.
55

44. *Hogg RS, Montaner JSG, Strathdee SA, Craib KJP, Le R, O’Shaughnessy MV, Schechter MT.
The effect of gender on the pattern of use of antiretrovirals in British Columbia. 5 th Annual
Canadian Conference on HIV/AIDS Research, Winnipeg, June 1995, Canadian Journal
Infectious Diseases 1995; 6(Suppl B):35b, #320.
45. Jackson L, Calzavara L, Millson ME, Rachlis A, Rowe C, Strathdee SA, Wagner C, Walmsley S.
Social, behavioral and psychological issues related to HIV infection among women living in
Ontario. 5 th Annual Canadian Conference on HIV/AIDS Research, Winnipeg, June 1995,
Canadian Journal Infectious Diseases 1995; 6(Suppl B):48b, #417.
46. *Craib KJP, Meddings DR, Strathdee SA , Hogg RS, Montaner JSG, O’Shaughnessy MV,
Schechter MT. Rectal gonorrhea as an independent risk factor for HIV infection in a cohort of gay men. 5 th Annual Canadian Conference on HIV/AIDS Research, Winnipeg, June 1995,
Canadian Journal Infectious Diseases 1995; 6(Suppl B):38b, #307.
47. *Sanderson B, Strathdee SA, Hogg RS, Blane S, Cornelisse PGA, Desmerais L, Montaner JSG,
O’Shaughnessy MV. A sociodemographic profile of HIV-positive aboriginal peoples: the St.
Paul’s hospital/Vancouver native health society partnership. 5 th Annual Canadian Conference on HIV/AIDS Research, Winnipeg, June 1995, Canadian Journal Infectious Diseases 1995;
6(Suppl B):35b, #341.
48. *Calzavara L, Strathdee SA, Ricketts M, Jackson L et al. Reported and unreported female
AIDS cases in Ontario: how many and who. 5 th Annual Canadian Conference on HIV/AIDS
Research, Winnipeg, June 1995, Canadian Journal Infectious Diseases 1995; 6(Suppl B):38B,
#305.
49. Harvey E, Eades G, Mertens M, Trussler T, Strathdee SA. Qualitative analysis of barriers to negotiation of safer sex among hard to reach youth. 5 th Annual Canadian Conference on
HIV/AIDS Research, Winnipeg, June 1995, Canadian Journal Infectious Diseases 1995;
6(Suppl B):56B, #436.
50. Hogg RS, O’Shaughnessy MV, McLean T, Strathdee SA, Cornelisse PGA, Montaner JSG,
Schechter MT, Mulchey RD. The diagnostic value of case mix groups as a test for prior AIDS diagnosis on a hospital discharge abstract. 5 th Annual Canadian Conference on HIV/AIDS
Research, Winnipeg, June 1995, Canadian Journal Infectious Diseases 1995; 6(Suppl B):40B,
#318.
51. Hogg RS, Raboud J, Strathdee SA , Craib KJP, O’Shaughnessy MV, Montaner JSG, Schechter
MT. The changing spectrum of hospital visits with an HIV/AIDS diagnosis in Canada, 1987-
1991. 5 th Annual Canadian Conference on HIV/AIDS Research, Winnipeg, June 1995,
Canadian Journal Infectious Diseases 1995; 6(Suppl B):32b, #319.
52. Cornelisse PGA, Hogg RS, Strathdee SA , Craib KJP, McLean T, O’Shaughnessy MV,
Schechter MT, Montaner JSG. Heterogeneity in the reporting of AIDS diagnoses in two provincial registries. 5 th Annual Canadian Conference on HIV/AIDS Research, Winnipeg, June
1995, Canadian Journal Infectious Diseases 1995 ; 6(Suppl B):38b, #306.
53. *Rothon DA, Strathdee SA, Cook D, Cornelisse PGA. Determinants of high risk behaviors for
HIV infection among young offenders in British Columbia detention centers. 5 th Annual
Canadian Conference on HIV/AIDS Research, Winnipeg, June 1995, Canadian Journal
Infectious Diseases 1995; 6(Suppl B):32b, #342.
54. *Patrick D, Strathdee SA, Cook D, Middleton P, Sutherland D, Rekart ML. Enhanced surveillance for HIV infection in British Columbia using HIV testing data. 5 th Annual Canadian
Conference on HIV/AIDS Research, Winnipeg, June 1995, Canadian Journal Infectious
Diseases 1995; 6(Suppl B):43b, #344.
55. *Harvey E, Strathdee SA , Patrick D, Archibald CH, Ofner M, Eades G, O’Shaughnessy MV.
Qualitative analysis of Injecting drug users following an outbreak of HIV infection in Vancouver.
5 th Annual Canadian Conference on HIV/AIDS Research, Winnipeg, June 1995, Canadian
Journal Infectious Diseases 1995; 6(Suppl B):56b, #415.
56. Hogg RS, Strathdee SA, Ricketts M, Craib KJP, Cornelisse PGA, Montaner JSG,
O’Shaughnessy MV, Schechter MT. HIV-related mortality without a prior reported diagnosis of
AIDS. 5 th Annual Canadian Conference on HIV/AIDS Research, Winnipeg, June 1995,
Canadian Journal Infectious Diseases 1995; 6(Suppl B):33b, #321.
56

57. Strathdee SA, Veugelers PJ, Moss AR, Page KA, Tindall B, Schechter MT, Coutinho RA, van
Griensven GJP. Is the HIVrelated kaposi’s sarcoma epidemic coming to an end? Insights from the Tricontinental Seroconverter Study. 5 th Annual Canadian Conference on HIV/AIDS
Research, Winnipeg, June 1995, Canadian Journal Infectious Diseases 1995; 6(Suppl B):43b,
#343.
58. *Strathdee SA , Craib KJP, Hogg RS, O’Shaughnessy MV, Montaner JSG, Schechter MT. A comparison of recruitment strategies for young men having sex with men (MSM) in an open cohort study of HIVseroincidence. long-term non-progression rates of HIV disease in a cohort of gay men. 5 th Annual Canadian Conference on HIV/AIDS Research, Winnipeg, June 1995,
Canadian Journal Infectious Diseases 1995; 6(Suppl B):35b, #345.
59. *Strathdee SA , Martindale SL, Hogg RS, Craib KJP, Montaner JSG, O’Shaughnessy MV,
Schechter MT. A comparison of recruitment strategies for young men having sex with men
(MSM) in an open cohort study of HIV seroincidence. 5 th Annual Canadian Conference on
HIV/AIDS Research, Winnipeg, June 1995, Canadian Journal Infectious Diseases 1995;
6(Suppl B):51b, #429.
60. Strathdee SA, Cornelisse PGA, Craib KJP, McLean T, Hogg RS, Montaner JSG,
O’Shaughnessy MV, Schechter MT. Under-reporting of AIDS in British Columbia (1982-1993).
5 th Annual Canadian Conference on HIV/AIDS Research, Winnipeg, June 1995, Canadian
Journal Infectious Diseases 1995; 6(Suppl B):44b, #353.
61. Strathdee SA, Patrick D, Archibald C, Ofner M, Eades G, Rekart M, Sutherland D,
O’Shaughnessy MV. An outbreak investigation of HIV INJECTING DRUG USERS in
Vancouver. 5 th Annual Canadian Conference on HIV/AIDS Research, Winnipeg, June 1995,
Canadian Journal Infectious Diseases 1995 6(Suppl B):36b, #346.
62. Major C, Li X, Strunc G, Galli R, Fearon M, Calzavara L, Peter A, Rachlis A, Palmer R,
Strathdee SA, Fisher M, Read S. HIV-1 viral load in progressors vs. non-progressors. 2 nd
Annual Meeting on HIV Surrogate Markers, Virginia, October 1995.
63. Major C, Li X, Strunc G, Galli R, Fearon M, Calzavara L, Peter A, Rachlis A, Palmer R,
Strathdee SA, Fisher M, Read S. HIV-1 viral load in progressors vs. non-progressors. 3 rd
Conference on Retroviruses and Opportunistic Infections, Washington. January 1996. Abstract number 43.261.
64. Patrick David M, Strathdee SA, Archibald CP, Ofner M, Craib KJP, Cornelisse PGA, Rekart ML.
Outbreak Vancouver: Why is HIV spreading among Injecting drug users in a city with longstanding needle exchange and outreach services? 3 rd Conference on Retroviruses and
Opportunistic Infections, Washington, January 1996. Abstract number 20.109.
65. Strathdee SA , Craib KJP, Hogg RS, O’Shaughnessy MV, Montaner JSG, Schechter MT.
Longterm nonprogression among a cohort of HIV-infected homosexual men. 3 rd Conference on
Retroviruses and Opportunistic Infections, Washington, January 1996. Abstract number 78.525.
66. Read SE, Major C, Li X, Strunc G, Galli R, Fearon M, Fisher M, Palmer R, Strathdee SA,
Calzavara L, Peter A, Rachlis A. Is viral load a predictor of clinical outcome? 11th International
Conference on AIDS, Vancouver, July 1996. Abstract number We.b.3380.
67. Craib KJP, Denotter DM, Hogg RS, Cornelisse PGA, Strathdee SA, Le R, Montaner JSG,
O’Shaughnessy MV, Schechter MT. A cross-sectional comparison of the nutritional intake of
HIV seropositive and seronegative homosexual men. 11th International Conference on AIDS,
Vancouver, July 1996. Abstract number Th.b.4240.
68. *Cook DA, Patrick DM, Rekart ML, Middleton PJ, Strathdee SA, Spencer D, Rees T,
MacDougall R, Marcin K. Enhanced surveillance for HIV infection in British Columbia. 11 th
International Conference on AIDS, Vancouver, July 1996. Abstract number Mo.c.333.
69. Archibald CP, Ofner M, Patrick DM, Strathdee SA, Eades G, Sutherland D, Rekart ML,
Schechter MT, O’Shaughnesy MV. Needle exchange program attracts high-risk Injecting drug users. 11th International Conference on AIDS, Vancouver, July 1996. Abstract number
Tu.c.320.
70. Yip B, Hogg RS, Frank O, Ostrow M, Strathdee SA , Montaner JSG, O’Shaughnessy MV,
Schechter MT. Comparative demographic analysis of patterns of HIV/AIDS mortality in industrialized nations. 11th International Conference on AIDS, Vancouver, July 1996. Abstract number Mo.c.1544.
57

71. Mandigo K, Hogg RS, Craib KJP, Strathdee SA, Gataric N, Yip B, Schechter MT,
O’Shaughnessy MV, Montaner JSG. The pattern of antiretroviral use in a province-wide drug distribution program is independent of gender. 11th International Conference On AIDS,
Vancouver, July 1996. Abstract number We.c.3397.
72. Devlin BL, Hogg RS, Heath KV, Strathdee SA , Montaner JSG, O’Shaughnessy MV, Schechter
MT. HIV/AIDS mortality in Canada: Evidence of gender, regional and local area differentials.
11th International Conference On AIDS, Vancouver, July 1996. Abstract number Mo.C.1542.
73. Ofner M, Archibald CP, Strathdee SA, Patrick DM, Millson P, Myers T, Palmer RWH, Eades G,
Sutherland D, O’Shaughnessy MV. High-risk behaviors of injection drug users in two large
Canadian cities. 11th International Conference on AIDS, Vancouver, July 1996. Abstract number Tu.c.2504.
74. *Craib KJP, Strathdee SA, Hogg RS, Leung B, Montaner JSG, Cassol S, Schechter MT,
O’Shaughnessy MV. Post-seroconversion HIV-1 viral load predicts progression to aids and death among seroconverters in a prospective study of homosexual men. 11th International
Conference on AIDS, Vancouver, July 1996. Abstract number Mo.c.902.
75. *Patrick DM, Strathdee SA, Ofner M, Archibald CP, Craib KJP, Cornelisse PGA, Schechter MT,
Eades G, O’Shaughnessy MV, Rekart ML. Explaining an outbreak: determinants of HIV seroconversion among Injecting drug users in Vancouver. 11th International Conference on
AIDS, Vancouver, July 1996. Abstract number Mo.c.463.
76. *Veugelers PJ, Strathdee SA, Kaldor JM, Page-Shafer KA, Schechter MT, Coutinho RA, Keet
IP, van Griensven GJP. Incidence and prognostic significance of symptomatic primary HIV-1 infection in homosexual men. 11th International Conference on AIDS, Vancouver, July 1996.
Abstract number mo.c.324.
77. Cornelisse PGA, Strathdee SA , Craib KJP, Montaner JSG, O’Shaughnessy MV, Schechter MT.
A comparison of risk factors for HIV transmission between two cohorts of gay men (1982/84 vs.
1995). 11th International Conference on AIDS, Vancouver, July 1996. Abstract number
Tu.c.2393.
78. *Martindale SL, Strathdee SA, Hogg RS, Craib KJP, Pitchford W, Montaner JSG,
O’Shaughnessy MV, Schechter MT. Risk behaviors and HIV prevalence among a cohort of young men who have sex with men in Vancouver. 11th International Conference On AIDS,
Vancouver, July 1996. Abstract number We.c.563.
79. Currie S, Harvey E, Strathdee SA , Patrick D, Ofner M, Archibald C, O’Shaughnessy MV.
Qualitative analysis of Injecting drug users following an outbreak of HIV infection in Vancouver.
11th International Conference On AIDS, Vancouver, July 1996. Abstract number Tu.c.2499.
80. Denotter DM, Strathdee SA, Craib KJP, Cornelisse PGA, Hogg RS, Raboud JM,
O’Shaughnessy MV, Schechter MT. The relationship of dietary micronutrient intake to disease progression in a cohort of HIV+ gay men. 11th International Conference On AIDS, Vancouver,
July 1996. Abstract number We.b.3259.
81. Coutinho RA, Strathdee SA, Veugelers PJ, Page-Shafer KA, Kaldor JM, Moss AR, Schechter
MT, van Griensven GJP. Lack of consistency between five definitions of nonprogression in cohorts of HIV-infected seroconverters. 11th International Conference on AIDS, Vancouver,
July 1996. Abstract number We.c.3470.
82. Strathdee SA, Patrick DM, Archibald C, Ofner M, Craib KJP, Cornelisse PGA, Eades G,
Schechter MT, O’Shaughnessy MV. Social determinants predict needle-sharing behavior among Injecting drug users in Vancouver. 11th International Conference On AIDS,
Vancouver, July 1996. Abstract number Mo.d.363.
83. *Strathdee SA, Hogg RS, Martindale SL, Cornelisse PGA, Craib KJP, Schilder A, Montaner
JSG, O’Shaughnessy MV, Schechter MT. Sexual abuse is an independent predictor of sexual risk-taking among young HIV-negative gay men: Results from a prospective study at baseline.
11th International Conference on AIDS, Vancouver, July 1996. Abstract number Mo.c.900.
84. *Strathdee SA, Patrick DM, Currie S, Cornelisse PGA, Rekart ML, Montaner JSG, Schechter
MT, O’Shaughnessy MV. Needle exchange is not enough: Lessons from the Vancouver injection drug use study. 4 th Annual Conference on Retroviruses and Opportunistic Infections,
Washington D.C., January 1997.
58

85. *Craib KJP, Heath KV, Sandford A, Strathdee SA, Veugelers PJ, Pare P, Montaner JSG,
Schechter MT, O’Shaughnessy MV. The relationship between ∆32 ccr5 genotype and survival in a cohort of HIV-1 seroincident gay men. 6 th Annual Canadian Conference On HIV/AIDS
Research, Ottawa, May 1997, Canadian Journal Infectious Diseases 1997; 8 (Suppl A):30a,
#232.
86. *Veugelers PJ, Cornelisse PGA, Craib KJP, Hogg RS, Strathdee SA, Montaner JSG,
O’Shaughnessy MV, Schechter MT. Models of survival following HIV injection: Impact of treatment. 6 th Annual Canadian Conference on HIV/AIDS Research, Ottawa, May 1997,
Canadian Journal Infectious Diseases 1997; 8 (Suppl A):23a, #202.
87. Estable MC, Mo T, Schechter MT, Strathdee SA , O’Shaughnessy MV, Sadowski IJ. Subtypes and genetic distances for HIV-1 circulating in the vlas and vinjecting drug users cohorts. 6 th
Annual Canadian Conference on HIV/AIDS Research, Ottawa, May 1997, Canadian Journal
Infectious Diseases 1997; 8 (Suppl A):37a, #254.
88. Hogg, RS, Sallar MA, Strathdee SA , Craib KJP, Montaner JSG, O’Shaughnessy MV, Schechter
MT. The life expectancy and health status of men living in two Vancouver neighborhoods with high HIV prevalence. 6 th Annual Canadian Conference on HIV/AIDS Research, Ottawa, May
1997, Canadian Journal Infectious Diseases 1997; 8 (Suppl A):34a, #246.
89. *Miller ML, Strathdee SA, Martindale SL, Cornelisse PG, Hogg RS, Cook D, Montaner JSG,
O’Shaughnessy MV, Schechter MT. Characteristics of male sex trade workers enrolled in a prospective study of HIV incidence. 6 th Annual Canadian Conference on HIV/AIDS Research,
Ottawa, May 1997, Canadian Journal Infectious Diseases 1997; 8 (Suppl A):8a, #101.
90. *Martindale SL, Strathdee SA, Hogg RS, Cornelisse PG, Egan J, Devlin B, Miller ML, Montaner
JSG, O’Shaughnessy MV, Schechter MT. Evidence of psychological distress in a cohort of young gay/bisexual men. 6 th Annual Canadian Conference on HIV/AIDS Research, Ottawa,
May 1997, Canadian Journal Infectious Diseases 1997; 8 (Suppl A):8a, #102.
91. *Hogg RS, Strathdee SA, Heath K, Sutherland D, Montaner JSG, O’Shaughnessy MV,
Schechter MT. Regional and gender differentials in patterns of HIV/AIDS mortality in Canada.
6 th Annual Canadian Conference on HIV/AIDS Research, Ottawa, May 1997, Canadian Journal
Infectious Diseases 1997; 8 (Suppl A):29a, #228.
92. *Craib KJP, Strathdee SA, Leung B, Veugelers PJ, Hogg RS, Montaner JSG, Schechter MT,
O’Shaughnessy MV. The relationship between pre-treatment changes in serum HIV-1 rna level and cd4 cell count and survival in a cohort of seroincident gay men. 6 th Annual Canadian
Conference on HIV/AIDS Research, Ottawa, May 1997, Canadian Journal Infectious Diseases
1997; 8 (Suppl A):31a, #233.
93. *Patrick DM, Strathdee SA, Currie S, Pitchford W, Rekart ML, FitzGerald MV, Montaner JSG,
Schechter MT, O’Shaughnessy MV. Incidence of HIV in the Vancouver injection drug users study cohort. 6 th Annual Canadian Conference on HIV/AIDS Research, Ottawa, May 1997,
Canadian Journal Infectious Diseases 1997; 8 (Suppl A):27a, #219.
94. *Currie S, Strathdee S, Estable M, Mo T, Patrick DM, Cornelisse PG, Koester S, Rekart ML,
Montaner JSG, Schechter MT, Sadowski I, O’Shaughnessy MV. Needle networks: An analysis of molecular, epidemiologic and qualitative data among Vancouver’s Injection drug users. 6 th
Annual Canadian Conference on HIV/AIDS Research, Ottawa, May 1997, Canadian Journal
Infectious Diseases 1997 ; 8 (Suppl A):11a, #112.
95. *Cornelisse PGA, Strathdee SA, van Haastrecht HJA, van Ameijden EJC, Currie S, Patrick DM,
Rekart ML, Montane r JSG, Schechter MT, O’Shaughnessy MV. Comparison of attenders of needle exchange and methadone maintenance programs in Vancouver versus Amsterdam. 6 th
Annual Canadian Conference on HIV/AIDS Research, Ottawa, May 1997, Canadian Journal
Infectious Diseases 1997; 8 (Suppl A):28a, #224.
96. *Palepu A, Strathdee SA, Anis AH, Patrick DM, Hogg RS, Rekart, ML, Montaner JSG,
Schechter MT, O’Shaughnessy MV. Health services utilization in a cohort of injection users:
Baseline results from the Vancouver injection drug users study. 6 th Annual Canadian
Conference on HIV/AIDS Research, Ottawa, May 1997, Canadian Journal Infectious Diseases
1997; 8 (Suppl A):27a, #217.
97. *Strathdee SA, Patrick DM, Cornelisse PG, Currie S, Pitchford W, Rekart M, Montaner JSG,
Schechter MT, O’Shaughnessy MV. Needle sharing in Vancouver: Who lends needles and
59

why. 6 th Annual Canadian Conference on HIV/AIDS Research, Ottawa, May 1997, Canadian
Journal Infectious Diseases 1997; 8 (Suppl A):10a, #111.
98. *Strathdee SA, Martindale SL, Hogg RS, Cornelisse PG, Egan J, Cook D, Rekart ML, Montaner
JSG, O’Shaughnessy MV, Schechter MT. HIV prevalence, incidence, and risk behaviors among a cohort of young gay/bisexual men. 6 th Annual Canadian Conference on HIV/AIDS
Research, Ottawa, May 1997, Canadian Journal Infectious Diseases 1997; 8 (Suppl A):24a
#204.
99. *Rekart ML, Strathdee SA, Patrick D, Cornelisse PG, Currie S, Montaner JSG, Schechter M,
O’Shaughnessy. AIDS Impact: biopsychological aspects of HIV infection determinants of HIVpositivity at inception of the Vancouver injection drug users study. Melbourne, Victoria,
Australia, June 1997.
100. *Strathdee SA, Patrick D, Cornelisse PG, Currie S, Rekart M, Montaner JSG, Schechter M,
O’Shaughnessy M. AIDS Impact: Biopsychological aspects of HIV infection, needle sharing in
Vancouver: Who lends needles and why. Melbourne, Victoria, Australia, June 1997.
101. FitzGerald JM, Patrick D, Strathdee SA, et al. Prevalence of tuberculosis infection in a population of Injecting drug users. Am J Respir Crit Care Med 1997; 155:4. Abstract A221.
102. FitzGerald JM, Patrick D, Strathdee SA, et al. Use of incentives to increase subject compliance to PPD skin testing among Injecting drug users. Am J Respir Crit Care Med 1997; 155:4.
Abstract number A561.
103. Strathdee SA, Palepu A, C ornelisse PGA, O’Shaughnessy MV, Schechter MT, Montaner JSG,
Hogg RS. HIV+ Injecting drug users eligible for antiretrovirals: what are the barriers to receiving therapy despite universal access? 5 th Conference on Retroviruses and Opportunistic
Infections, Chicago, February 1- 5, 1998.
104. Dufour A, Strathdee SA, Alary M, Martindale SL, Otis J, Voigt R, Remis RS, Schechter MT.
Comparison between young men who have sexual and affective relations with men (MSM) participating in two cohort studies in Montreal and Vancouver. 7th Annual Canadian
Conference on HIV/AIDS Research, Quebec City, April 30 – May 3, 1998, Canadian Journal
Infectious Diseases 1998; 9 (Suppl A): 44a, #258p.
105. Patrick D, Cornelisse PGA, Sherlock CH, Rekart ML, Montaner JSG, Strathdee SA, Schechter
MT, O’Shaughnessy MV. Hepatitis C prevalence and incidence in Vancouver Injecting drug users. 7th Annual Canadian Conference on HIV/AIDS Research, Quebec City, April 30 -May 3,
1998, Canadian Journal Infectious Diseases 1998 ; 9 (Suppl A): 38a, #236.
106. Schechter MT, Strathdee SA , Cornelisse PGA, Currie S, Patrick D, Rekart ML, O’Shaughnessy
MV. Needle exchange does not promote HIV transmission among injection drug users in
Vancouver. 7th Annual Canadian Conference on HIV/AIDS Research, Quebec City, April 30 -
May 3, 1998, Canadian Journal Infectious Diseases 1998; 9 (Suppl A): 37a, #233.
107. Palepu A, Yip B, Hogg RS, Strathdee SA, Sherlock C, Schechter MT, Montaner JSG,
O’Shaughnessy MV. Lesser virologic response to antiretroviral therapy in Injecting drug users in a drug treatment program. 7th Annual Canadian Conference on HIV/AIDS Research,
Quebec City, April 30 -May 3, 1998, Canadian Journal Infectious Diseases 1998; 9 (Suppl A):
35a, #224.
108. Heath K, Strathdee SA , Palepu A, Schechter MT, O’Shaughnessy MV. Determinants of HIV infection in a cohort of native Canadian Injecting drug users. 7th Annual Canadian Conference on HIV/AIDS Research, Quebec City, April 30- May 3, 1998, Canadian Journal Infectious
Diseases 1998; 9 (Suppl A): 30a, #208.
109. Patrick DM, Schechter MT, Strathdee SA, Cornelisse PGA, Rekart ML, Cook D, Montaner JSG,
O’Shaughnessy MV. HIV incidence in Vancouver Injecting drug users follows a predictable decline. 7th Annual Canadian Conference on HIV/AIDS Research, Quebec City, April 30- May
3, 1998, Canadian Journal Infectious Diseases 1998; 9 (Suppl A): 47a, #270p.
110. Strathdee SA , Cornelisse PGA, Currie S, Martindale S, MV O’Shuaghnessy, MT Schechter.
Feasibility of HIV vaccine trials among high risk cohorts in Vancouver. 7th Annual Canadian
Conference on HIV/AIDS Research, Quebec City, April 30 – May 3, 1998, Canadian Journal
Infectious Diseases 1998: 9 (Suppl A): 32a, #216.
111. Strathdee SA, Palepu A, Hogg R, Cornelisse PGA, Montaner JSG, Schechter MT,
O’Shaughnessy MV. Barriers to receiving antiretroviral therapy among Injecting drug users.
60

7th Annual Canadian Conference on HIV/AIDS Research, Quebec City, April 30 - May 3, 1998,
Canadian Journal Infectious Diseases 1998; 9 (Suppl A): 35a, #226.
112. Craib KJP, Strathdee SA, Hogg RS, Cornelisse PGA, Willoughby BC, Sestak P , Schechter MR,
O’Shaughnessy MV. Incidence rates of HIV-1 infection, AIDS progression and mortality in the
Vancouver lymphadenopathy-AIDS study: Results at 14 years. 7th Annual Canadian
Conference On HIV/AIDS Research, Quebec City, April 30 - May 3, 1998, Canadian Journal
Infectious Diseases 1998;9(Suppl A): 31a, #213.
113. Craib KJP, Harrigan PR, Strathdee SA, Cornelisse PGA, Leung B, Hogg RS, Montaner JSG,
Schechter MT, O’Shaughnessy MV. The relationship between longitudinal changes in serum
HIV-1 RNA level and CD4 cell count and survival in a cohort of seroincident gay men. 7th
Annual Canadian Conference on HIV/AIDS Research, Quebec City, April 30 - May 3, 1998,
Canadian Journal Infectious Diseases 1998; 9(Suppl A): 32a, #216.
114. Currie SL, Strathdee SA , Cornelisse PGA, McGuire J, Turvey J, Schechter MT, O’Shaughnessy
MV. Risk profile of Injecting drug users accessing mobile needle exchange vans vs. a fixed site. 7th Annual Canadian Conference on HIV/AIDS Research, Quebec City, 1998, April 30 –
May 3, 1998, Canadian Journal Infectious Diseases 1998; 9 (Suppl A): 37a, #232.
115. Martindale SL, Strathdee SA, Miller ML, Cornelisse PGA, Hogg RS, De Wit J, Willoughby B,
Woodfall B, Schechter MT. Unsafe sex and elevated HIV incidence among young men having sex with men. 7th Annual Canadian Conference on HIV/AIDS Research, Quebec City, April 30-
May 3. Canadian Journal Infectious Diseases 1998; 9 (Suppl A): 32a, #214.
116. Schilder AJ, Laframboise S, Strathdee SA, Goldstone I, Trussler T, Schechter MT,
O’Shaughnessy MV. The social identity and self-concept of HIV-positive transgendered persons intervenes in HIV care. 12th World AIDS Conference, Geneva, June 28- July 3, 1998. Abstract number 60309.
117. O’Shaughnessy MV, Montaner JSG, Strathdee SA, Schechter MT. Deadly public policy. 12th
World AIDS Conference, Geneva, June 28 - July 3, 1998. Abstract number 44233.
118. Schilder AJ, Strathdee SA , Goldstone I, Trussler T, Schechter MT, O’Shaughnessy MV.
Disclosure in health care experiences of HIV-positive bisexual men can influence access to antiretroviral therapy. 12th World AIDS Conference, Geneva, June 28- July 3, 1998. Abstract number 32428.
119. Schilder AJ, Hogg RS, Goldstone I, Strathdee SA , Schechter MT, O’Shaughnessy MV. Adult social identity is part of culturally competent HIV care for sexual minorities and affects careseeking behaviors and therapeutic adherence. 12th World AIDS Conference, Geneva, June 28-
July 3, 1998. Abstract number32355.
120. Schechter M, Martindale S, Miller ML, Strathdee SA, Cornelisse PGA, Tetlock FTK, Tigchelaar
J. Characteristics of male sex trade workers in a prospective study of HIV incidence and behaviors in young men having sex with men. 12th World AIDS Conference, Geneva, June 28-
July 3, 1998. Abstract number 23525.
121. Schechter MT, Heath K, Strathdee SA, Palepu A. Determinants of HIV infection in a cohort of native Canadian Injecting drug users. 12th World AIDS Conference, Geneva, June 28 -July 3,
1998. Abstract number 23513.
122. Bastos FI, Telles PR, Bastos Jr. W, Strathdee SA. Higher frequency of commercial sex among crack smokers in a sample of Injecting drug users, in Rio de Janeiro. 12th World AIDS
Conference, Geneva, June 28- July 3, 1998. Abstract number 23212.
123. Patrick MD, Cornelisse PGA, Sherlock CH, Rekart ML, Strathdee SA. Hepatitis C prevalence and incidence in Vancouver Injecting drug users during an outbreak of HIV infection. 12th
World AIDS Conference, Geneva, June 28- July 3, 1998. Abstract number 13296.
124. Martindale S, Miller ML, Strathdee SA, Cornelisse PGA, Tetlock FTK, Tigchelaar J, Schechter
MT. Characteristics of male sex trade workers in a prospective study of HIV incidence and behaviors in young men having sex with men. 12th World AIDS Conference, Geneva, June 28-
July 3, 1998. Abstract number 33196.
125. Currie SL, Strathdee SA , O’Shaughnessy MV, Patrick DM, Rekart ML, Turvey J, Schechter MT.
Maximizing needle exchange coverage among Injecting drug users: Do mobile programs attract those at highest risk? 12th World AIDS Conference, Geneva, June 28 -July 3, 1998.
Abstract number 33196.
61

126. Celentano D, Hogg RS, Vlahov D, Strathdee SA, Moore RD, Palepu A, Cohn S. Barriers to HIV antiretroviral therapy among Injecting drug users in settings with and without universal health insurance coverage. 12th World AIDS Conference, Geneva, June 28 -July 3, 1998. Abstract number 500*/42285.
127. *Cornelisse PGA, van Haastrecht H, van Ameijden E, Schechter MT, Coutinho RA, Strathdee
SA. A comparison of active Injecting drug users attending needle exchange and methadone maintenance programs in Vancouver versus Amsterdam. 12th World AIDS Conference,
Geneva, June 28 - July 3, 1998. Abstract number 33385.
128. *Strathdee SA , O’Shaughnessy MV, Montaner JSG, Martindale S, Currie S, Schechter MT.
Feasibility and willingness to participate in HIV-vaccine trials in cohorts of young men having sex with men (MSM) and Injecting drug users. 12th World AIDS Conference, Geneva, June 28
- July 3, 1998. Abstract number 33214.
129. *Strathdee SA, Martindale S, Miller ML, Hogg RS, Woodfall B, Sestak P, Schechter MT.
Evidence of elevated HIV incidence and relapse to unsafe sex among young men having sex with men (MSM) in Vancouver. 12Tth World AIDS Conference, Geneva, June 28 - July 3, 1998.
Abstract number 23118.
130. *Schechter MT, Strathdee SA, Currie S, Patrick DM, Rekart ML, Montaner JSG,
O’Shaughnessy MV. Harm reduction, not harm production: Needle exchange does not promote HIV transmission among injection drug users in Vancouver. 12th World AIDS
Conference, Geneva, June 28 - July 3, 1998. Abstract number 33379.
131. *Strathdee SA. Injection drug use and HIV transmission: Feasibility of HIV vaccine among highrisk cohorts in Vancouver. 11th Annual BC HIV/AIDS Conference, Vancouver, November 23-
24, 1998.
132. Crape B, Marx MA, Junge B, Latkin CA, Brookmeyer RS, Strathdee SA, Vlahov D. No increase in arrests with introduction of needle exchange program. 10 th International Conference on the
Reduction of Drug Related Harm, Geneva, March 21-25, 1999.
133. Marx MA, Beilenson P, Brahmbhatt H, Huettner S, Strathdee SA, Alexander C, Vlahov D.
Attitudes of adolescents about illicit drug use and needle exchange programs. 10 th International
Conference on the Reduction of Drug Related Harm, Geneva, March 21-25, 1999.
134. Strathdee SA, Celentano DD, Shah N, Lyles C, Stambolis V, Johnson L, Nelson KE, Vlahov D.
Bridges to treatment: Factors with entry into detoxification and methadone maintenance. 10 th
International Conference on the Reduction of Drug Related Harm, Geneva, March 21-25, 1999.
135. *Arria AM, Fuller C, Strathdee SA, Vlahov D. Sex differences in the prevalence of drug dependence among young injecting drug users ascertained by community outreach. College on Problems of Drug Dependence Annual Meeting, Acapulco, June 12-19, 1999.
136. Ompad D, Fuller C, Vlahov D, Strathdee SA. Drug use patterns among newly initiated Injecting drug users before and after introduction of a needle exchange program. College on Problems of
Drug Dependence Annual Meeting, Acapulco, June 12-19, 1999.
137. Fuller C, Strathdee SA, Ompad D, Vlahov D. Patterns of heroin, cocaine, and crack use prior to initiation of injection among adolescents and young adults. College on Problems of Drug
Dependence Annual Meeting, Acapulco, June 12-19, 1999.
138. Riley E, Vlahov D, Safrahein M, Junge B, Beilenson P, Strathdee SA. Gender differences in drug use patterns and successful referrals to drug treatment among Baltimore needle exchange participants. College on Problems of Drug Dependence Annual Meeting, Acapulco, June 12-19,
1999.
139. *Macalino G, Nelson KE, Vlahov D, Celentano DD, Safaeian M, Strathdee SA. Temporal trends, demographics, and behavioral risk factors for HIV seroconversion among Baltimore drug users, 1988-1997. College on Problems of Drug Dependence Annual Meeting, Acapulco, June
12-19, 1999.
140. Marx MA, Crape B, Junge B, Latkin C, Brookmeyer R, Strathdee SA, Vlahov D. Does introduction of a needle exchange program result in increased crime in needle exchange program areas? College on Problems of Drug Dependence Annual Meeting, Acapulco, June
12-19, 1999.
62

141. Strathdee SA, Celentano DD, Shah N, Lyles C, Stambolis V, Johnson L, Nelson KE, Vlahov D.
Needle exchange and health care utilization promote entry into detoxification. College on
Problems of Drug Dependence Annual Meeting, Acapulco, June 12-19, 1999.
142. Fuller C, Vlahov D, Safarian M, Ompad D, *Monterosso E, Strathdee SA. Correlates of HIV infection among newly-initiated adolescent and young adult Injecting drug users (REACH II).
SER Meeting, Baltimore, June 10-12, 1999.
143. *Nelson KE, Macalino GE, Vlahov D, Celentano DD, Safarian M, Strathdee SA. Temporal trends, demographics, and behavioral risk factors for HIV seroconversion among Baltimore drug users. SER Meeting, Baltimore, June 10-12, 2002.
144. *Macalino GE, Celentano DD, Kuo I, Strathdee SA, Vlahov D. A comparison of audio computerassisted self –interviews (ACASI) to interviewer-administered questionnaires (IAQ) among a cohort of injecting drug users. SER Meeting, Baltimore, June 10-12, 1999.
145. Crape B, *Marx MA, Junge B, Latkin C, Brookmeyer R, Strathdee SA, Vlahov D. No evidence for increased crime rates following introduction of a needle exchange program. SER Meeting,
Baltimore, Maryland, June 10-12, 1999.
146. Palepu A, Leon H, Anis AH, Muller J, Miller D, King S, Rae S, Strathdee SA, Hogg RS,
Schechter MT, Montaner JSG, O’Shaughnessy MV. Does HIV affect the cost of hospitalization in Injecting drug users? Can J Infect Dis 1999; 10 (suppl b):44b, #c307.
147. *Ompad D, Fuller C, Vlahov D, Thomas D, Strathdee SA. Sexually transmitted disease among adolescent and young adult Injecting drug users in Baltimore (REACH II). 127 th Apha Meeting,
Chicago, November 7-11, 1999.
148. *Marx MA, Beilenson P, Brahmbhatt H, Alexander C, Strathdee SA, Vlahov D. According to city high school students: Needle exchange programs do not encourage them to use illicit drugs.
127 th American Public Health Association Meeting, Chicago, November 7-11, 1999.
149. *Macalino GE, Celentano DD, Kuo I, Mehta SH, Strathdee SA, Vlahov D. Assessing the validity of self-reported HIV risk behaviors collected by audio computer-assisted self –interview (ACASI) among a cohort of Injecting drug users. 127 th American Public Health Association Meeting,
Chicago, November 7-11, 1999.
150. *Fuller C, Vlahov D, Ompad D, *Monterosso E, Strathdee SA. Circumstances associated with younger age of initiation among young Injecting drug users (REACH II). 127 th American Public
Health Association Meeting, Chicago, November 7-11, 1999.
151. *Fuller C, Vlahov D, Safarian M, Ompad D, Monterosso E, Strathdee SA. Correlates of HIV infection among newly initiated adolescent and young adult Injecting drug users (REACH II).
127 th American Public Health Association Meeting, Chicago, November 7-11, 1999.
152. *Vertefeuille J, Marx MA, Riley E, Tun W, Strathdee SA,Vlahov D. Six-month follow-up of risk behaviors in HIV seropositive participants in a needle exchange program. 127 th American Public
Health Association Meeting, Chicago, November 7-11, 1999.
153. Riley E, Strathdee SA, Junge B, Latkin C, Beilenson P, Vlahov D. Baseline gender differences in drug use history and patterns of drug use among Baltimore needle exchange participants.
127 th American Public Health Association Meeting, Chicago, November 7-11, 1999.
154. *Arria A, Fuller C, Strathdee SA, Vlahov D. Sex differences in drug dependence among young
Injecting drug users ascertained by community outreach. 127 th American Public Health
Association Meeting, Chicago, November 7-11, 1999.
155. Bastos FI, Strathdee SA, Derrico M, Morgado MG. Human T-lymphotropic virus infection among Brazilian Injecting drug users: a challenge seldom addressed by harm-reduction initiatives in Brazil. Revista do instituto de medicina tropical de Sao Paulo, 1999; 41(suppl.
11):s12.
156. Jacobson LP, Gore ME, Strathdee SA, Phair J, Riddler S, Detels R. Characterizing therapynaïve HIV-positives in the era of potent anti-retroviral therapy. 7 th Conference on Retroviruses and Opportunistic Infections, San Francisco October, 2000.
157. *Kuo I, Vlahov D, Brooner R, Brady J, Butler c, Schwartz R, Strathdee SA. Comparisons of mobile LAAM versus methadone maintenance treatment among participants referred by a community needle exchange program. American Public Health Association Annual Meeting,
Washington, November, 2000.
63

158. *Safaeian M, Latkin C, Brookmeyer R, Marx M, Brown M, Vlahov D, Strathdee SA. Validation of self reported NEP attendance: Do high risk individuals over-report NEP attendance? 11 th
International Conference On Reduction Of Harm. Jersey, United Kingdom, April 7-20, 2000.
159. *Brahmbhatt H, Sarin E, Samson L, Dorabjee J, Sweat Mw, Strathdee SA. Sociodemographic and behavioral characteristics of injection drug users attending a harm-reduction program in
Delhi India. 11 th International Conference On Reduction Of Harm. Jersey, United Kingdom, April
7-20, 2000.
160. Brown M, Safaiean M, Marx M, Kidorf M, Brooner R, Strathdee SA. Needle exchange as a bridge to drug abuse treatment: A two-way street. 11 th International Conference On Reduction
Of Harm. Jersey, United Kingdom, April 7-20, 2000.
161. *Kuo I, Brady J, Schwartz R, Butler C, Brooner R, Vlahov D, Strathdee SA. Feasibility of mobile
LAAM treatment among Injecting drug users referred from a NEP. 11 th International
Conference On Reduction Of Harm. Jersey, United Kingdom, April 7-20, 2000.
162. Lin M, Celentano DD, Strathdee SA , Vlahov D. Self-reported adherence to antiretroviral therapies among HIV seropositive Injecting drug users in Baltimore. College on Problems of
Drug Dependence 62 nd Annual Scientific Meeting, San Juan Puerto Rico, June 17-22, 2000
[Poster #37].
163. Fuller C, Vlahov D, Arria AM, Ompad DC, Shah N, Strathdee SA. High-risk behaviors associated with transition from non-injection drug use among young drug users: A case-control study. College on Problems of Drug Dependence 62 ND Annual Scientific Meeting, San Juan
Puerto Rico, June 17-22, 2000.
164. Henderson L, Vlahov D, Strathdee SA. Readiness of drug abuse treatment among attenders and non-attenders of a needle exchange program (NEP). College on Problems of Drug
Dependence 62 ND Annual Scientific Meeting, San Juan Puerto Rico, June 17-22, 2000.
165. *Kuo I, Brady J, Schwartz R, Butler C, Brooner R, Vlahov D, Strathdee SA. Feasibility of mobile
LAAM treatment among Injecting drug users referred from a needle exchange program (NEP).
CPDD 62 nd Annual Scientific Meeting, San Juan Puerto Rico, June 17-22, 2000.
166. Vertefeuille J, Safaeian M, Marx M, Riley E, Huettner S, Vlahov D, Strathdee SA.
Consequences of closure of a pharmacy-based NEP site. 13th International AIDS Conference,
Durban, South Africa, July 9-14, 2000. Abstract number Weped728.
167. *Fuller C, Vlahov D, Arria AM, Ompad DC, Shah N, Strathdee SA. High risk behaviors associated with transition from non-injection drug use among young drug users: A case-control study. 13th International AIDS Conference, Durban, South Africa, July 9-14, 2000. Abstract number Thped5490.
168. Brahmbhatt H, Sarin E, Samson L, Dorabjee J, Sweat MD, Strathdee SA. HIV risk behaviors among Injecting drug users attending a harm reduction program in Delhi, India. 13th
International AIDS Conference, Durban, South Africa, July 9-14, 2000. Abstract number
Thped5471.
169. Ostrow D, Fox K, Chmiel JS, Silvestre A, Visscher BR, Vanable P, Jacobson LP, Strathdee SA for the Multicenter AIDS Cohort Study. Attitudes towards highly active antiretroviral therapy
(HAART) predict sexual risk-taking among HIV-infected and uninfected gay men in the multicenter aids cohort study. 13th International AIDS Conference, Durban, South Africa, July
9-14, 2000. Abstract number Thorc719.
170. Sweat MD, Samson L, Sarin E, Dorabjee J, Brahmbhatt H, Strathdee SA. Risk factors for HIV-
1, hepatitis B, hepatitis C, and syphilis infection among buprenorphine injectors in New Delhi.
13th International AIDS Conference, Durban, South Africa, July 9-14, 2000. Abstract number
Thped5498.
171. Nelson KE, Galai N, Safaein M, Strathdee SA, Celentano DD, Vlahov D. Temporal trends in
HIV incidence and risk behaviors among Injecting drug users in Baltimore, 1988-1998. 13th
International AIDS Conference, Durban, South Africa, July 9-14, 2000. Abstract number
Tupec3405.
172. Lai S, Bareta J, Celentano DD, Macalino G, Vlahov D, Strathdee SA. Does repeated interviewing using ACASI lead to dampened responses of sensitive behaviors? 13th
International AIDS Conference, Durban South Africa, July 9-14, 2000.
64

173. Lai S, Strathdee SA, Celentano DD, Johnson L, Nelson KE, Vlahov D. Differential patterns of needle sharing among males and female HIV-infected Injecting drug users. 13th International
AIDS Conference, Durban South Africa, July 9-14, 2000. Abstract number Tupec3379.
174. Riley E, Robnett T, Vlahov D, Vertefeuille J, Strathdee SA, Chaisson R. Higher reports of HIV- and TB-related risk behaviors using audio-computer-assisted self-interviews (ACASI) compared to interviewer-administered questionnaires (IAQ). 13th International AIDS Conference, Durban
South Africa, July 9-14, 2000. Abstract number Wepec4442.
175. Vlahov D, Strathdee SA. Sex differences in longitudinal HIV-1 plasma RNA level dynamics among seroconverters. 13th International AIDS Conference, Durban, South Africa, July 9-14,
2000.
176. *Sterling T, Astemborski J, Quinn T, Urban C, McNairm D, Strathdee SA, Vlahov D. Initial HIV-
1 plasma RNA level after seroconversion does not predict progression to AIDS in women. 13th
International AIDS Conference, Durban, South Africa, July 9-14, 2000. Abstract number
Tuorb402.
177. *Strathdee SA, Safaeian M, Latkin C, Marx M, Vlahov D, Brookmeyer R. HIV seroconverters over-report attendance at NEPs: Implications for evaluating program effectiveness. 13th
International AIDS Conference, Durban, South Africa, July 9-14, 2000. Abstract number
Tuppd1276.
178. Strathdee SA, Galai N, Safaeian M, Celentano D,Vlahov D, Nelson KE for the ALIVE Study.
Gender differences in risk factors for HIV seroconversion among Injecting drug users: A tenyear perspective. 13th International AIDS Conference, Durban, South Africa, July 9-14, 2000.
Abstract number Tupec3458.
179. Latkin C, Shah N, Vlahov D, Ompad DC, Strathdee SA. Sexual risk correlates associated with injecting among young drug users in Baltimore, 1997-1999. 13th International AIDS
Conference, Durban, South Africa, July 9-14, 2000. Abstract number Tupec3481.
180. Arria AM, Shah N, Latkin C, Fuller C, Vlahov D, Strathdee SA. Drug treatment utilization among young drug users ascertained by community outreach in Baltimore. 13th International AIDS
Conference, Durban, South Africa, July 9-14, 2000. Abstract number Thped5489.
181. Kuo I, Brooner R, Brady J, Butler C, Schwartz R, Vlahov D, Strathdee SA. Comparison of needle exchange attenders referred to mobile LAAM versus methadone maintenance treatment programs in Baltimore. 13th International AIDS Conference, Durban, South Africa, July 9-14,
2000. Abstract number Tuppd1272.
182. Brahmbhatt H, Bareta J, Huettner S, Marx M, Vlahov D, Strathdee SA. Morality and causes a death among attenders and non-attenders of a needle exchange program. International Harm
Reduction Association Meeting, New Delhi, April 1-8, 2001.
183. Strathdee SA, Ikeda R, Shah N, Vlahov D, Morse E, Fuller C, Bailey S, Kerndt P, Maslow C,
Garfein RS. Childhood sexual abuse predicts early initiation of injection. International Harm
Reduction Association
Meeting, New Delhi, April 1-8, 2001.
184. *Strathdee SA, Ikeda R, Shah N, Vlahov D, Morse E, Fuller C, Bailey S, Kerndt P, Maslow C,
Garfein RS. Childhood sexual abuse independently predicts early initiation of injection drug use. Congress of Epidemiology 2001, Toronto, June 13-16, 2001.
185. *Kerndt PR, Bailey S, Des Jarlais D, Lopez-Zetina J, Morse E, Strathdee SA, Vlahov D, Garfein
RS. HIV infection among Injecting drug users. Methamphetamine use and geographic differences among young Injecting drug users in five large metropolitan areas. 129th Annual Meeting of the
American Public Health Association, Atlanta, October 21-25, 2001.
186. *Des Jarlais DC, Maslow C, Vlahov D, Strathdee SA, Ouellet L, Kerndt P, Morse E, Perlis T,
Garfein RS. Use of syringe exchange and HIV risk behavior in different cities. 129th Annual
Meeting of the American Public Health Association, Atlanta, October 21-25, 2001.
187. Ompad DC, Guimond T, Sherman SG, Fuller CM, Vlahov D, Strathdee SA. Club drug use among a cohort of young, recently initiated Injecting drug users. College on Problems of Drug
Dependence, Quebec City, June 2002.
188. *Sherman SG, Shepherd M, Vlahov D, Bareta J, Valente TW, Huettner S, Strathdee SA. HIV risk reduction behaviors among secondary syringe exchangers: Their natural role in HIV
65

prevention efforts among Injecting drug users. 14th International Conference on AIDS,
Barcelona, July 2002. Abstract number Moord1061.
189. Strathdee SA, Safaeian M, Doherty M, Garfein RS, Fuller CM, Sherman G, Ompad DC, Vlahov
D. Correlates of HIV infection among young new initiates to injection drug use in Baltimore:
1994-2000. 14th International AIDS Conference, Barcelona, July 7-12, 2002.
190. Gardner LI, Krawczyk C, Metsch L, Strathdee SA, Del Rio C, Mahoney P, Holmberg SD.
Physician characteristics associated with discussing HIV prevention messages in a multicenter study. 14th International Conference on AIDS, Barcelona, July 2002. Abstract number
Thped7763.
191. Shepard MD, Sherman SG, Valente TW, Brookmeyer RS, Vlahov D, Bareta J, Huettner S,
Strathdee SA. Individual and network characteristics associated with return of syringes to a syringe exchange program. 14th International Conference on AIDS, Barcelona, July 2002.
Abstract number Thpec7452.
192. Sherman SG, Safaiean M, Garfein RS, Doherty M, Fuller CM, Ompad D, Vlahov D, Strathdee
SA. Correlates of receptive needle sharing among young new initiates to injection drug use in
Baltimore. 14th International Conference on AIDS, Barcelona, July 2002. Abstract number
Weped6366.
193. Garfein RS, Valverde R, Swartzendruber A, Williams IT, Jarlais D Des, Strathdee SA, Morris
E, Vlahov D, Kerndt P, Ouellet L, Monterroso ER. Differences in correlates of HIV, hepatitis B virus (HBV) and hepatitis C virus (HCV) infections among young, street-recruited Injecting drug users in United States metropolitan areas. 14th International Conference on AIDS, Barcelona,
July 2002. Abstract number Mopec3403.
194. *Strathdee SA, Zafar T, Brahmbhatt H, Hassan S. Higher level of needle sharing among
Injecting drug users in Lahore, Pakistan, in the aftermath of the US-Afghan war. 14th
International Conference on AIDS, Barcelona, July 2002. Abstract number Moppc2018.
195. *Strathdee SA, Safaeian M, Doherty M, Garfein RS, Fuller CM, Sherman SG, Ompad DC,
Vlahov D. Correlates of HIV infection among young new initiates to injection drug use in
Baltimore, 1994-2000. 14th International Conference on AIDS, Barcelona, July 2002. Abstract number Weped6366.
196. Tun W, Gange SJ, Vlahov D, Strathdee SA, Celentano DD. Modest change in sexual risk by level of immunologic response to HAART among HIV-infected Injecting drug users. 14th
International Conference on AIDS, Barcelona, July 2002. Abstract number Mopec3393.
197. Galai N, Safaeian M, Celentano DD, Vlahov D, Strathdee SA. Longitudinal risk patterns after notification of HIV seroconversion among Injecting drug users: The alive study 1998-2000.
14th International Conference on AIDS, Barcelona, July 2002. Abstract number Thpec7404.
198. Frangakis C, Scharfstein D, Strathdee SA, Safaiean M, Varadhan R, Brookmeyer R, Vlahov D.
Reduction in HIV incidence associated with needle exchange program attendance in Baltimore:
1994-2000. 14th International Conference on AIDS, Barcelona, July 2002. Abstract number
Tupec4832.
199. Golub ET, Bareta JC, Vlahov D, Huettner S, Strathdee SA. Correlates of unsafe syringe disposal among injection drug users in Baltimore. 14th International Conference on AIDS,
Barcelona, July 2002. Abstract number Mopec3397.
200. Duggal P, An P, Beaty TH, Strathdee SA, Farzadegan H, Markham RB, Vlahov D, Winkler CA,
O’Brien SJ. Genetic influence of STRL33 chemokine receptor alleles on pcp mediated AIDS progression among African American Injecting drug users. 14th International Conference on
AIDS, Barcelona, July 2002. Abstract number Wepea5764.
201. *Sterling TR, Hoover DR, Astemborski J, Vlahov D, Bartlett JG, Strathdee SA. Schupbach J.
Heat-denatured HIV-1 p24 antigen predicts disease progression and correlates with HIV-1 viral load and CD4+ t-lymphocyte level in adults with early-stage disease. 14th International
Conference on AIDS, Barcelona, July 2002. Abstract number Mopeb3098.
202. Purvis LA, Golub ET, Sapun M, Safaeian M, Beyrer C, Tun W, Vlahov D, Strathdee SA.
Changes in willingness to participate in HIV vaccine trials among Injecting drug users. 14th
International Conference on AIDS, Barcelona, July 2002. Abstract number Tupec4835.
66

203. Bareta JC, Golub ET, Vlahov D, Huettner S, Strathdee SA. Syringe acquisition and HIV status among Injecting drug users in Baltimore. 14th International Conference on AIDS, Barcelona,
July 2002. Abstract number Mopec3406.
204. *Vlahov D, Galai N, Bareta J, Cohn S, Sterling T, Margolick JB, Strathdee SA. Pre and post
HAART-era survival among HIV-infected Injecting drug users at different cd4 strata. 14 th
International Conference on AIDS, Barcelona, July 2002. Abstract number Mopec3340.
205. Lin MK, Sethi A, Wu A, Strathdee SA., Celentano DD, Vlahov D. Adherence to HAART, HIV-1
RNA level, and genotypic resistance among Injecting drug users in Baltimore. 14th
International Conference on AIDS, Barcelona, July 2002. Abstract number Wepeb5850.
206. Metsch LR, Pereyra M, del Rio C, Gardner LI, Loughlin AM, Kerndt P, Anderson-Mahoney P,
Duffus WA, Dickinson G, McCoy CB, Valverde E, Strathdee SA. Delivery of HIV prevention messages at HIV medical care settings in four United States cities. 14th International
Conference on AIDS, Barcelona, July 2002.
207. *Latimer WW, Strathdee SA, Bolla K, Selnes O. Executive dysfunction and HIV risk behaviors among young Injecting drug users, American Public Health Association 130 th Annual Meeting,
Philadelphia, November 9-13, 2002, Abstract number 33546.
208. Kuo I, Sherman SG, Mudrick D, Thomas DL, Strathdee SA. Prevalence and correlates of hepatitis B virus (HBV) Injecting drug users and non-Injecting drug users in Baltimore.
American Public Health Association 130 th Annual Meeting, Philadelphia, November 9-13, 2002,
Abstract number 47277.
209. *Loughlin AM, Strathdee SA. Accessibility of HCV care for infected drug users: Methadone maintenance treatment programs as a potential HCV treatment venue. American Public Health
Association, 130 th Annual Meeting, Philadelphia, November 9-13, 2002.
210. Sherman SG, Shah NG, Ompad D, Fuller C, Vlahov D, Strathdee SA. Factors associated with transition to injection drug among young Injecting drug users. American Public Health
Association 130 th Annual Meeting, Philadelphia, November 9-13, 2002.
211. *Safaeian M, Doherty M, Garfein RS, Fuller CM, Sherman SG, Ompad DC, Vlahov D, Strathdee
SA. Correlates of HIV infection among young new initiates to injection drug use in Baltimore,
1994-2000. American Public Health Association 130 th Annual Meeting, Philadelphia, November
9-13, 2002.
212. *Ahmed MA, Zafar T, ul Hassan S, Bareta J, Brahmbhatt H, Strathdee SA. HIV/AIDS risk behaviors and correlates of injection drug use among drug users in Pakistan. American Public
Health Association 130 th Annual Meeting, Philadelphia, November 9-13, 2002.
213. *Buxton MB, Vlahov D, Strathdee SA, Des Jarlais DC, Morse EV, Ouellet L, Kerndt P, Garfein
RS. Association of select drug use behaviors and duration of drug use among newly initiated injecting drug users. 130 th Annual Meeting of the American Public Health Association,
Philadelphia, November 10-13, 2002.
214. Shah NG, Galai N, Celentano DD, Vlahov D, Strathdee SA, Vlahov D, Valverde R,
Swartzendruber A, Garfein RS. Predictors of cessation of injection and subsequent relapse among a cohort of injecting drug users in Baltimore. American Public Health Association 130 th
Annual Meeting, Philadelphia, November 9-13, 2002.
215. Broyles L, Perlis T, Kerndt P, Morse E, Ouellet L, Strathdee SA,Vlahov D, Valverde R,
Swartzendruber A, Garfein RS. Correlation between housing changes and HIV risk behaviors among young njecting drug users. American Public Health Association 130 th Annual Meeting,
Philadelphia, November 9-13, 2002.
216. Burris S, Strathdee SA, Vernick J. Syringe access policy in United States. American Public
Health Association 130 th Annual Meeting, Philadelphia, November 9-13, 2002. Abstract number
#41514.
217. Ompad DC, Strathdee SA, Celentano DD, Latkin CA, Kellam SG, Poduska J, Ialongo N.
Correlates and predictors of oral sex among adolescents in Baltimore. American Public Health
Association 130 th Annual Meeting, Philadelphia, November 9-13, 2002. Abstract number
#41519.
218. *Garfein RS, Ouellet L, Vlahov D, Des Jarlais D, Kerndt P, Strathdee SA, Swartzendruber,
Hagan H, Morse E. HIV and hepatitis C virus prevention among new Injecting drug users: An
67

assessment of opportunities for intervention. 2003 National HIV Prevention Conference,
Atlanta, July 27-30, 2003.
219. Latka M, Hagan H, Kapadia F, Golub ET, Garfein RS, Strathdee SA. For the STRIVE Project
Team. Primary health care seeking among young hepatitis C virus (HCV)-infected Injecting drug users. American Public Health Association, 131 st Annual Meeting and Exposition, San
Francisco, November 15-19, 2003. Abstract # 70526.
220. Strathdee SA, Latka M, Golub ET, Pollini R, Pilibosian ED, Garfein RS, Thomas D, Hagan H. for the STRIVE Project Team. Factors associated with willingness for hepatitis C virus (HCV) therapy among young HCV-infected Injecting drug users. American Public Health Association,
131 st Annual Meeting and Exposition, San Francisco, November 15-19, 2003.
221. *Hagan H, Latka M, Campbell JV, Golub ET, Garfein RS, Thomas DL, Strathdee SA. Eligibility for medical treatment among hepatitis C virus (HCV) antibody positive Injecting drug users: A
Multi-site Study. 131st Annual Meeting of the American Public Health Association, San
Francisco, November 15-19, 2003.
222. *Campbell JV, Hagan H, Latka M, Garfein RS, Golub ET, Thomas DL, Strathdee SA. Alcohol use among hepatitis C virus antibody positive Injecting drug users in three US cities. 131st
Annual Meeting of the American Public Health Association, San Francisco, November 15-19,
2003.
223. *Golub ET, Havens JR, Latkin CA, Hobelmann KY, Garfein RS, Sherman SG, Strathdee SA.
Injection-related risk factors for hepatitis C virus infection among young Injecting drug users in
Baltimore. 131st Annual Meeting of the American Public Health Association, San Francisco,
November 15-19, 2003.
224. Golub ET, Pilibosian ED, Huettner S, Latkin C, Cornelius L, Bishai D, Strathdee SA.
Motivations and expectations surrounding entry into drug treatment among needle exchange program attenders. College on Problems of Drug Dependence, 65 th Annual Scientific Meeting,
Bal Harbour, June 14-19, 2003.
225. Cornelius LJ, Bishai D, Latkin C, Huettner S, Brown M, Pilibosian E, Strathdee SA. A descriptive profile of HIV- negative and HIV-positive needle exchange program recipients. 15 th Annual
National Conference on Social Work and HIV/AIDS, Albuquerque, May 29-June 1, 2003.
226. Havens JR, Latkin C, Huettner S, Bishai D, Cornelius L, Pilibosian E, Strathdee SA. Current psychiatric symptoms as barriers to methadone maintenance treatment entry among treatmentseeking Injecting drug users. College on Problems of Drug Dependence, 65 th Annual Scientific
Meeting, Bal Harbour, June 14-19, 2003.
227. *Hagan H, Latka M, Campbell J, Golub ET, Garfein RS, Thomas DA, Strathdee SA. Eligibility for treatment of hepatitis C virus (HCV) infection among Injecting drug users in a multi-site study. 2nd International Conference on Urban Health, New York, October 15-19, 2003.
228. *Golub E, Latka M, Hagan H, Havens JR, Hudson SM, Kapadia F, Campbell JV, Garfein RS,
Thomas DL, Strathdee SA. A comparison of CES-D versus the BDI as a screening tool for depression among HCV-infected Injecting drug users. 2nd International Conference on Urban
Health, New York, October 15-19, 2003.
229. *Latka M, Hagan H, Bonner S, Kapadia F, Hough E, Golub ET, Garfein RS, Strathdee SA. The
STRIVE Study: An evaluation of a secondary prevention intervention for young HCV+ Injecting drug users in New York City, Seattle, and Baltimore. 2nd International Conference on Urban
Health, New York, October 15-19, 2003.
230. *Campbell J, Hagan H, Latka M, Garfein RS, Golub E, Kapadia F, Thomas D, Strathdee SA.
Alcohol use among hepatitis C virus antibody positive Injecting drug users in three US cities.
2nd International Conference on Urban Health, New York, October 15-19, 2003.
231. *Strathdee SA , Latka M, Golub ET, Campbell J, Kapadia F, Pollini R, O’Driscoll P, Garfein RS,
Thomas D, Hagan H. Factors associated with willingness for hepatitis C virus (HCV) therapy among young HCV-infected injecting drug users. 2nd International Conference on Urban
Health, New York, October 15-19, 2003.
232. *Hagan H, Latka M, Campbell J, Golub E, Garfein R, Thomas D, Kapadia F, Strathdee SA.
Eligibility for treatment of hepatitis C virus infection among young Injecting drug users in a US multi-site study. 15 th International Conference on Reduction of Drug Related Harm, Melbourne,
Australia, April 20-24, 2004.
68

233. Havens JR, Latkin C, Huettner S, Bishai D, Cornelius L, Pilibosian E, Strathdee SA. Case management and drug treatment entry among Injecting drug users with co-morbid antisocial personality disorder. 15 th International Conference on the Reduction of Drug Related Harm,
Melbourne, Australia, April 20-24, 2004.
234. Huettner S, Pilibosian E, Havens J, Bishai D, Cornelius L, Latkin C, Strathdee SA. Drug use patterns, incarceration, and needle exchange program utilization among Injecting drug users referred to drug treatment from a needle exchange program. 15 th International Conference on the Reduction of Drug Related Harm, Melbourne, Australia, April 20-24, 2004.
235. Pilibosian E, Huettner S, Cornelius L, Havens J, Latkin C, Bishai D, Strathdee SA. Retention in
Methadone Maintenance Treatment among injection drug users Referred from a Needle
Exchange Program. 15 th International Conference on the Reduction of Drug-Related Harm,
Melbourne, Australia, April 20-24, 2004.
236. Lloyd JJ, Latkin C, Pilibosian E, Cornelius L, Bishai D, Huettner S, Strathdee SA. Social support factors associated with entry into methadone maintenance treatment (MMT) among
Injecting drug users. Annual Scientific Meeting of the College on Problems of Drug
Dependence, San Juan, Puerto Rico, June 12-17, 2004.
237. Golub ET, Pilibosian E, Cofrancesco J Jr, Strathdee SA, Dobs A. Drug use, depression, and hypogonadism in community-based cohort study (SHINE study). Annual Scientific Meeting of the College on Problems of Drug Dependence, San Juan, Puerto Rico, June 12-17, 2004.
238. Havens J, Latkin C, Huettner S, Bishai D, Cornelius L, Pilibosian E, Strathdee SA. Predictors of needle exchange utilization post drug treatment entry among Injecting drug users. Annual
Scientific Meeting of the College on Problems of Drug Dependence, San Juan, Puerto Rico,
June 12-17, 2004.
239. *Strathdee SA , Latka M, Golub E, Campbell J, Kapadia F, *Pollini R, O’Driscoll P, Garfein R,
Thomas D, Hagan H. Factors associated with willingness for hepatitis C virus (HCV) therapy among young HCV-infected Injecting drug users. 15 th Annual International Conference on the
Reduction of Drug Related Harm, Melbourne, Australia, April 20-24, 2004.
240. Galai N, Strathdee SA, Vlahov D, Bareta J, Macalino G, Celentano D. ACASI versus interview administered questionnaires for sensitive risk behaviors: Results of a cross-over randomized trial among injecting drug users. 15 th International AIDS Conference, Bangkok, July 11-16,
2004.
241. Washington TA, Galai N, Cohn S, Celentano D, Vlahov D, Strathdee SA. A comparison of selfreport sexual orientation and male sexual behavior among male Injecting drug users. 15 th
International AIDS Conference, Bangkok, July 11-16, 2004.
242. Hagan H, Strathdee SA , Vlahov D, Bailey SM, O’Driscoll P. Unexpectedly low HIV & HCV prevalence in young injectors in a US multi-site study. 15 th International AIDS Conference,
Bangkok, Thailand, July 11-16, 2004.
243. Kuo I, ul-Hasan S, Zafar T, Galai N, Sherman G, Strathdee SA. Prevalence of HIV, HCV and changes in drug supply and cost related to transition to injection among Injecting drug users in
Pakistan. 15 th International AIDS Conference, Bangkok, July 11-16, 2004.
244. Garfein RS, Latka M, Hagan H, Ouellet L, Hudson SM, Strathdee SA, Purcell D. Effectiveness of respondent-driven sampling (RDS) to recruit high-risk young adult Injecting drug users for an HIV and HCV prevention intervention trial: The Drug Users Intervention Trial (DUIT). 15 th
International AIDS Conference, Bangkok, July 11-16, 2004.
245. Brown AS, Suriyanon V, Sahay S, Paranjape R, Bollinger RC, Liu S, Yu X, Boss-Victoria R,
Strathdee SA, Chiliade P, Harro C, Charron KR, Beyrer C. Predictors of willingness to participate in preventive AIDS vaccine trials: Implications for international trials. 15 th
International AIDS Conference, Bangkok, July 11-16, 2004.
246. Strathdee SA , O’Driscoll PT, Galai N, Lin J, Gallant J, Bareta J, Celentano D, Vlahov D. Trends in use of optimal, suboptimal and no HIV antiretroviral therapy among clinically-eligible HIVinfected injecting drug users. 15 th International AIDS Conference, Bangkok, July 11-16, 2004.
247. Strathdee SA, Vlahov D, Galai N, Safaeian M, Lin M, Sterling TR. Selection into treatment and effectiveness of HAART among Injecting drug users in late stage HIV infection. 15 th
International AIDS Conference, Bangkok, July 11-16, 2004.
69

248. *Strathdee SA, Fraga MA, Davila-Fraga W, *Brouwer KC, Gracia Perez S, Case P. Vive para consumirla y consume para vivir. “I live to inject and inject to live”: High risk injection behavior in
Tijuana. International Conference on Drug Abuse and HIV/AIDS Research, Miami. August
2004.
249. Fraga MA, Davila-Fraga W, Case PL, *Brouwer KC, Strathdee SA. Awareness of needle exchange programs among Injecting drug users in Tijuana, Mexico. 3 rd International
Conference on Urban Health, Boston, October 20-22, 2004.
250. Case P, Fraga MA, Brouwer KC, Davila-Fraga W, Strathdee SA. “Coctel de la muerte”:
Methamphetamine use in Tijuana. 3 rd International Conference on Urban Health, Boston,
October 20-22, 2004.
251. Strathdee SA, Pilibosian E, Huettner S, Cornelius L, Bishai D, Havens JR, Lloyd JJ, Beilenson
P, Rapp C, Latkin CA. Case management as a predictor of entry into drug treatment among injecting drug users referred from a needle exchange program. 3 rd International Conference on
Urban Health, Boston, October 20-22, 2004.
252. Kuo I, ul-Hasan S, Zafar T, Galai N, Imam G, Sherman SG, Strathdee SA. Factors associated with recent-onset injection drug use among drug users in Pakistan. 3 rd International Conference on Urban Health, Boston, October 20-22, 2004.
253. *Golub ET, Strathdee SA, Latka M, Hagan H, Bailey SL, Hudson SM, Garfein RS. Distributive syringe sharing among young Injecting drug users in five U.S. Cities. 3 rd International
Conference on Urban Health, Boston, October 20-22, 2004.
254. *Magis C, *Brouwer KC, Morales S, Lozada R, Ortiz R, Pilibosian E, Strathdee SA. Correlates of receptive needle sharing among Injecting drug users in the US-Mexican border city of
Tijuana. 3 rd International Conference on Urban Health, Boston, October 20-22, 2004.
255. *Strathdee SA , Hagan H, Vlahov D, Hudson SM, Bailey SL, O’Driscoll P, Garfein RS.
Unexpectedly low HIV and HCV prevalence in young injectors in a US multi-site study. 132nd
Annual Meeting of the American Public Health Association, Washington, November 6-10, 2004.
256. *Thiede H, Hagan H, Campbell JV, Kapadia F, Strathdee SA, Bailey SL, Hudson SM, Garfein
RS. Prevalence and correlates of non-syringe paraphernalia sharing among younger injectors:
The DUIT Study. 132nd Annual Meeting of the American Public Health Association,
Washington, November 6-10, 2004.
257. *Bailey SL, Strathdee SA, Ouellet LJ, Garfein RS. Correlates of receptive syringe sharing: The
DUIT study. 132nd Annual Meeting of the American Public Health Association, Washington,
November 6-10, 2004.
258. *Golub ET, Strathdee SA, Latka M, Hagan H, Bailey SL, Hudson SM, Bareta J, Garfein RS.
Prevalence and correlates of distributive syringe sharing among Injecting drug users in five
U.S. cities: Drug Users Intervention Trial/ Collaborative injecting drug users Study-III
(DUIT/CIDUS-III). 132nd Annual Meeting of the American Public Health Association,
Washington, November 6-10, 2004.
259. *Hogg RS, *Brouwer KC, Magis-Rodriguez C, Bravo E, Gayet C, Bertozzi SM, Strathdee SA.
Estimated numbers of men and infected with HIV in Tijuana. 16 th International Conference on the Reduction of Drug Related Harm, Belfast, Northern Ireland, March 20-24, 2005.
260. Miller C, Strathdee S, Kerr T, Li K, Wood E. Factors associated with early adolescent initiation into injection drug use: Implications for injection drug use intervention program. Canadian
Association for HIV Research, May 16-18, 2005.
261. Miller C, Strathdee S, Kerr T, Small W, Li K, Wood E. Factors associated with willingness to participate in a heroin prescription program among Injecting drug users. Canadian Association for HIV Research, Vancouver, May 16-18, 2005.
262. Miller C, Spittal P, Strathdee S, Li K, Schechter M, Wood E. Higher prevalence and incidence of HIV and hepatitis C and associated risk factors among young aboriginal Injecting drug users. Canadian Association for HIV Research,Vancouver May 16-18, 2005.
263. *Bailey SL, Latka M, Hagan H, Hudson SM, Strathdee SA, Ouellet L, Gao W, Kapadia F, Thiede
H, Golub E, Kerndt P, Garfein RS, for the CIDUS III-DUIT Team. Unprotected anal intercourse among young male Injecting drug users who have sex with men (MSM): A report from the
Collaborative Injection Drug use Study--III /Drug Users Intervention Trial. National HIV
Prevention Conference, Atlanta, June 12-15, 2005.
70

264. *Garfein, RS, Latka, M, Hagan H, Ouellet L, Hudson SM, Strathdee SA, Purcell D, Williams IT,
Thiede H, Golub ET, Bailey S, Kerndt P, Kapadia F, for the CIDUS III/DUIT Study Team. A randomized, controlled trial of a peer-education-focused behavioral intervention to prevent HIV and hepatitis C virus infection among 15-30 year old Injecting drug users. National HIV
Prevention Conference, Atlanta, June 12-15, 2005.
265. *Carr JK, Saad M, Nadai I, Tishkova F, Eyzaguirre L, Strathdee SA, Stachowiak J, Beyrer C,
Earhart K, Birx D, Sanchez JL. Outbreak of a West Africa HIV-1 recombinant, CRF02_AG, in
Central Asia. [MoOa0407] 3rd International AIDS Society Conference on HIV Pathogenesis and
Treatment, 24-27 July 2005, Rio de Janiero. Oral Presentation.
266. *Hagan H, Campbell JV, Thiede H, Strathdee SA, Ouellet LJ, Kapadia F, Hudson SM, Garfein
RS. Awareness of hepatitis C virus serostatus and risk behavior in young Injecting drug users in five US cities. The 2005 National Viral Hepatitis Prevention Conference, Washington,
December 5-9, 2005.
267. *Garfein RS, Latka M, Hagan H, Ouellet L, Hudson SM, Strathdee SA, Thiede H, Golub ET,
Bailey SL, Kerndt P, Kapadia F, Hanson D, Purcell D. CIDUS-III/DUIT: Results of a peereducation-focused behavioral intervention to prevent HIV and hepatitis C virus (HCV) infection among young Injecting drug users. American Public Health Association
133rd Annual Meeting & Exposition, Philadelphia, December 10-14, 2005.
268. *Coady MH, Latka M, Hudson SM, Vernon Campbell J, Bailey SL, Strathdee SA, Andreopoulos
E, Garfein RS. CIDUS-III/DUIT: Opportunities for reducing sexual HIV risk among young
Injecting drug users through substance abuse treatment. American Public Health Association
133rd Annual Meeting & Exposition, Philadelphia, December 10-14, 2005.
269. *White E, *Brouwer KC, Garfein RS, Lozada R, Ramos R, Firestone M, Strathdee SA. Hepatitis
C Virus prevalence among Injecting drug users in two U.S.-Mexican Border Cities. Crossroads in Global Health: The Dual Challenge of Infectious and Chronic Diseases, Toronto, April 19-21,
2006.
270. *Stachowiak JA, Stibich MA, Mogilnii V, Strathdee SA, Beyrer C. Experiences with drug treatment among Injecting drug users in Dushanbe, Tajikistan. 17 th International Conference on the Reduction of Drug Related Harm, Vancouver, April 30-May 4, 2006.
271. *Stibich MA, Stachowiak JA, Peryshkina A, Konakova A, Strathdee SA, Beyrer C. Occupational use of injected methamphetamine in commercial sex workers in Moscow. 17 th International
Conference on the Reduction of Drug Related Harm, Vancouver, April 30-May 4, 2006.
272. *Strathdee SA, Stachowiak JA, Stibich MA, Tishkova FK, Mogilnii V, Latypov A, Beyrer C.
Correlates of receptive needle sharing among Injecting drug users in Dushanbe, Tajikistan.
17 th International Conference on the Reduction of Drug Related Harm, Vancouver, April 30-May
4, 2006.
273. *Azim T, Chowdhury EI, Reza M, Ahmed M, Taslimuddin M, Khan R, Ahmed Giasuddin,
Rahman M, Khondokar I, Strathdee SA. Vulnerability to HIV infection among female Injecting drug users in Dhaka, Bangladesh. 17 th International Conference on the Reduction of Drug
Related Harm, Vancouver, April 30-May 4, 2006.
274. *Ramos R, Miller CM, Firestone M, Burris S, Ramos ME, Case P, *Brouwer KC, Fraga M,
Strathdee SA . Injecting drug users’ experiences of policing practices in two Mexican-US border cities. 17 th International Conference on the Reduction of Drug Related Harm,
Vancouver, April 30-May 4, 2006.
275. *Ramos R, Lozada R, *Brouwer KC, Firestone M, Ramos ME, Loza O, Magis C, Strathdee SA.
High prevalence of injection risk behaviors among Injecting drug users in two Mexican-U.S. border cities. 17 th International Conference on the Reduction of Drug Related Harm,
Vancouver, April 30-May 4, 2006.
276. Brouwer KC, Ramos R, Lozada R, Firestone M, Patterson TL, Loza O, Magis-Rodriguez C,
Strathdee SA. Drug use behaviors associated with border crossing among Injecting drug users along the Mexico-U.S. border. 17 th International Conference on the Reduction of Drug
Related Harm, Vancouver, April 30-May 4, 2006.
277. Mantsios A, Firestone M, Ramos R, Lozada R, *Brouwer KC, Case P, Miller C, Latkin CA,
Strathdee SA. Gender differences in drug use behaviors in two Mexican-U.S. border cities. 17 th
71

International Conference on the Reduction of Drug Related Harm, Vancouver, April 30-May 4,
200.
278. Kuo I, *Brouwer KC, Lozada R, Ramos R, Firestone M, Magis-Rodriguez C, Strathdee SA.
Drug market perceptions and the effect on injection behaviors among Injecting drug users in
Mexico. 17 th International Conference on the Reduction of Drug Related Harm, Vancouver,
April 30-May 4, 2006.
279. Case P, Ramos R, *Brouwer KC, Firestone M, Patterson TL, Fraga M, Mantsios A, Strathdee
SA. On the edge: Methamphetamine in two Mexican-U.S. border cities. 17 th International
Conference on the Reduction of Drug Related Harm, Vancouver, April 30-May 4, 2006.
280. *Pollini R, Mehta S, Gange S, Celentano D, Vlahov D, Strathdee SA. Non-fatal overdose among Injecting drug users in Baltimore: Targeting overdose survivors for preventive interventions. 17 th International Conference on the Reduction of Drug Related Harm,
Vancouver, April 30-May 4, 2006.
281. Cheng WS, Garfein RS, Strathdee SA, Semple S, Zians J, Patterson TL. The Goose and the gander: Gender differences in cohort of HIV-negative, heterosexual methamphetamine users in
San Diego. 2nd Annual Congress of Epidemiology, Seattle, June 21-24, 2006.
282. Cheng WS, Garfein RS, Strathdee SA, Semple S, Zians J, Patterson TL. “Who shot Tina?” A comparison of injecting and non-injecting heterosexual HIV-negative methamphetamine users in San Diego. 2nd Annual Congress of Epidemiology, Seattle, June 21-24, 2006.
283. *Strathdee SA, Hagan H, Golub ET, Farzana K, Campbell J, Garfein RS, Thomas DL, Pu M,
Bonner S, Thiel T, Latka M for the STRIVE Project Team. Demonstrated efficacy of a peermentoring intervention to reduce high risk injection behaviors among young HCV-infected
Injecting drug users: The study to reduce intravenous exposures (STRIVE). 16th International
AIDS Conference, Toronto, August 13-18, 2006.
284. Pollini RA, Brouwer KC, Lozada R, Fireston M, Magis-Rodriguez C, Case P, Burris S, Miller C,
Strathdee SA. Arrests for syringe possession and shooting gallery use are associated with receptive needle sharing in two Mexican-U.S. border cities. 16th International AIDS
Conference, Toronto, August 13-18, 2006.
285. Patterson TL, Fraga M, Staines H, Bucardo J, De la Torre A, Salazar J, Semple SJ, Orozovich
P, Pu M, Amaro H, Magis-Rodriguez C, Strathdee SA. High prevalence of HIV and sexually transmitted infections among female sex workers associated with injection drug use in two
Mexico-U.S. border cities. 16th International AIDS Conference, Toronto, August 13-18, 2006.
286. Volkow P, Brouwer KC, Ramos R, Lozada R, Garfein R, Magis-Rodriguez C, Loza O, Firestone
M, Strathdee SA. Cross-Border paid plasma donation among Injecting drug users in Mexico-
U.S. border cities. 16th International AIDS Conference, Toronto, August 13-18, 2006.
287. *Deiss R, Brouwer KC, Loza O, Lozada R, Ramos, Firestone M, Patterson TL, Magis-Rodriguez
C, Strathdee SA. High risk sexual and drug using behaviors among male Injecting drug users who have sex with men in two Mexico-U.S. border cities. 16th International AIDS Conference,
Toronto, August 13-18, 2006.
288. Lozada R, Pollini RA, Patterson TL, *Brouwer KC, Fireston M, Mantsios A, Case P, Strathdee
SA, for Proyecto El Cuete. Meth moves south: Factors associated with an emerging epidemic of methamphetamine injection in the Mexico-US border city of Tijuana. 16th International AIDS
Conference, Toronto, August 13-18, 2006.
289. Larios SE, Semple SJ, Fraga M, Bucardo J, De la Torre A, Salazar J, Orozovich P, Staines H,
Amaro H, Magis-Rodriguez C, Strathdee SA, Patterson TL. Risky business: A comparison of risk behaviors among female sex workers who work in bars versus in the street in two Mexican-
US border cities. 16th International AIDS Conference Toronto, August 13-18, 2006.
290. Cheng WS, Garfein RS, Strathdee SA, De mple S, Zians J, Patterson TL. “Who shot Tina?” A comparison of injecting and non-injecting heterosexual HIV-negative methamphetamine users in San Diego. 16th International AIDS Conference, Toronto, August 13-18, 2006.
291. Miller CL, Strathdee SA, Li K, Kerr T, Wood E. Premature mortality among young Injecting drug users: Consequential health risk or human rights issue? 16th International AIDS
Conference, Toronto, August 13-18, 2006.
72

292. Gray G, Bastos F, Andia I, Maier M, McIntyre J, Grinsztein B, Todd C, Strathdee SA, Bangsberg
D, Hogg R. Determinants of HAART use among women of reproductive age in Brazil, Uganda, and South Africa. 16 th International AIDS Conference, Toronto, August 13-18, 2006.
293. Maier M, Andia I, Emenyonu N, Pepper L, Strathdee SA, Bangsberg D, Hogg R. The association between HIV optimism and sexual and fertility behavior among HIV-positive among in Mbarara, Uganda. 16th International AIDS Conference, Toronto, August 13-18, 2006.
294. Phillips KA, Galai N, Astemborski J, Strathdee SA, Vlahov D, Kirk GD, Mehta SH. The impact of incarceration on HIV infection among Injecting drug users. 16th International AIDS
Conference, Toronto, August 13-18, 2006.
295. Pollini RA, Thiel TK, Golub ET, Latka M, Hagan H, Garfein RS, Kapadia F, Campbell JV,
Thomas DL, Strathdee SA, for the STRIVE Project Team. Effects of a behavioral intervention on hepatitis C knowledge among young HCV-infected Injecting drug users. 16th International
AIDS Conference, Toronto, August 13-18, 2006.
296. O’Driscoll P, Galai N, Mehta S, Kirk GD, Strathdee SA, Vlahov D, Celentano D. Psychotropic medication usage is associated with HIV status among Injecting drug users. 16th International
AIDS Conference, Toronto, August 13-18, 2006.
297. Garfein RS, Hagan H, Latka M, Golub ET, Kapadia F, Campbell J, Thomas DL, Pu M, Bonner
S, *Pollini RA, Thiel TK, Strathdee SA, for the STRIVE Project Team. Influence of a peer mentoring intervention on HCV-related healthcare utilization among young HCV-infected
Injecting drug users. 16th International AIDS Conference, Toronto, August 13-18, 2006.
298. Patterson TL, Mausbach B, Semple S, Zians J, Strathdee SA. Life in the fastlane: Testing the efficacy of a behavioral intervention to reduce high risk sexual behaviors among HIV-negative, heterosexual methamphetamine users. 16th International AIDS Conference, Toronto, August
13-18, 2006.
299. Eyzaguirre L, Nadai Y, Brouwer KC, Patterson TL, Strathdee S, Carr JK. First molecular surveillance report of H IV in injecting drug users and commercial sex workers in Mexico. 16th
International AIDS Conference, Toronto, August 13-18, 2006.
300. Patterson TL, Maushbach B, Semple S, Zians, Strathdee SA . Postcards from the ‘EDGE’: An effective behavioral intervention for increasing safer sex among HIV-positive MSM in the context of ongoing methamphetamine use. 16th International AIDS Conference, Toronto, August 13-18,
2006.
301. Drumright LN, Strathdee SA, Little SJ, Araneta RG, Slymen DJ, Malcarne VL, Daar ES,
Gorbach PM. Associations between unprotected anal intercourse and substance use before and after HIV diagnosis among recently HIV-infected men who have sex with men. 16th
International AIDS Conference, Toronto, August 13-18, 2006.
302. Drumright LN, Strathdee SA, Little SJ, Gorbach PM. Club drug use as a risk factor for HIV acquisition among men having sex with men with recent HIV infection. 16th International AIDS
Conference, Toronto, August, 13-18, 2006.
303. Sipan CL, Strathdee SA, Hagan H, Hudson S, Kapadia F, Ouellet L, Garfein RS, for the DUIT
Study Team. Correlates of unprotected sex among young injection drug users participating in the CIDUS III/DUIT Study: A longitudinal analysis. 16th International AIDS Conference,
Toronto, August 13-18, 2006.
304. Zuniga ML, Brennan JJ, Scolari R, Strathdee SA. Barriers to HIV care in the context of crossborder health care utilization in HIV+ persons living in the California/Baja California US-Mexico border area. 16th International AIDS Conference, Toronto, August 13-18, 2006.
305. Cheng WS, Garfein RS, Strathdee SA, Semple S, Zians J, Patterson TL. The Goose and the gander: Gender differences in cohort of HIV-negative, heterosexual methamphetamine users in
San Diego. Society for Epidemiologic Research Conference, July 2006.
306. Brouwer KC, Lozada R, Firestone M, Pollini RA, Magis-Rodriguez C, Case PL, Burris S,
Strathdee SA. Correlates of shooting gallery use among injecting drug users along the US-
Mexico border. 16th International AIDS Conference, Toronto, August 13-18, 2006.
307. *Todd CS, Abed A, Strathdee SA, Botros BA, Safi N, Earhart KC. Prevalence of HIV, viral hepatitis, syphilis and risk behaviors among Injecting drug users in Kabul, Afghanistan. 16th
International AIDS Conference, Toronto, August 13-18, 2006.
73

308. Garfein RS, Bailey S, Golub ET, Greenberg A, Hagan H, Hanson DL, Hudson S, Kapadia F,
Kerndt P, Latka M, Ouellet L, Purcell DW, Strathdee SA, Thiede H, Williams IT, for the DUIT
Study Team. Reduction in injection risk behaviors among young Injecting drug users using a peer-education intervention: The CIDUS-III/DUIT Study. 16th International AIDS Conference,
Toronto, August 13-18, 2006.
309. Strathdee SA, Lozada R, Staines H, Fraga M, Orozovich P, Pu M, De la Torre A, Amaro H, C
Magis-Rodriguez, Patterson TL., for Proyecto Mujer Segura. The eye of the storm: Female sex workers with American clients in two Mexico-US border cities. 14th Conference on Retroviruses and Opportunistic Infections, Los Angeles, February 25-28, 2007.
310. Garfein RS, Rodwell TC, Brouwer KC, Catanzaro A, Laniado-Laborin R, Pu M, Lozada R,
Mantsios A, Chiles PG, Deiss R, Strathdee SA. Prevalence and correlates of M. tuberculosis infection among injection drug users at risk for HIV in Tijuana. 6 th International Conference on
Urban Health, Baltimore, October 31-November 2, 2007.
311. *Pollini RA, Lozada R, *Brouwer KC, Alvelais J, Mantsios A, Strathdee SA. Injection first: A unique group of injection drug users in Tijuana. 6 th International Conference on Urban Health,
Baltimore, October 31-November 2, 2007.
312. *Philbin M, Mantsios A, Lozada R, Pollini RA, Alvelais J, Case P, Latkin CA, Rhodes T,
Strathdee SA. Stakeholder attitudes towards and feasibility of interventions to reduce drugrelated harms in Tijuana. 6 th International Conference on Urban Health, Baltimore, October 31-
November 2, 2007.
313. *Strathdee SA, Lozada R, Pollini RA, Brouwer KC, Mantsios A, Abramovitz DA, Rhodes T,
Latkin CA, Patterson TL, for Proyecto El Cuete. Individual, social, and environmental influences associated with HIV infection among injecting drug users in Tijuana. 10 on HIV/AIDS, Leon, Mexico, November 26 – December 1, 2007. th National Conference
314. *Pollini RA, Brouwer KC, Lozada R, Firestone-Cruz M, Magis-Rodrigues C, Case P, Burris S,
Miller C Ramos R, Strathdee SA. Syringe possession arrests and shooting gallery use are associated with receptive needle sharing in two Mexico-U.S. border cities. 10
Conference on HIV/AIDS, Leon, Mexico, November 26 – December 1, 2007. th National
315. Alvelais J, Staines-Orozco H, Lozada R, Strathdee SA, Martinez G, Fraga-Vallejo M, Nguyen L,
Orozovich P, Bucardo J, Magis-Rodriguez C, Patterson TL. Condom coverage among female sex workers in two Mexico-US border cities. 2008 International Conference on AIDS, Mexico
City, Mexico, August 3-8, 2008.
316. Burgos JL, Baustista S, Valencia A, Strathdee SA, Deiss R, Laniado R, Castaneda R, Lozada
R, Garfein R. Cost-effectiveness of a targeted tuberculosis screening program employing quantiferon TB gold assay among populations with high HIVrisk in Tijuana, Mexico: Project preve tb. 2008 International Conference on AIDS, Mexico City, Mexico, August 3-8, 2008.
317. Deiss RG, Lozada MR, Strathdee SA, Alvelais J, Gallardo M, Orozovich J, Cuevas J, Garfein R.
HIV Prevalence among non-injecting drug users in Tijuana, Mexico. 2008 International
Conference on AIDS, Mexico City, Mexico, August 3-8, 2008.
318. Garfein RS, Liu L, Lozada R, Rodwell TC, Catanzaro A, Laniado-Laborin R, Brouwer KC,
Mantsios A, Chiles PG, Deiss R, Strathdee SA. Prevalence and correlates of mycobacterium tuberculosis infection by quantiferon TB gold in-tube assay among injection drug users in
Tijuana, Mexico. 2008 International Conference on AIDS, Mexico City, Mexico, August 3-8,
2008.
319. Garfein RS, Deiss R, Laniado-Laborin R, Lozada R, Rodwell TC, Alvelais J, Gallardo M, Cuevas
J, Cerecer P, Orozovich P, Catanzaro A, Strathdee SA. More HIV testing needed to prevent reactivation of latent tuberculosis infection (LTBI) among hidden populations at risk for HIV infection in Tijuana, Mexico. 2008 International Conference on AIDS, Mexico City, Mexico,
August 3-8, 2008.
320. Loza O, Strathdee SA, Semple S, Lozada R, Staines H, Fraga MA, Martinez G, de la Torre A,
Amaro H, and Patterson TL for Proyecto Mujer Segura. Correlates of early initiation into sex work in two Mexico-US border cities. 2008 International Conference on AIDS, Mexico City,
Mexico, August 3-8, 2008.
321. Magis-Rodriguez C, Lozada R, Deiss R, Patterson TL, Alvelais J, Vera A, Nguyen L, Brouwer
KC, Strathdee SA. One way bridge or two-way street? Male injectors trading sex as an
74

HIVtransmission bridge-- an exploratory analysis in Tijuana, Mexico. 2008 International
Conference on AIDS, Mexico City, Mexico, August 3-8, 2008.
322. Moreno JGB, Philbin MM, Lozada R, Mantsios A, Alvelais J, Case P, Magis-Rodriguez C,
Strathdee SA, for Proyecto El Cuete. Stakeholder attitudes towards and feasibility of needle exchange programs to reduce drug-related harm in Tijuana, Mexico. 2008 International
Conference on AIDS, Mexico City, Mexico, August 3-8, 2008.
323. Nasir A, Todd C, Stanekzai M R, Strathdee SA, Bautista C, Botros B, Scott P, Tjaden J.
Prevalence of HIV, viral hepatitis, syphilis and risk behaviors among injection drug users in
Hirat, Afghanistan. 2008 International Conference on AIDS, Mexico City, Mexico, August 3-8,
2008.
324. Ojeda V, Strathdee SA, Lozada R, Fraga M, Orozovich P, Magis-Rodriguez C, De La Torre A,
Amaro H, Patterson TL. Migration factors as correlates of sexually transmitted infections and
HIV risk behaviors among female sex workers in Tijuana, Mexico submitted to 2008
International Conference on AIDS, Mexico City, Mexico, August 3-8, 2008.
325. Patterson TL, Mausbach B, Lozada R, Staines-Orozco H, Semple S, Fraga-Vallejo M,
DelaTorre A, Amaro H, Magis-Rodriguez C, Strathdee SA. Predictors of sexual risk reduction among female sex workers enrolled in a behavioral intervention in two Mexico-US border cities.
2008 International Conference on AIDS, Mexico City, Mexico, August 3-8, 2008.
326. Patterson TL, Orozco-Staines H, Lozada R, Abramavitz DA, Fraga-Vallejo M, Martinez G,
Orozovich P, De La Torre A, Magis-Rodriguez C, Amaro H, Strathdee SA. Contextual factors associated with higher rates of unprotected sex among female sex workers in two Mexico-US border cities. 2008 International Conference on AIDS, Mexico City, Mexico, August 3-8, 2008.
327. Philbin MM, Lozada R, Zúñiga ML , Mantsios A, Magis-Rodriguez C, Case P, Latkin CA,
Strathdee SA, for Proyecto El Cuete. Exploring stakeholder perceptions and socio-cultural influence in acceptability of harm reduction programs in Tijuana, Mexico. 2008 International
Conference on AIDS, Mexico City, Mexico, August 3-8, 2008.
328. Pollini RA, Alvelais J, Gallardo M, Vera A, Lozada R, Magis-Rodriguez C, Strathdee SA. The harm inside: prevalence and correlates of injection during incarceration among injection drug users (IDUs) in Tijuana, Mexico. 2008 International Conference on AIDS, Mexico City, Mexico,
August 3-8, 2008.
329. Pollini RA, Alvelais J, Lozada R, Brouwer KC, Vera A, Strathdee SA. Factors associated with barriers to pharmacy-based syringe purchase among injection drug users (IDUs) in Tijuana,
Mexico. 2008 International Conference on AIDS, Mexico City, Mexico, August 3-8, 2008.
330. Rusch M, M Gallardo, KC Brouwer, R Lozada, A Vera, P Gonzales, Strathdee SA. Correlates of syphilis infection among male and female injection drug users in Tijuana, Mexico. 2008
International Conference on AIDS, Mexico City, Mexico, August 3-8, 2008.
331. Rusch M, KC Brouwer, R Lozada, Strathdee SA, M Fraga-Vallejo, J Bucardo, P Orozovich, C
Magis-Rodriguez, TL Patterson. Distribution of sexually transmitted infections and HIV among female sex workers in Tijuana, Mexico. 2008 International Conference on AIDS, Mexico City,
Mexico, August 3-8, 2008.
332. Staines-Orozco H, Strathdee SA, Gallardo M, Abramavitz D, Martinez G, Lozada R, Fraga-
Vallejo M, Ojeda V, Orozovich P, Magis-Rodriguez C, Patterson TL. HIV testing coverage among high risk female sex workers in two Mexico-US border cities. 2008 International
Conference on AIDS, Mexico City, Mexico, August 3-8, 2008.
333. Strathdee SA, Lozada R, Magis-Rodriguez C, Abramovitz D, Vera A, Alvelais J, Brouwer KC,
Pollini RA, Patterson TL for Proyecto El Cuete and Prevencasa. Predictors of needle exchange program utilization during its implementation and expansion in Tijuana, Mexico. 2008
International Conference on AIDS, Mexico City, Mexico, August 3-8, 2008.
334. Strathdee SA, Lozada R, Ojeda V, Vera A, Pollini RA, Brouwer KC, Cornelius W, Nguyen L,
MagisRodriguez C, Patterson TL. No man’s land: Deportation and migration as risk factors versus protective factors for HIV infection among male and female injection drug users in
Tijuana, Mexico. 2008 International Conference on AIDS, Mexico City, Mexico, August 3-8,
2008.
335. Ulibarri MD, Strathdee SA, Lozada R, Fraga M, MagisRodríguez C, De La Torre A, Amaro H,
O’Campo P, Patterson TL. Intimate partner violence among female sex workers in Two Mexico-
75

US border cities. 2008 International Conference on AIDS, Mexico City, Mexico, August 3-8,
2008.
336. Vera A, Alvelais J, Lozada R, Gallardo M, Patterson TL, Case P, Nguyen L, Strathdee SA.
Correlates of using hit doctors in Tijuana, Mexico. 2008 International Conference on AIDS,
Mexico City, Mexico, August 3-8, 2008.
337. Cheng SW, Garfein RS, Semple S, Strathdee SA, Patterson T, Zians JK. Differences in
HIV/STI-risk behavior among male and female HIV(-), heterosexual methamphetamine users in
San Diego. APHA 136th Annual Meeting & Exposition, San Diego, CA, October 25-29, 2008.
338. Rondinelli AJ, Strathdee SA, Latka MH, Ouellet LJ, Hudson SM, Hagan H, Garfein RS.
Prevalence and correlates of HIV infection among young adult injection drug users (IDUs): The
Collaborative Injection Drug Users Study III/Drug Users Intervention Trial (CIDUS III/DUIT)
2002-2004. APHA 136th Annual Meeting & Exposition, San Diego, CA, October 25-29, 2008.
339. Deiss R, LaniadoLaborín R, Luis Burgos J, Remedios Lozada M, Strathdee SA, Cerecer P,
Orozovich P, Cuevas J Garfein RS, Tuberculosis Knowledge of High-Risk Individuals in the
Endemic Border City of Tijuana, Mexico. APHA 136th Annual Meeting & Exposition, San Diego,
CA, October 25-29, 2008.
340. Garfein RS, Rodwell TC, LaniadoLaborín R, Remedios Lozada M, Deiss R, Cuevas J, Cerecer
P, Moser K, Catanzaro A, Luisa Volker M, Strathdee SA. Prevalence of latent tuberculosis infection (LTBI) and active TB among hidden populations at risk for HIV infection in Tijuana,
Mexico: Project PreveTB . APHA 136 th Annual Meeting & Exposition, San Diego, CA, October
25-29, 2008.
341. Brouwer KC, Lozada MR, Vera A, MagisRodriguez C, Zúñiga ML, Ojeda V, Strathdee SA.
Reduced infectious disease risk among recent border crossing injection drug users along the
Mexico/U.S. border. APHA 136th Annual Meeting & Exposition, San Diego, CA, October 25-29,
2008.
342. Deiss RG, Garfein RS, Lozada MR, Burgos JL, Brouwer KC, Moser KS, Zuniga ML, Rodwell
TC, Ojeda VD, Strathdee SA. Cross-border mobility linked to tuberculosis diagnosis and treatment interruption among injection drug users in Tijuana, Mexico. APHA 136th Annual
Meeting and Exposition, San Diego, CA, October 25-29, 2008.
343. Ojeda VD, Strathdee SA, Lozada R, Fraga M, Orozovich P, Magis-Rodriguez C, De La Torre A,
Amaro H, Patterson TL. Established vs. new migrant status as a correlate of sexually transmitted infections and HIV risk behaviors among female sex workers in Tijuana, Mexico.
APHA 136th Annual Meeting and Exposition, San Diego, CA, October 25-29, 2008.
344. Rodwell TC, Moore M, Moser KS, Brodine S, Strathdee SA. Human tuberculosis from mycobacterium bovis in Southern California: A reemerging disease of globalization. APHA
136th Annual Meeting and Exposition, San Diego, CA, October 25-29, 2008.
345. Rusch M, Lozada R, Pollini R, Vera A, Patterson TL, Case P, Strathdee SA. Patterns of methamphetamine use by gender among injection drug users in Tijuana, Mexico. APHA 136th
Annual Meeting and Exposition, San Diego, CA, October 25-29, 2008.
346. Ulibarri MD, Strathdee SA, Lozada R, Fraga M, MagisRodríguez C, De La Torre A, Amaro H,
O’Campo P, Patterson TL. Abuse by clients among female sex workers in two Mexico-U.S. border cities APHA 136th Annual Meeting and Exposition, San Diego, CA, October 25-29, 2008.
347. Zúñiga M, Cazares L, Brennan J, Scolari R, Strathdee SA. Stigma as a barrier to HIV care in the context of binational care access among HIV-positive Latinos living in the California/Baja
California US-Mexico border region, APHA 136th Annual Meeting and Exposition, San Diego,
CA, October 25-29, 2008.
348. Deiss R, LaniadoLaborín R, Burgos JL, Lozada R, Strathdee SA, Cerecer P, Orozovich P,
Cuevas J, Garfein RS. Tuberculosis Knowledge of High-Risk Individuals in the Endemic Border
City of Tijuana, Mexico. APHA 136th Annual Meeting and Exposition, San Diego, CA, October
25-29, 2008.
349. Garfein RS, Rodwell TC, LaniadoLaborín R, Lozada R, Deiss R, Cuevas J, Cerecer P, Moser
K, Catanzaro A, Volker M, Strathdee SA. Prevalence of latent tuberculosis infection (LTBI) and active TB among hidden populations at risk for HIV infection in Tijuana, Mexico: Project
PreveTB APHA 136th Annual Meeting and Exposition, San Diego, CA, October 25-29, 2008.
76

350. Loza O, Strathdee, SA, Semple S, Lozada R , Staines H , Fraga M, Martinez G, De la Torre A,
Amaro H, Patterson TL. Correlates of early initiation into sex work in two Mexico-U.S. border cities APHA 136th Annual Meeting and Exposition, San Diego, CA, October 25-29, 2008.
351. Ojeda VD, Robertson A, Hiller S. Lozada R, Strathdee SA.
Experiencias Migratorias de
Tijuaneses Vulnerables yFactores de Riesgo para VIH. Reunion: Políticas Públicas y la
Migración. UCSD Instituto de las Americas 23 de junio del 2009.
352. Strathdee SA, Lozada R, Staines-Orozco H, Abramovitz D, Semple S, Martinez G, Patterson
TL. No Effect of a Sexual Risk Intervention on Condom Use with Female Sex Workers and their
Regular Partners in Two Mexico-US Border Cities. Annual Meeting of the International Harm
Reduction Association, Bangkok, Thailand, April 19-23, 2009.
353. Strathdee SA, Condom Access: Associations with Consistent Condom Use among Female Sex
Workers in two Northern Border Cities of México. 137th APHA Annual Meeting & Exposition,
November 7-11, 2009.
354. Zúñiga M, Blanco E, Scolari R, Strathdee SA. Improving cultural and community relevance of health behavior theories & models for application in secondary HIV Prevention: Considerations for access to care among communities in the US-Mexico border 2009 CDC HIV Prevention
Conference August 24, 2009.
355. Sirotin N, Strathdee SA, Lozada R, Nguyen L, Gallardo M, Vera A, Patterson TL.Sex worker registration: does it work? Evaluation of registration and health outcomes of female sex workers in Tijuana, Mexico. IAS 2009.
356. Patterson TL, Strathdee SA VIH, Infec ciones de Transmisión Sexual (ITS) y Perfil de
Comportamiento de Riesgo entre los Clientes de las Trabajadoras Sexuales (TS) en Tijuana,
México.
357. Strathdee SA, Pandillas y salud: Correlates of gang membership among injection drug users
(IDUs) in Tijuana, Mexico. 137th APHA Annual Meeting & Exposition November 7-11, 2009.
358. Lozada R, Vera A, Staines H, Pollini R, Strathdee SA. ¿Qué onda, te me capeas? Las trabajadoras sexuales que se inyectan drogas y sus experiencias con la policía en Tijuana y
Ciudad Juárez. XI Congreso Nacional Sobre VIH/SIDA, Chiapas, Mexico. Nov. 2009.
359. Staines H, Vera A, Staines H, Pollini R, Strathdee SA. Comportamientos de Riesgo Sexual según Tipo de Pareja entre Trabajadoras Sexuales que se inyectan drogas en Tijuana y Ciudad
Juárez. XI Congreso Nacional Sobre VIH/SIDA, Chiapas, Nov. 27 – Dec. 1, 2009.
360. Lozada R, Vera A, Staines H, Pollini R, Strathdee SA. Necesidades de Servicios de VIH entre trabajadoras sexuales que se inyectan drogas en Tijuana y Ciudad Juárez. XI Congreso
Nacional Sobre VIH/SIDA, Chiapas, Nov. 27
– Dec. 1, 2009.
361. Aguirre N, Vera A, Staines H, Pollini R, Strathdee SA. Comparación de la prueba rápida contra microscopia directa para la detección de Tricomonas vaginalis (TV) entre trabajadoras sexuales en Tijuana, México. XI Congreso Nacional Sobre VIH/SIDA, Chiapas, Nov. 27 – Dec. 1, 2009.
362. Patterson TL, Staines H, Lozada R, Strathdee SA. Prevalencia de VIH, Infecciones de
Transmisión Sexual y Perfil de Comportamiento de Riesgo entre los Clientes de las
Trabajadoras Sexuales en Tijuana, México. XI Congreso Nacional Sobre VIH/SIDA, Chiapas,
Nov. 27 – Dec. 1, 2009.
363. Martinez G, Lozada R, Vera A, Staines H, Strathdee SA. Alta Prevalencia de Infecciones de
Transmisión Sexual y Menos Conciencia sobre la Infección entre Trabajadoras Sexuales que se Inyectan Drogas en Tijuana y Ciudad Juárez. XI Congreso Nacional Sobre VIH/SIDA,
Chiapas, Nov. 27 – Dec. 1, 2009.
364. Perez A, Staines H, Lozada R, Strathdee SA, Patterson TL. Comparación de comportamientos sexuales y de uso de drogas e infe cciones de transmisión sexual entre trabajadoras sexuales en Tijuana, Ciudad Juárez, y Mexicali. XI Congreso Nacional Sobre VIH/SIDA, Chiapas, Nov.
27 – Dec. 1, 2009.
365. Sirotin N, Martinez G, Lozada R, Vera A, Staines H, Strathdee SA ¿Funciona el registro de las trabajadoras sexuales ?: Comparación de las TS registradas y no registradas en Tijuana,
México. XI Congreso Nacional Sobre VIH/SIDA, Chiapas, Nov. 27 – Dec. 1, 2009.
366. Magis C. Martinez G, Lozada R, Vera A, Staines H, Strathdee SA. La Superposición de las
Epidemias de VIH y Sífilis en Poblaciones Vulnerables de la frontera de México y Estados
77

Unidos: Una Sinergia Peligrosa. XI Congreso Nacional Sobre VIH/SIDA, Chiapas, Nov. 27 –
Dec. 1, 2009.
367. Wagner KD, Pollini RA, Palinkas LA, Strathdee SA. When Qualitative and Quantitative Findings
Diverge: Reconciling Findings from Mixed-methods Research on Drug Use. Poster presentation at Harm Reduction 2010 - the International Harm Reduction Association's 21st
International Conference . Liverpool, England. April 28, 2010.
368. Wagner KD, Pollini RA, Lozada MR, Patterson TL, Ojeda VD, Brouwer KC, Vera A, Volkmann
TA, Strathdee SA (2010). Correlates of Mexico-US Drug Injection Relationships among IDUs in
Tijuana, Mexico. Poster presentation at College on Problems of Drug Dependence . Scottsdale,
Arizona. June 15, 2010.
369. Volkmann T, Shin SS, Strathdee SA, Garfein R. (2010, April) Correlates of Cross-border
Injection Drug Use among San Diego Drug Users Travelling to Tijuana, Mexico.
Poster
Presentation at the International Harm Reduction Association International Conference
Liverpool, England.
370. *Volkmann T, Lozada R, Anderson CM, Patterson TL, Vera A, Strathdee SA. (2010, April)
Combined Effects of Police Practices on Drug-related Harms in Tijuana, Mexico. Oral
Presentation at the International Harm Reduction Association International Conference
Liverpool, England.
371. *Todd C, Nasir A, Stanekzai MR, Rasuli MZ, Fiekert K, Orr M, Strathdee SA, Vlahov D.
Hepatitis C and HIV incidence among injecting drug users in Kabul, Afghanistan. XVIII
International AIDS Conference, Vienna, Austria, July 19, 2010.
372. Stockman JK, Martinez G, Lozada R, Patterson TL, Ulibarri MD, Vera A, Strathdee SA.
Prevalence of use, mis-use and correlates of female condom use among female sex workers who inject drugs. XVIII International AIDS Conference, Vienna, Austria, July 20, 2010.
373. Schilder AJ, Palmer A, Orchard TR, Kantors S, O’Brien N , Michelow W, Patterson TL,
Strathdee SA, Montaner JSG, Moore D, Hogg RS, Vanguard Study.
HIV-positive men who have sex with men reporting a high frequency of sex and unprotected insertive anal intercourse are independently associated with high rates of HIV resistance in Vancouver, Canada. XVIII
International AIDS Conference, Vienna, Austria, July 20, 2010.
374. *Malta M, Furtado Passos da Silva CM, Mendes Pereira GF, Alves de Sousa AI, Bastos FI,
Strathdee SA. Survival benefit of universal HAART access in Brazil: a ten-year nation-wide comparison. XVIII International AIDS Conference, Vienna, Austria, July 20, 2010.
375. *Strathdee SA. HIV and the risk environment among people who inject drugs: past, present, and projections for the future. XVIII International AIDS Conference, Vienna, Austria, July 20, 2010.
376. Pollini RA, Lozada R, Abramovitz D, Vera A, Magis-Rodriguez C, Strathdee SA. Environmental factors increase mortality risk among injection drug users in Tijuana, Mexico. XVIII International
AIDS Conference, Vienna, Austria, July 20, 2010.
377. Strathdee SA, Lozada R, Vera A, Pollini RA, Rusch ML, Abramovitz D, Magis-Rodriguez C.
Predictors of HIV serconversion among injection drug users in Tijuana, Mexico. XVIII
International AIDS Conference, Vienna, Austria, July 20, 2010.
378. Nasir A, Todd C, Stanekzai MR, Rasuli MZ, Fiekert K, Orr M, Vlahov D, Strathdee SA.
Prevalence of HIV, syphilis, and hepatitis B and C among injection drug users in Kabul,
Afghanistan: baseline assessment for a prospective cohort. XVIII International AIDS
Conference, Vienna, Austria, July 20, 2010.
379. Brouwer KC, Rusch ML, Weeks JR, Lozada R, Vera A, Magis-Rodriguez C, Strathdee SA.
Spatial epidemiology of HIV among injection drug users in Tijuana, Mexico. XVIII International
AIDS Conference, Vienna, Austria, July 20, 2010.
380. Strathdee SA, Staines-Orozco H, Lozada R, Vera A, Martinez G, Rusch ML, Nguyen L, Pollini
RA, Uribe-Salas F, Pat terson TL. ‘It’s the devil you know or the devil you don’t: structural drivers of HIV infection among female sex workers who inject drugs. XVIII International AIDS
Conference, Vienna, Austria, July 20, 2010.
381. Schilder AJ, Orchard TR, Chan K, Michelow W, Patterson TL, Strathdee SA, Montaner JSG,
Moore D, Hogg RS, Vanguard Study. Childhood violence is an independent predictor of HIV serconversion in a cohort of young men who have sex with men in Vancouver, Canada. XVIII
International AIDS Conference, Vienna, Austria, July 20, 2010.
78

382. Stockman JK, Lozada R, Zu ñiga ML, Ulibarri MD, Rusch ML, Vera A, Patterson TL, Strathdee
SA. Condom negotiation at a heavy price: violence experienced by female sex workers who inject drugs in the context of condom use negotiation. XVIII International AIDS Conference,
Vienna, Austria, July 20, 2010.
383. Rusch ML, Strathdee SA, Tyndall MW, Fox A, Montaner JSG, Shannon K. Mapping the heterogeneity of HIV risks by mobility: patterns of drug use, violence and public sex work among female sex workers. XVIII International AIDS Conference, Vienna, Austria, July 20, 2010.
384. Rusch ML, Brouwer KC, Lozada R, Vera A, Magis-Rodriguez C, Strathdee SA. Intersecting epidemics: spatial patterns of HIV, syphilis infection and methamphetamine use among injection drug users in Tijuana, Mexico. XVIII International AIDS Conference, Vienna, Austria, July 20,
2010.
385. Goldenberg S, Strathdee SA , Gallardo M, Rhodes T, Wagner K, Patterson TL. “Over here, it’s just drugs, women, and all the madness”: the HIV risk environment of clients of female sex workers in Tijuana. XVIII International AIDS Conference, Vienna, Austria, July 20, 2010.
386. Burgos JL, Gaebler JA, Strathdee SA, Lozada R, Staines-Orozco H, Patterson TL. Costeffectiveness of a brief behavioral intervention to reduce HIV/STI incidence and promote condom use among female sex workers in the Mexico-US border region. XVIII International
AIDS Conference, Vienna, Austria, July 20, 2010.
387. *Patterson TL, Gallardo M, Anderson C, Semple SJ, Goldenberg S, Strathdee SA.
Deconstructing the HIV transmission bridge: which male clients are having unprotected sex with female sex workers and with their wives? XVIII International AIDS Conference, Vienna, Austria,
July 21, 2010.
388. Patterson TL, Gallardo M, Goldenberg S, Artamonova I, Semple SJ, Robertson A, Strathdee
SA. Sex under the influence: HIV risks among male clients frequenting female sex workers in
Tijuana, Mexico when one or both partners are high during sex. XVIII International AIDS
Conference, Vienna, Austria, July 21, 2010.
389. Zuñiga ML, Blanco E, Kozo J, Pachter LM, Scolari R, Strathdee SA. Changing the récipe: patient-initiated changes to antiretroviral therapy regimens among Latinos living in the U.S.-
Mexico border region. XVIII International AIDS Conference, Vienna, Austria, July 21, 2010.
390. *Booth R, Dvoryak S, Anderson C, John B, Strathdee SA. Police brutality is independently associated with sharing injection equipment among injection drug users in Odessa, Ukraine.
XVIII International AIDS Conference, Vienna, Austria, July 22, 2010.
391. *Strathdee SA. Epidemiology, trends and drivers. XVIII International AIDS Conference, Vienna,
Austria, July 22, 2010.
392. Goldenberg S, Strathdee SA, Nguyen L, Gallardo M, Semple SJ, Patterson TL. Location, location, location: how important are venue-based HIV risks among clients of female sex workers? XVIII International AIDS Conference, Vienna, Austria, July 22, 2010.
393. Patterson TL, Strathdee SA
, Semple S, Limón SAB, Rangel G. Correlates of unprotected anal intercourse among men having sex with men in Tijuana, Mexico. 6 th IAS Conference on HIV
Pathogenesis, Treatment and Prevention, Rome, Italy, 2010. Abstract number A-361-0203-
02207.
394. Strathdee SA, Lozada R, Martinez G, Rangel G, Staines H, Abramovitz D, *Vera A, Magis-
Rodriguez C, Patterson T Muje r Mas Segura (“More Healthy Women”): Preliminary Findings from a Behavioral Intervention to Reduce HIV/STI Incidence among Female Sex Workers who
Inject Drugs in Two Mexico-US Border Cities. 6th IAS Conference on HIV Pathogenesis,
Treatment and Prevention, Rome, Italy, July 2011. Abstract number A-361-0176-02235.
395. Strathdee SA, Lozada R, Martinez G, Rangel G, Staines H, Abramovitz D, *Vera A, Magis-
Rodriguez C, Patterson T, Proyecto Mujer Mas Segura.Efficacy of Combined Sexual and Injection
Risk Reduction Interventions for Female Sex Workers on the Mexico-US Border: Differential
Effects in the Presence of a Community-wide Structual Interverntion. International AIDS
Conference, 2012.
396. Werb D, Vera A, Arredondo J, Beletsky L, Gonzalez-Zuniga P, Strathdee SA, Gaines T.
Approaches to improving adherence to prevention interventions. International AIDS Conference
July 21 2014.
79

397. Strathdee, SA. The Critical Partnership for HIV Prevention: Building Positive Relationships with
Police to Support Civil Cociety and HIV Programmes. Community Skills Development Workshop.
International AIDS Conference, July 21 2014.
398. Strathdee, SA. HIV, Drugs, and the Legal Environment. International AIDS Conference, July 21
2014.
399. Patterson TL, Abramovitz CV, Chavarin SJ, Semple GA, Aarons DV, Mendoza SA, Strathdee SA.
STI/HIV prevalence in 13 Mexican cities: relationship to municipal-level characteristics.
International AIDS Conference, July 21 2014.
400. Manian S, Staines H, Patterson T, Strathdee SA. The effect of Mexico’s drug was on consistent condom use among female sex workers who inject drugs: a quantitative analysis. International
AIDS Conference, July 22 2014.
401. Robertson AM, Rangel G, Martinez G, Ulibarri MD, Syvertsen JL, Bazzi SA, Roesch S, Pines HA,
Strathdee SA. Incidence and predictors of HIV and sexually transmitted infections among high risk heterosexual couples in Northern Mexico: a prospective, multilevel study. International AIDS
Conference, July 22 2014.
402. Strathdee, SA. The global epidemiology of HIV among female sex workers: structural determinants. International AIDS Conference, July 22 2014.
403. Strathdee, SA. Operationalising the enabling environment. International AIDS Conference, July 23
2014.
404. Mehta S, Brouwer K, Strathdee SA, Patterson T, Vargas M, Rangel G, Smith D. HIV transmission dynamics in Tijuana, Mexico: isolated clusters suggest multiple new sources of viral introductions.
International AIDS Conference, July 23 2014.
405. Strathdee SA, Abramovitz D, Patterson TL, Conzalez-Zuniga, P, Garfein RS, Magis-Rodriguez C.
Predictors of HIV infection among people who inject drugs (PWID) in Tijuana, Mexico. International
AIDS Conference, July 24 2014.
*mentee
I NVITED P RESENTATIONS (Total: 119)
1. Strathdee SA. Ontario graduate students in Epidemiology Conference, Queen’s University; Kingston,
Ontario, 1989. The reliability of an assay for 2-5A synthetase.
2. Strathdee SA. University of British Columbia, Department of Health Care and Epidemiology, June,
1993, Vancouver, B.C. Quantitative measures of HIV-specific antibodies as predictors of progression to AIDS, 1993.
3. Strathdee SA, Schechter MT. 7th Annual Conference on AIDS in British Columbia, October 1993;
Vancouver, B.C. Update on the epidemiology of HIV/AIDS in Canada.
4. Strathdee SA, Schechter MT, Montaner JSG, O’Shaughnessy MV. Second Annual Meeting of
HIV/AIDS Surveillance and Epidemiology, November 1993, Ottawa. Building an HIV knowledge base in British Columbia.
5. Strathdee SA, Schechter MT. Health Conference 1993, November, 1993; Vancouver, B.C. The epidemiology of HIV/AIDS in Canada.
6. Strathdee SA. 3rd Annual Meeting on HIV Surveillance and Epidemiology, Ottawa, November, 1994.
Estimating the number of HIV-infected persons in British Columbia.
7. Rothon D, Strathdee SA, Schechter MT. 8th Annual British Columbia AIDS Conference, Vancouver,
November 6, 1994. HIV prevalence among young offenders in British Columbia.
8. Strathdee SA, Hogg RS, Craib KJP, O’Shaughnessy MV, Montaner JSG, Schechter MT. 8th Annual
British Columbia AIDS Conference, Vancouver, November 6, 1994. Long-term survivors: An overview of the literature.
80

9. Strathdee SA, Hogg RS, Craib KJP, O’Shaughnessy MV, Montaner JSG, Schechter MT. 8th Annual
British Columbia AIDS Conference, Vancouver, November 6, 1994. Socioeconomic determinants of
HIV disease progression.
10. Strathdee SA, Suthe rland D, Schechter MT, Hogg RS, Le TN, O’Shaughnessy MV, Montaner JSG.
Interdisciplinary AIDS Care Rounds, St Paul’s Hospital, Vancouver, September, 1994. The changing spectrum of AIDS index diseases in Canada.
11. Strathdee SA. The epidemiology of HIV/AIDS in women: An overview. Women and HIV National
Workshop, Montreal, March 1995.
12. Strathdee SA. The epidemiology of AIDS in Canada. 3rd Annual Conference of the Canadian
Association of Nurses in AIDS Care, Vancouver, April 1995.
13. Harvey E, Ofner M, Strathdee SA, Eades G, Patrick D, Archibald C, O’Shaughnessy MV. 7th Social
Work Symposium, School of Social Work, University of British Columbia, Vancouver, May 1995.
Qualitative research investigating an HIV outbreak among Injecting drug users in B.C.
14. Strathdee SA. HIV behind bars: Incarcerated women and youth at risk for HIV infection. 3rd Annual
Conference on Women, Youth and HIV, Vancouver, September 1995.
15. Hogg RS, Schechter MT, Craib KJP, Strathdee SA, Montaner JSG, O’Shaughnessy MV. 9th Annual
B.C. AIDS Conference, Vancouver, November 6, 1995. HIV/AIDS mortality in Canada: Evidence for gender and regional differences.
16. Hogg RS, Raboud J, Strathdee SA, Craib KJP, O’Shaughnessy MV, Montaner JSG, Schechter MT.
9th Annual B.C. AIDS Conference, Vancouver, November 6, 1995. The changing spectrum of hospital visits with an HIV/AIDS diagnosis in Canada, 1987-1991.
17. Harvey E, Ofner M, Strathdee SA, Eades G, Patrick D, Archibald C, O’Shaughnessy MV.9th Annual
B.C. AIDS Conference, Vancouver, November 6, 1995. Qualitative research investigating an HIV outbreak among Injecting drug users in British Columbia.
18. Rothon DA, Strathdee SA, Cook D, Cornelisse PGA. 9th Annual B.C. AIDS Conference, Vancouver,
November 1995. Determinants of high risk behaviors for HIV infection among young offenders in
British Columbia detention centers.
19. Eades G, Strathdee SA, Patrick D, Ofner M, Archibald C, Harvey E, O’Shaughnessy MV.9th Annual
B.C. AIDS Conference, Vancouver, November 6, 1995. Strategies for development of communitybased research initiatives with Injecting drug users.
20. Strathdee SA, Martindale S, Craib KJP, Hogg RS, Montaner JSG, O’Shaughnessy MV, Schechter
MT.9th Annual B.C. AIDS Conference, Vancouver, November 6, 1995. The Vanguard Project:
Update on an HIV seroincidence cohort in young gay men.
21.
Strathdee SA, Craib KJP, Hogg RS, O’Shaughnessy MV, Montaner JSG, Schechter MT. Long-term nonprogression among a cohort of HIV-infected homosexual men. International Workshop on Long-
Term Nonprogression in HIV Infection, London, November 25, 1995.
22. Strathdee SA, Craib KJP, Schechter MT, Kaldor JM, Cooper DA, Veugelers PJ, Keet IPM, Coutinho
RA, van Griensven GJP, Moss AR, Page-Shafer KA, Winkelstein W Jr. Definitions and proportions of non-progression: The Tricontinental Seroconverter Study. International Workshop on Long-Term
Nonprogression in HIV Infection, London, November 25, 1995.
23. Strathdee SA, Craib KJP, Schechter MT, Kaldor JM, Cooper DA, Veugelers PJ, Keet IPM, Coutinho
RA, van Griensven GJP, Moss AR, Page-Shafer KA, Winkelstein W Jr. Definitions and proportions of non-progression: The Tricontinental Seroconverter Study. 16th International AIDS Conference,
Toronto, August 13-18, 2006.
24. Strathdee SA, Craib KJP, Hogg RS, O’Shaughnessy MV, Montaner JSG, Schechter MT. Long-term nonprogression among a cohort of HIV-infected homosexual men. International Workshop on Long-
Term Nonprogression in HIV Infection, London, November 25, 1995.
25. Archibald C, Strathdee SA,Patrick D, Ofner M, Eades G, Rekart M, O’Shaughnessy MV. An outbreak investigation of HIV infection among Injecting drug users in Vancouver. 4th Annual HIV
Serosurveillance Meeting, Banff, December 4, 1995.
26. Strathdee SA, Martindale S, Craib KJP, Hogg RS, Montaner JSG, O’Shaughnessy MV, Schechter
MT. The Vanguard Project: Update on an HIV seroincidence cohort in young gay men. 4th Annual
HIV Serosurveillance Meeting, Banff, December 4, 1995.
27. Strathdee SA. Overview of the effectiveness of needle exchange programs. Advisory Group on Harm
Reduction in B.C. Prisons, Victoria, January 22, 1996.
81

28. Strathdee SA. Update on HIV epidemiology. Family Practice Residency Program, St. Paul’s Hospital,
Vancouver, March 5, 1996.
29. Strathdee SA. Behavior change after an HIV –positive test: A look at yesterday, today, and tomorrow. Standing Industry Advisory Group on Blood Issues, Vancouver, March 21, 1996.
30. Strathdee SA. Hogg RS, Hanvelt R. Evaluating HIV/AIDS prevention programs in Canada: Where do we go from here? Research Priorities Workshop of the Canadian Policy Research Networks Inc. and the AIDS Education and Prevention Unit, Health Canada, Vancouver, March 1996.
31. Strathdee SA. Overview of the Vancouver Lymphadenopathy-AIDS Study. Biochemistry Rounds,
University of British Columbia, July 28, 1996.
32. Strathdee, SA. Social Determinants Related to HIV Infection and Progression to AIDS. Presented to the House of Commons, Subcommittee on AIDS, November 5, 1996.
33. Strathdee, SA. HIV Hits the Streets: An Overview of HIV Infection among Injecting drug users in
Canada. Grand Rounds in Medicine, Lionsgate Hospital, November 12, 1996.
34. Strathdee, SA. Open Cohort Investigation into the Determinants of Transmission of HIV among injecting drug users and into the Efficacy of Interventions. Determinants of HIV-Related Risk
Behavior. Government Conference Center, Ottawa, November 25, 1996.
35. Strathdee, SA. The Epidemiology of HIV Infection among injecting drug users and Prisoners in
Canada. British Columbia Ministry of Corrections Health Care Workshop May 6, 1997.
36. Strathdee, SA. Trends in HIV/AIDS Epidemiology in British Columbia: Implications for Care.
Vancouver Strategic Plan Forum for HIV/AIDS Care. June 10, 1997.
37. Strathdee, SA. High HIV Prevalence and Incidence in injecting drug users Despite Needle
Exchange: The Vancouver Experience. Residency Rounds in Community Health, University of
British Columbia. April 5, 1997.
38. Strathdee, SA. HIV Prevalence, Incidence and Risk Behaviors Among a Cohort of Young
Gay/Bisexual Men. Northwest Regional Workshop, Seattle, September 3 - 5, 1997.
39. Miller ML, Strathdee SA, Martindale S, Cornelisse PG. Hogg RS, Cook D, Montaner JSG,
O’Shaughnessy MV, Schechter MT. Boystown: The Male Sex Trade. 10th Annual BC Conference on AIDS, Vancouver, October, 1997.
40. Martindale S, Strathdee SA, Hogg RS, Cornelisse PG, Devlin B, Miller ML, Montaner JSG,
O’Shaughnessy MV, Schechter MT. Men Who Have Sex with Men: Critical Points of Crisis. 10th
Annual BC Conference on AIDS, Vancouver, October, 1997.
41. Hankins C, Myers T, Strathdee SA, Schilder A, Nguyen M, McLeod A. Community-Based Research.
10th Annual BC Conference on AIDS, Vancouver, October, 1997.
42. Strathdee SA. Men Who Have Sex with Men: Is Prevention Moving Forward? 10th Annual BC
Conference on AIDS, Vancouver, October, 1997.
43. Strathdee SA, Woodfall B. High HIV Incidence and Relapse to Unsafe Sex Among Young Gay Men in Vancouver. 5th Annual HIV Serosurveillance Meeting, Health Canada, Quebec City, Nov 22-24,
1997.
44. Strathdee SA, Schechter MT. Trends in HIV Incidence among Injecting drug users in Vancouver.
5th Annual HIV Serosurveillance Meeting, Health Canada, Quebec City, Nov 22-24, 1997.
45. Strathdee SA. HIV Prevalence, Incidence + Risk Behaviors among Young Gay Men in Vancouver.
8th Annual Conference on HIV/AIDS for Practical Approaches for Health Care, Toronto, Dec 4-5,
1997.
46. Strathdee SA. HIV Outbreak among Injecting drug users in Vancouver. 8th Annual Conference on
HIV/AIDS Practical Approaches for Health Care, Toronto, Dec 4-5, 1997.
47. Strathdee SA. Overview of the HIV epidemic among Injecting drug users in British Columbia.
Washington State Department of Health, Mar 2, 1998.
48. Strathdee SA. Barriers to receiving HIV antiretroviral therapies among Injecting drug users. British
Columbia First Nations AIDS Society 2nd Annual Aboriginal HIV/AIDS Conference, Prince George,
BC, March 12-14, 1998.
49. Strathdee SA. The eye of the storm: The role of needle exchange in preventing HIV transmission.
British Columbia First Nations AIDS Society 2nd Annual Aboriginal HIV/AIDS Conference, Prince
George, BC, March 12-14, 1998.
50. Strathdee SA. What is to be done about drugs and AIDS? Community Workshop, Vancouver, April
9, 1998.
82

51. Strathdee SA. The Vancouver Study: Data Interpretation. HIV Prevention Strategies for injecting drug users, Nordic Hills Conference Center, April 27, 1999.
52. Strathdee SA. Behavior Change and Harm Reduction. HIV Prevention Strategies for Injection Drug
Users, Nordic Hills Conference Center, April 27, 1999.
53. Strathdee SA. Harm Reduction: Needle Exchange and Alternative Approaches. HIV/AIDS – A
Communicable Disease in Evolution Symposium, September 15, 1999.
54. Strathdee SA, Kumas MS, Mani VS, Singh RA. Case Studies: Drug Abuse Prevention/Treatment
Intervention in India. Building International Research on Drug Abuse: Drug Abuse Treatment in the
New Millennium. NIDA International Symposium, San Juan, Puerto Rico. June 15-17, 2000.
55. Strathdee SA. HIV Prevention among Drug Users: New Strategies and Best Practices. 3rd
International HIV Prevention Works Symposium. Durban, South Africa. July 7, 2000.
56. Strathdee SA. Building International Research on Drug Abuse: Drug Abuse Treatment in the New
Millennium. Case Studies: Drug Abuse Prevention/Treatment Interventions in India. El Caribe
Hilton, San Juan, Puerto Rico, June 15-17, 2000.
57. Strathdee SA. Role of harm reduction in the war against the HCV epidemic. HCV Research and
Prevention. HV Global Foundation – 4th International HCV Conference. San Francisco, August 10-
13, 2000.
58. Strathdee SA. Innovative outreach and engagement strategies. 2000 Conference on Addictions,
Effective Addiction Treatment: How Treatment works in the healthcare, social service and criminal justice systems. Hunt Valley, MD, October 19, 2000.
59. Strathdee SA. HIV Epidemiology among injecting drug users. Rounds, Pediatric Gastroenterology.
Johns Hopkins Hospital, Baltimore, November 20, 2000.
60. Strathdee SA. Needle Exchange as a Bridge to Drug Treatment. Grand Rounds, Addiction Medicine.
Johns Hopkins Bayview Medical Campus, Baltimore, November 28, 2000.
61. Strathdee SA. National health research development program (NHRDP), health policy research nexxus. Retrospective of an NHRDP research career. Queen’s University, Kingston, Ontario,
December 1, 2000.
62. Strathdee SA. Needle Exchange Programs in the 21st Century: Creating a Climate for Social
Change. International Conference on the Reduction of Drug Related Harm, New Delhi, India, April 2,
2001 (plenary presentation).
63. Strathdee SA. Innovative strategies to improve access to drug abuse treatment in Baltimore. Greater
Baltimore Committee, Baltimore MD, May 21, 2001.
64. Strathdee SA. Recruiting and retaining high risk individuals in prospective studies, HIV vaccine trial networks. Phase III Planning Committee Meeting, Washington, May 9, 2001.
65. Strathdee SA. Sexual transmission of HIV infection among Injecting drug users and non-Injecting drug users. International Conference on AIDS in Asia and the Pacific, Melbourne, Australia, October
8, 2001.
66. Strathdee SA. Interventions to reduce HIV transmission among drug users in countries with
Generalized Epidemic. Global Research Network Meeting on HIV Infection among injecting drug users, Melbourne, Australia, October 11, 2001.
67. Strathdee SA. The role of needle exchange programs in the prevention of blood borne infections:
Where science and politics collide. Center for Epidemiology and Policy Lecture, Bloomberg School of Public Health, Baltimore, November 12, 2001.
68. Strathdee SA. Project ACCESS: Improving access to care for HIV-infected disadvantaged persons.
Association for Baltimore Area Grant holders, Baltimore, Nov 27, 2001.
69. Strathdee SA. Sexual transmission of HIV among drug users: Does it really matter? Urban Health
Conference, Vancouver, January 19, 2002.
70. Strathdee SA. From mountains to molehills: Science and the politics of needle exchange programs in America. RAND Research Institute, Grant Hill Drug Policy Research Center, Los Angeles, April 9,
2002.
71. Strathdee SA. Expanding drug treatment options in Baltimore City. Greater Baltimore Leadership
Committee Health Fair, Baltimore, April 22, 2002.
72. Strathdee SA. HIV/AIDS among Injecting drug users in America: Raising the Titanic. Associated
Black Charities, Baltimore, June 5, 2002.
83

73. Strathdee SA. The role of injection drug use in creating generalized HIV epidemics. Global Research
Network on HIV Prevention in Drug-using Populations: HIV and Drug Use - The Global Situation,
14th International AIDS Conference Barcelona, July 7, 2002 [Discussant].
74. Strathdee SA. The role of injection drug users in generalized HIV epidemics, XIV International AIDS
Conference, Barcelona, July 7, 2002 [Discussant].
75. Strathdee SA. Estimating coverage of needle exchange programs. UNAIDS, Vienna, Austria, July 5,
2002.
76. Strathdee SA. The effectiveness of needle exchange programs in reducing the risk of blood-borne infections. First International Conference on Inner City Health, Toronto, Ontario, October 3-6, 2002.
77. Strathdee SA. The role of HIV infection among injecting drug users and non-injecting drug users.
National Institute of Health, National Institute on Drug Abuse: HIV Acquisition and Transmission:
Future research strategies. Washington, October 10-11, 2002.
78. Strathdee SA. Barriers to prevention and care of blood-borne infections among injecting drug users.
Association of Behavioral Medicine Research, Lake Tahoe, California, June 5, 2003.
79. Strathdee SA. Epidemiology studies of HIV and HCV among injecting drug users. Center for
Behavioral Epidemiology and Community Health, San Diego State University; San Diego, May 10,
2004.
80. Strathdee SA. Making Lemonade from Lemons: My Career Path. Women in Science and
Engineering, UCSD, Feb, 2005.
81. Strathdee SA. When HIV Interventions Have Unintended Consequences. (Keynote address). AIDS
Impact Meeting, Capetown, South Africa, April, 2005.
82. Strathdee SA. Epidemiology of HIV among High Risk Populations in Two Mexican-US border cities.
UCSD Antiviral Research Center Grand Rounds, May 20, 2005.
83. Strathdee SA. When Science and Policy Collide: The Story of Needle Exchange Programs toPrevent HIV/AIDS. UCSD Science Policy Analysis Roundtable, July 14, 2005.
84. Strathdee SA. Epidemiologic Studies on Populations at High Risk of HIV Infection in Mexico. UCSD
Summer Research Program, July 20, 2005.
85. Strathdee SA. Drug trends in San Diego. BEWG, San Antonio, TX, September 14, 2005.
86. Strathdee SA. Understanding Injection Drug Use as a Vector of HIV Transmission in India. US-Indo
Working Group on HIV and Drug Abuse in Northeast India, October 25, 2005.
87. Strathdee SA. UCSD Student Trainees in HIV/AIDS US-Mexico Border Study. UCSD International
Education Week, November 15, 2005.
88. Strathdee SA. Women at the Forefront of HIV/AIDS Research in Canada: Their Successes,
Challenges, and Lessons Learned. Keynote Address, Ontario HIV Treatment Network Annual
Research Day, November 25, 2005.
89. Strathdee SA. HIV among Drug Users in International Settings: Mature Epidemics, Emerging
Epidemics, and Countries at Risk. NIDA Press Conference, Nov 29, 2005.
90. Strathdee SA. HIV/AIDS Research and training experiences in Mexican-US border cities. IFMSA-
USA National Convention, San Diego, January 14, 2005.
91. Stratheee SA, Pollini RA. Drug trends in San Diego County. Phoenix, January 18, 2006.
92. Strathdee SA. Epidemiology of HIV/AIDS among Drug Users in Northwestern Mexico. California
Office of AIDS, Sacramento, May 17, 2006.
93. Strathdee SA. A Cross-border HIV Prevention Training Program in the Northwestern Mexico-US
Border Region. Higher Education and Development Conference, Washington, August 9, 2006.
94. Strathdee SA. HIV and Substance Abuse in the US-Mexico Border Region. Annual Meeting of the
National Hispanic Substance Abuse Network, Scottsdale, September 14-16, 2006.
95. Strathdee SA. Opiate Substitution Therapy as HIV Prevention: A Public Health Perceptive. National
Meeting of Mexican HIV/AIDS Coordinators and Drug Abuse Treatment Coordinators, Tijuana,
October 5, 2006.
96. Strathdee SA. Efficacy of a Behavioral Intervention to Reduce Transmission Risks and Facilitate
Access to Care for HCV-infected Injecting drug users in Three US Cities. British Columbia Center for Excellence in HIV/AIDS Speaker Series, November 1, 2006.
97. Strathdee SA. Efficacy of a Behavioral Intervention to Reduce Transmission Risks and Facilitate
Access to Care for HCV-infected Injecting drug users in Three US Cities. Institute of Public Health
(ICDDRB), Dhaka, Bangladesh, December 11, 2006.
84

98. Strathdee SA. Mapping Drug Trafficking Routes and HIV Subtypes: Lessons from Southeast and
Central Asia. Annual AAAG meeting, San Francisco, May 19, 2007.
99. Strathdee SA. Utilization and Adherence to Antiretroviral Therapies among HIV+ Drug Users. Office of AIDS Research, Meeting on HIV in the Middle East and North Africa. Tunis, Tunisia, May 1-4,
2007.
100. Strathdee SA. Update on HIV among Drug Users in Domestic and International Settings. (Plenary address). National Institute on Drug Abuse, May 8, 2007.
101. Strathdee SA. Efficacy of a behavioral intervention to reduce transmission risks and facilitate assess to care for HIV-infected injecting drug users in Three US Cities. Annual Meeting on Toxomania,
Hepatitis, and AIDS, Biarritz, France, October 25, 2007.
102. Strathdee SA. Studies on HIV/AIDS in the Mexico-US border Region. Joint Seminar with the UCSD division of International Health and Cross Cultural Medicine and El Colegio de la Frontera Norte.
January 30 2008.
103. Strathdee SA. Mexico's Evolving HIV Epidemic: A Horse Already out of the Barn? British Columbia
Center for Excellence in HIV/AIDS, Vancouver, BC, February 13, 2008.
104. Strathdee SA. and Harrison G. Development of a University of California School-Wide Program in
Global Health. Fogarty International Center, Washington, D.C. May 16, 2008.
105. Strathdee SA. A Global Health Framework Partnership between the University of California San
Diego and San Diego State University. Fogarty International Center, Washington, D.C. May 16,
2008.
106. Strathdee SA. Epidemiologic studies of HIV, TB and HCV in No Man’s Land. Management of TB,
STDs, HIV, Hepatitis C and Substance Abuse at the Border. UCLA Border Health Education
Collaborative. San Ysidro, CA, June 6-7, 2008.
107. Strath dee SA. HIV Prevention Research in No Man’s Land: Highlights from a Cross-Border
Research and Training Program on the Mexico-US Border. NIDA Tutorial Workshop. San Juan,
Puerto Rico, June 14, 2008.
108. Strathdee SA. The Migration of HIV/AIDS: Reporting the Human Side from Both Sides of the US-
Mexico Border. San Diego, CA Aug 9-11, 2008.
109. Strathdee SA. Public Health Implications of Emerging Trends in Drug Use on the US-Mexico Border.
Annual APHA Meeting & Exposition. San Diego, CA Oct 25-29, 2008 [Discussant].
110. Strathdee SA. The UCSD/SDSU Joint Doctoral Program in Public Health: Global Health
Concentration. UC-wide Workshop on Pandemic Infectious Diseases. Oct 8, 2008.
111. Strathdee SA. Universities Without Walls 2009. Summer Learning Institute on Interdisciplinary
HIV/AIDS Research in Canada. Toronto, Canada July 15, 2009.
112. Strathdee SA. Moderator. HIV Treatment as Prevention Workshop, BC Center for Excellence in
HIV/AIDS, April 2011.
113. Strathdee SA. Discussant, AAAS Annual Meeting, Vancouver, British Columbia. February 19, 2012
114. Strathdee SA. How Lessons from the Global South can Inform the National AIDS Strategy. Society for Prevention Research, May 30, 2013.
115. Strathdee SA. Have We Come a Long Way Baby? Reflections on HIV Prevention among Women
Substance Users across the Globe. InWomen’s Confernce, June 14, 2013.
116. Strathdee SA, Beletsky L and Kerr, T. HIV, Drugs and the Legal Environment. Invited Presentation,
United Nations Office on Drug Control Policy, March 11, 2014.
117. Strathdee SA. Reproductive Health Needs of Vulnerable Women on the Mexico-US Border
Region. Center for Gender Equity and Health Colloquiam, March 19, 2014.
118. Strathdee SA. Border Stories: A Binational Research and Training Program on the Mexico-US
Border. Horizons of Global Health Conference, UCSD, May 30, 2014.
119. Strathdee SA. A Binational Research and Training Program on the Mexico-US Border. Border
Infectious Disease Conference, El Paso, TX, June 11, 2014.
V ISITING L ECTURER
2014 University of New South Wales, Australia (Brett Tindall Memorial Lecture), July 19
2014 University of Washington, Department of Global Health, April 19
2013 University of California, San Francisco, Dept of Medicine, May 29
85

2013 University of California, Berkeley, School of Public Health, Apr 18
2012 New York University, School of Nursing, March 13
2012 University of North Carolina, Center for AIDS Research, March 2
2011 University of Southern California, Center on Global Health, Sept 10
2011 University of Washington, Center for AIDS Research, March 22
2008 University of California, Los Angeles, Dept. of Epidemiology, Oct 10
2008 University of California, Los Angeles, Dept. of Epidemiology, April 24
2006 University of British Columbia, Dept. of Health Care and Epidemiology, October 12
2006 University of California, San Francisco, Center for AIDS Prevention Studies, March 24
2005 Universidad Autonoma de Baja California School of Medicine, June 16
2003 National Institute on Development Research, New York City, Nov 14
2003 University of California, Los Angeles, School of Public Health, May 23
2003 Morgan State University, Department of Public Health, Drug Abuse Research Program, March 4
2003 University of California, San Diego, Department of Family Health Sciences, January 15
2002 University of California, Los Angeles, Keynote Address, CHIPTS Conference, April 10
2000 Municipal Health Service, Amsterdam, Dec 19
1999 Maryland Association of County Health Officers, Baltimore, September 15
1999 Universite Laval, Department of Epidemiology, Quebec City, June 21
1998 University of Illinois at Chicago, School of Public Health, Chicago, February
1997 Johns Hopkins University, School of Hygiene and Public Health, Baltimore, September 26
1997 Rollins School of Public Health, Emory University, Atlanta, March 6
1997 U.S. Centers for Disease Control and Prevention, Atlanta, March 5
1996 Municipal Health Service, Amsterdam, December 17
1995 Post-doctoral fellow, University of Amsterdam, September-November
LANGUAGES: French (conversational, written and spoken)
86